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Hypoestoxide is a novel diterpenoid isolated from a tropical shrub, hypoestes 
rosea.  It has been shown to exhibit promising anti - cancer, malarial, and 
inflammatory activity.  In particular, the in vivo anti-angiogenic activity that inhibits 
vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) 
make it especially interesting.  Along with this biological profile, the challenging 
macrocyclic structure of hypoestoxide makes it a target of great interest to the 
synthetic community.  The synthesis of this molecule’s complex macrocyclic core was 
accomplished by using relay ring closing metathesis, and post-cyclization 
modifications were controlled by the shape of the molecule. 
 Platensimycin is a recently isolated natural product produced by Streptomyces 
platensis.  It was discovered in a novel antibiotic assay by screening a large number of 
South African soil samples.  Platensimycin has been shown to have a unique 
mechanism of action by inhibiting Fab F, an enzyme responsible for bacterial fatty 
acid synthesis.  In addition to the exciting biological activity, platensimycin has an 
intriguing molecular structure consisting of a hydrophobic and structurally compact 
core, and a hydrophilic aromatic head group.  The synthesis of this molecule relied on 
a novel vinyl oxirane ring expansion to access the oxa-bicyclic moiety and an 
alkylative dearomatization to complete the carbocyclic core. 
  
 Guttiferone G belongs to the family of [3.3.1] bicyclic polyprenylated 
phloroglucinol derived natural products, which have been isolated from various plant 
species found primarily in the tropical or subtropical regions.  Their biological profiles 
have been shown to rival any known natural product class in terms of diversity and 
activity.  It is this vast biological activity and structural similarity that make the 
development of a general approach to this family of particular interest.  The common 
bicyclic core of these compounds was accessed by using an intramolecular bis-radical 
cyclization into a dienone that was itself made by oxidative dearomatization. 
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PREFACE 
 
Natural product total synthesis is an exciting area of research for many reasons.  
Organic synthesis makes it possible to assemble molecules of varying complexity in 
creative and efficient ways.  These molecules might possess interesting biological 
activity, or have a really unique and challenging structure.  Regardless, the ability to 
make complex molecules efficiently from readily available starting materials will 
always be an important accomplishment.  In addition, synthesis gives us the 
opportunity to make minor modifications to the route and generate a vast array of 
structural analogs that can be screened for their activity.  During the process of 
completing a total synthesis, obstacles may arise that require innovative thinking and 
often the design of new methods to overcome them.  It is often these methods that are 
of most use to the chemical community.  Finally, the training one receives while 
working on the total synthesis of a natural product can often be considered as valuable 
as the eventual outcome of the project.  Organic synthesis is a discipline that is central 
to all areas of chemistry and the skills attained can be applied to countless areas of 
research. 
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Chapter 1 
 
Hypoestoxide and Verticillol 
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1.1 Background and Significance 
Hypoestoxide (1.1, Scheme 1.1) was isolated from the tropical shrub hypoestes 
rosea, found in the Nigerian rain forests.1  The extracts from these shrubs have been 
used for generations in folk medicine to treat various skin rashes and infections.  
Hypoestoxide has been shown in recent studies to exhibit promising anti- cancer,2 
malarial,3 and inflammatory activity.4  Our interest stems primarily from encouraging 
anti-angiogenic activities, in which hypoestoxide was shown to inhibit the growth of a 
number of human and murine tumor cell lines in vivo.  In terms of angiogenesis, 
hypoestoxide inhibited vascular endothelial growth factor (VEGF) and basic fibroblast 
growth factor (BFGF).  Hypoestoxide is a bicyclo[9.3.1]pentadecane diterpenoid 
containing a rigid “inside-outside” ring system decorated with an exocyclic enone, two 
epoxides and an acetate moiety.  This rare ring system has also been described for the 
verticillanes,5 of which verticillol (1.2)6 is the most well known.  It is tempting to 
propose that hypoestoxide, as a more oxygenated variant of verticillol, is formed from 
the same common cationic precursor (1.4) as both verticillol7 and taxol (1.3),8 which in 
turn originates from consecutive cyclizations of geranyl-geranyl pyrophosphate.  In 
the case of verticillol, the cation (1.4) is trapped with water, while for taxol and 
hypoestoxide it undergoes endocyclic and exocyclic elimination followed by 
oxygenation and cyclization.  As part of our efforts to evaluate the molecular 
mechanisms9 of promising natural product anticancer agents, we have focused our 
investigations on hypoestoxide and the verticillanes.   
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Scheme 1.1.  Proposed Biosynthetic Origin of Hypoestoxide and Verticillol 
 
1.2 Other Relevant Synthetic Work 
Although no other synthetic efforts toward hypoestoxide have been published to 
date, work has been done toward verticillol and verticillene (dehydrated verticillol) 
and these efforts will be summarized below.  Despite their complex structure and 
promising biological activity a surprisingly small number of accounts have been 
published in this area to date.   
The first synthetic work came in 1981 from the lab of Tadahiro Kato (Scheme 
1.2).10  The first key step in the synthesis involves a bio-inspired carbocation cascade 
triggered by the addition of SnCl4 to form the six-membered ring and bring together 
all of the carbons of the verticillene core (1.7).  Their plan to assemble the macrocycle 
was to deprotonate  to the sulfone in order to displace the allylic bromide to access 
the core.  Unfortunately under the conditions of the reaction, the allylic bromide 
isomerized from E to Z prior to being displaced, affording only the Z-olefin in the 
newly formed macrocycle 1.9 in rather low yield.   
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Scheme 1.2. Kato’s First Synthetic Efforts Toward Verticillene 
 
The second paper detailing work toward verticillene was published in 1990 by the 
Pattenden group (Scheme 1.3).11  This synthesis uses Stork-Danheiser chemistry to 
attach the diene chain needed for the macrocycle (1.11).  The final carbon of the 
macrocycle is then installed by formylating the silyl enol ether followed by Grignard 
addition and dehydration to afford enal 1.13.  A selective allylic oxidation with 
selenium and subsequent manganese dioxide oxidation gave the bis-aldehyde 1.15 
needed to faciliate macrocylization.  The aldehydes were reductively coupled with 
titanium trichloride and zinc copper couple to give the macrocycle.  Verticillene was 
formed by 1,4-reduction of the resulting tetraene with sodium and liquid ammonia. 
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Scheme 1.3. Pattenden’s Synthesis of Verticillene 
 
The third paper in this area was again the work of Kato and used much of the same 
chemistry as before (Scheme 1.4).12  An analogous cationic cyclization was carried out 
as before using allylic chloride 1.18 with the hope of eliminating the troublesome 
allylic scrambling that occurred in their first paper during the cyclization step.  With 
the chloride in place, the macrocyclization proceeded smoothly without any mention 
of olefin scrambling.  With this success behind them, they installed the required 
tertiary alcohol by lactonization and reduction to diol 1.21, albeit with the wrong 
tertiary alcohol stereochemistry.  Their synthesis of epiverticillol was completed by 
oxidizing the primary alcohol and deformylating using Wilkinson‘s catalyst. 
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Scheme 1.4.  Kato’s Synthesis of Epiverticillol 
 
1.3 Our Synthetic Efforts13 
  Several factors were considered before beginning our synthetic efforts.  First, 
with a trans-[9.3.1] bicyclic framework two different atropisomers are possible for 
hypoestoxide (Scheme 1.5).  We were encouraged by calculations indicating that 
hypoestoxide was 4.1 kcal/mol (B3LYP/6-311+G(d,p)) more stable than the 
atropisomer (1.22).  Therefore, we imagined that a macrocyclization would 
preferentially form the natural atropisomer.  In addition, the barrier to interconvert 
hypoestoxide and its atropisomer was estimated to be 65 kcal/mol, suggesting that 
atropisomer interconversion would not be possible. 
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Scheme 1.5.  Possible Atropisomers of Hypoestoxide 
 
Taking these observations into consideration, diene 1.23 seemed like an ideal 
target, and we decided to construct it using a conformationally controlled ring closing 
metathesis (Scheme 1.6).  This diene provided four different ring closing metathesis 
options.  The C5-C6 and C9-C10 olefins would originate from a standard mono-
substituted carbenoid or alternatively from a di-substituted carbenoid, such as 1.24, 
which would be accessed using relay ring closing metathesis (RRCM).14  Our analysis 
suggested that in closing the macrocycle it would be advantageous to bring together a 
more substituted carbene with a less hindered terminus to minimize competing 
dimerization pathways.  We further postulated that ruthenium carbene 1.24 (C5-C6 
disconnection) would be the better candidate for macrocyclization, since the 
equivalent C10-di-substituted carbene would be more sterically hindered and suffer 
from unfavorable interactions with the C12 hydroxy group.  Concurrently, we 
proposed to rigidify the macrocyclization substrate in order to bring the two olefin 
termini closer together15 and ensure formation of the correct atropisomer. Ketone 1.25 
would serve as the branch-point that would allow us at a late stage to evaluate several 
fused ring sizes.  Cyclization precursor 1.25 would be assembled from three simple 
building blocks (1.26-1.28).  Our endgame towards hypoestoxide would rely on 
substrate controlled bis-epoxidation. 
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Scheme 1.6. Retrosynthesis of Hypoestoxide 
 
Our synthetic efforts commenced with a Grignard addition to methacrolein 1.29, 
followed by a Johnson-Claisen rearrangement16 to generate ethyl ester 1.30 (Scheme 
1.7).  This ester was reduced to the aldehyde with DIBAL-H, and another Grignard 
addition afforded allylic alcohol 1.31.  We next utilized a [2,3]-rearrangement17 to 
stereoselectively install the second trisubstituted olefin.  The hydroxyacid was 
exhaustively reduced and the resulting diol was cleaved with lead tetraacetate to give 
aldehyde 1.28.  The other key component, enone 1.32, was readily assembled by 
employing the Stork-Danheiser methodology.18   This enone was then subjected to a 
conjugate addition and in situ trapping to form the trimethylsilyl enol ether19 needed to 
couple with aldehyde 1.28.  It was determined that the addition of ZnCl220 was required 
to promote the desired aldol reaction to form tetraene 1.33 with the desired trans 
arrangement21 on the six-membered ring.  This route efficiently assembled the versatile 
synthetic intermediate 1.33 in only 10 steps from methacrolein. 
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Scheme 1.7. Synthesis of Metathesis Precursor 
 
Encouraged by the rapid assembly of metathesis precursor 1.33, we decided to 
evaluate 5- and 7-membered ring tethers.  Accordingly, we converted ketone 1.33 to 
an enol triflate and deprotected the silyl ether to give 1.34 (Scheme 1.8).  The 5-
membered ring tether was accessed via carbonylation22 of 1.34 to give the lactone, 
however, this lactone and its reduced variants (1,4 and 1,2-reductions) failed to 
undergo ring closing metathesis.  The 7-membered ring series was accessed by 
reducing the lactone to diol 1.35 and tethering the two hydroxyl groups with 
triphosgene to give carbonate 1.36.  This carbonate turned out to be an ideal 
macrocyclization substrate.  Optimized conditions using Grubbs second generation 
catalyst23 in refluxing toluene afforded bicyclic substrate 1.37 in excellent yield.  
Deprotection of 1.37 gave diol 1.38.  Successful metathesis cyclizations took place 
using Grubbs 2nd generation catalyst.  With a successful cyclization substrate in hand, 
we wondered if two steps could be eliminated from the synthetic sequence by 
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tethering the diol in situ using titanium additives.24  Gratifyingly, adding excess 
titanium isopropoxide prior to the metathesis catalyst formed triene 1.38 in equally 
high yield directly from diol 1.35. 
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Scheme 1.8. Tether-Assisted Ring Closing Metathesis 
 
Extensive NMR analysis of 1.38 revealed a couple of additional problems with the 
structure.  The ring closing metathesis not only gave the undesired Z-olefin, but had 
done so with the C12-bearing tether in an axial position instead of the more stable 
equatorial position thus forming the wrong atropisomer of the natural product.  
Although this unexpected result revealed a flaw in our planned facial bias, it did 
confirm our tethered-cyclization strategy.  This metathesis product (1.38) was then 
bis-acetylated, and the two trisubstituted macrocyclic olefins were subjected to 
substrate controlled bis-epoxidation, which afforded 1.39 as the only product.  Tsuji’s 
reductive allylic transposition25 was used to form the desired exo-methylene moiety in 
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1.40.  Allylic oxidation was achieved with selenium dioxide and the resulting alcohol 
was oxidized with Dess-Martin periodinane to enone 1.41.  This nineteen step 
synthesis of an isomer of hypoestoxide highlights the efficiency of our synthetic 
assembly. 
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Scheme 1.9. Synthesis of Hypoestoxide Isomer 
 
To complete a total synthesis of atrop-hypoestoxide we needed to invert both the 
C12 stereocenter and the C5-C6 olefin geometry.  Toward that end, the primary 
alcohol group in metathesis product 1.38 (Scheme 1.10) was selectively protected and 
the C12 alcohol was converted to a ketone using the Ley oxidation.  Substrate 
controlled reduction of the ketone gave the inverted diol 1.42 as a single product.26 We 
then turned our attention to the more challenging task of inverting the C5-C6 
trisubstituted olefin.  We accomplished this by acylating the diol and dihydroxylating 
the more reactive C5-C6 olefin to give 1.43.  The inversion was solved by forming 
diol 1.44 using a substrate controlled oxidation/reduction sequence.  The hydroxyl 
groups of 1.44 could then be tied together to form a cyclic thiocarbonate, which when 
subjected to the Corey-Winter deoxygenation conditions27 afforded the desired E,E-
triene 1.45. Following bis-epoxidation of the macrocyclic diene moiety, palladium 
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mediated allylic transposition was again successfully employed to form the desired 
exo-methylene group.  Unfortunately, 1.46 could not be oxidized to atrop-
hypoestoxide. 
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Scheme 1.10. Synthesis of Desoxy atrop-Hypoestoxide 
 
In an effort to further test the final allylic oxidation protocol, diol 1.42 was again 
bis-acetylated and then subjected to mCPBA which selectively epoxidized the more 
reactive Z-double bond to give 1.47.  The remaining macrocyclic double bond was 
then dihydroxylated and the secondary alcohol was selectively converted to the 
hydroxy mesylate 1.48.  Treatment with DBU afforded the cis-epoxide 1.49.  
Palladium catalyzed transposition of the allylic acetate in 1.49 gave the desired 
exocyclic olefin to test the allylic oxidation.  This double cis-epoxide isomer of atrop-
hypoestoxide smoothly afforded another isomer of hypoestoxide (1.50) when treated 
with pentafluorophenylselenic acid.    
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Scheme 1.11. Synthesis of Another Isomer of atrop-Hypoestoxide 
 
We decided to explore an additional tethering strategy to achieve an even more 
expedient synthetic assembly of both hypoestoxide and verticillol.  We were interested 
in learning how a six-membered ring tether would affect the selectivity of the ring 
closing metathesis (Scheme 1.12).  Grignard addition to ketone 1.33 afforded a single 
diol diastereomer, which could be readily tethered as a cyclic carbonate (1.51).   When 
treated with Grubbs second generation catalyst 1.51 formed a single macrocyclic 
isomer which, upon deprotection, afforded diol 1.52.  NMR analysis of 1.52 indicated 
that the undesired Z-olefin and incorrect atropisomer were again formed as the only 
bicyclic product in the ring closing metathesis reaction. This diol could, however, be 
converted to an isomer of verticillol (1.53) by selective mesylation of the secondary 
alcohol and reductive removal of the resulting sulfonate ester.  This synthetic route to 
an isomer of verticillol constituted only sixteen synthetic steps from methacrolein. 
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Scheme 1.12. Synthesis of a Verticillol Isomer 
 
In summary, we have reported the first synthetic efforts towards the natural product 
hypoestoxide.  An efficient flexible synthetic route that also provides access to the 
verticillane family of natural products has been devised.  This synthetic roadmap has 
been utilized to accomplish a synthesis of 18-desoxy-atrop-hypoestoxide as well as 
isomers of both hypoestoxide and verticillol.   
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2.1 Background and Significance 
Recently, researchers at Merck disclosed a new natural product, platensimycin 
(2.1, Figure 2.1),1 which was obtained by screening a large collection of South African 
soil samples using a novel antibiotic assay.  Characterization revealed a unique 
compact core connected to an aminohydroxy salicylic acid group via a propionate 
tether.   Platensimycin has a novel mechanism of action, inhibiting the -ketoacyl-
(acyl carrier protein) synthase (FabF) in the bacterial fatty acid synthetic pathway.2  It 
was shown that the salicylic acid group present in platensimycin competes with the 
malonyl-acyl-carrier-protein for the malonyl binding site of FabF.  Platensimycin is 
quite effective towards various gram-positive bacteria including multiresistant strains 
of staphylococci and enterococci.  Due to its unique mechanism of action, no cross 
resistance to existing drugs have been reported to date.  Several new members of this 
class have since been reported,3 differing only in functionalization of the carboxylate 
terminus.  This attractive natural product target has also encouraged researchers to 
engineer strains to improve its production.4 Recently, several derivatives obtained by 
modifying platensimycin have been reported.5  Nicolaou has pursued a different 
approach, replacing the oxatetracyclic core with carbocyclic and adamantyl mimics, 
which were equipotent with the natural product.6  These results bode well for analog 
approaches utilizing diverted total synthetic strategies.7 
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O
O
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O HO
HO CO2H
Platensimycin (2.1) Platensic Acid (2.2)  
 
Figure 2.1. Structures of Platensimycin and Platensic Acid 
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2.2 Other Relevant Synthetic Work 
Despite a flurry of synthetic activity,8 only two groups have completed total 
syntheses of platensimycin (2.1) to date.  All other reported efforts have focused on 
constructing the platensimycin core (2.3).  To highlight the diversity of these synthetic 
approaches we have chosen to emphasize the final bond formed by each group to 
complete the polycyclic core of platensimycin (Figure 2.2).  Altogether there have 
been fourteen unique approaches to this exciting molecule and each of these efforts is 
summarized below.   
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Our Work
Ghosh
E. Lee
D. Lee
Yamamoto
 
 
Figure 2.2. Synthetic Approaches to Complete the Platensimycin Core 
 
The first total synthesis of platensimycin was published in 2006 by K. C. Nicolaou 
(Scheme 2.1).9  The first key step in the synthesis was a ruthenium-catalyzed 
cycloisomerization to generate the spirocyclic compound 2.5.  The next ring was 
constructed using a samarium iodide mediated radical cyclization and the final ring 
was achieved through an acid-catalyzed etherification with trifluoroacetic acid.  
Having attained the tetracyclic core of platensimycin (2.3), the next task was to attach 
the aromatic sidechain.  This was accomplished by using a HATU mediated amide 
coupling reaction between the carboxylic acid 2.9 and protected aniline 2.10.  Then, 
21 
the first total synthesis of platensimycin was completed by straightforward protecting 
group removal.   
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Scheme 2.1. Nicolaou’s Total Synthesis of Platensimycin 
   
The Nicolaou group subsequently reported two unique enantioselective approaches 
(Scheme 2.2) to the platensimycin core.10  The first asymmetric approach mirrors that 
of their first paper and uses a cycloisomerization to install the spiro-ring system.  
Asymmetric induction was achieved by employing a rhodium-catalyzed 
cycloisomerization in the presence of (S)-BINAP to give 2.13 in greater than 95% ee.  
This route was completed as before, utilizing first a samarium iodide mediated 
cyclization followed by a trifluoroacetic acid catalyzed etherification to give the first 
enantioselective synthesis of the platensimycin core 2.3.   
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Another route described in the same paper uses a chiral auxiliary approach to 
assemble the platensimycin core in an asymmetric fashion. The asymmetry was 
achieved using Myers' asymmetric alkylation method11 with (S,S)-pseudoephedrine to 
bring together the aryl group and the amide auxiliary in 85% de.  After cleaving the 
auxiliary and carrying out minor structural modifications, the key spiro system was 
constructed using a iodine-catalyzed cyclodearomatization reaction with an allyl silane 
as the required nucleophile to generate 2.17.  This enantioenriched product was then 
carried forward using the previously described method (Scheme 2.1) to complete the 
first asymmetric total synthesis of (-)-platensimycin.               
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Scheme 2.2. Nicolaou’s Asymmetric Syntheses of Platensimycin 
 
Recently, the Snider group described a very concise route to the platensimycin 
core (Scheme 2.3).12  The synthesis begins with an intramolecular 5-exo-trig radical 
cyclization between a vinyl radical and an -unsaturated ketone to give 2.19.  After 
ketone reduction, the final ring was formed by an acid-catalyzed etherification 
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reaction forming 2.21.  The formal synthesis was completed by carrying out a 
dehydration and subsequent allylic oxidation with selenium dioxide.    
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Scheme 2.3. Snider’s Synthesis of Platensimycin 
 
Nicolaou and coworkers followed up by publishing an alternate formal synthesis 
of racemic platensimycin (Scheme 2.4).13  The 6,6-fused ring system of 2.23 was 
accessed by using an intramolecular Stetter reaction and the subsequent ring was 
achieved through a 5-exo-trig radical cyclization into the remaining -unsaturated 
ketone to give 2.24.  After ketone reduction, the final ring of the core was again 
accessed by using acid-catalyzed etherification.  The ketone reduction unfortunately 
gave a 1:1 mixture of diastereomers that were separated and the undesired alcohol was 
re-oxidized and reduced to give more of the desired alcohol that was competent for the 
cyclization.  The thioketal of 2.26 was then oxidatively removed with Dess-Martin 
periodinane to complete the formal synthesis of platensimycin. 
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Scheme 2.4. Nicolaou’s Stetter/Radical Based Synthesis of Platensimycin 
 
The research group of Hisashi Yamamoto was the next to produce a synthesis of 
platensimycin (Scheme 2.5).14  Lactone 2.28 was prepared using a Baeyer-Villiger 
oxidation of ketone 2.27. Under the reaction conditions the initially formed lactone 
isomerized to form the more stable fused lactone 2.28.  Functionalizing both five 
membered rings led to the -unsaturated ketone 2.29, which was used to test the key 
annulation.  The reaction was accomplished in one pot using L-proline as a catalyst to 
mediate the initial intramolecular Michael addition, followed by sodium hydroxide 
treatment to facilitate the subsequent aldol condensation. 
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Scheme 2.5. Yamamoto’s Synthesis of Platensimycin 
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Mulzer et al. also reported an approach to platensimycin (Scheme 2.6).15  The 
synthesis of the diketone 2.31, previously reported by Mander,16  involves the 
cyclodearomatization of a diazo-ketone generated by addition of TMS-diazomethane 
to acid chloride 2.30.  The regio- and stereoselective addition of methylmagnesium 
iodide to 2.31 followed by stereoselective allylic bromination provided 2.32, which 
subsequently cyclized under basic conditions to complete the core of platensimycin.  
The core was then exhaustively hydrogenated and re-oxidized to complete the formal 
synthesis. 
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Scheme 2.6. Mulzer’s Synthesis of Platensimycin 
 
The next approach came from the lab of Corey and coworkers (Scheme 2.7).17  The 
first step of the synthesis was an oxidative acetalization of 2.34 with ethylene glycol to 
give the -unsaturated ketone 2.35, which was then subjected to an enantioselective 
conjugate addition to introduce the asymmetry in the synthesis.  The synthesis later 
relied on an intramolecular bromoetherification reaction of MEM-ether 2.37 to install 
the tetrahydrofuran moiety and the bromine atom necessary to complete the core.  The 
next step was to remove the silyl protecting group thereby allowing for the desired 
alkylative dearomatization to give the platensimycin core. 
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Scheme 2.7. Corey’s Synthesis of Platensimycin 
 
Another route based on chiral pool reactants again came from the Nicolaou group 
(Scheme 2.8).18  The synthesis started from (R)-(-) carvone 2.39, which was treated 
with Grignard reagent 2.40 followed by oxidation of the resulting tertiary alcohol to 
give the desired enone 2.41.  This was followed by regioselective oxymercuration of 
the disubstituted olefin.  When the resulting organo-mercury species was reduced with 
sodium borohydride, the resulting primary radical underwent 1,4-addition to the enone 
generating the [3.2.1] bicyclic system 2.42.  Other key steps in the synthesis included 
a samarium iodide mediated 6-endo radical cyclization and an acid-catalyzed 
etherification to complete the core of platensimycin. 
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Scheme 2.8. Nicolaou’s Chiral Pool Based Synthesis of Platensimycin 
 
The next paper published was from the research group of Eun Lee (Scheme 2.9).19  
The key step in the synthesis involved a carbonyl ylide cycloaddition of 2.48 to 
generate all but one of the rings in the platensimycin core.  The final step to complete 
the core was a high yielding aldol condensation under acidic conditions. 
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Scheme 2.9. Eun Lee’s Synthesis of Platensimycin 
 
28 
A synthetic approach by Matsuo and coworkers is summarized in Scheme 2.10.20  
The first key step in the sequence was a palladium catalyzed cyclization of 2.51 to 
form dihydropyran 2.52.  The ketone group in 2.52 was then converted to the vinyl 
triflate and reduced to 2.53.  Selective addition of thiophenol to the enol ether in 2.53 
generated the monothioketal 2.54, which was poised to form the final C-C bond of the 
core.  A transannular radical cyclization was realized using standard conditions to 
afford 2.3 after deacetylization.    
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Scheme 2.10. Matsuo’s Synthesis of Platensimycin 
 
An approach by Daesung Lee (Scheme 2.11)21 was also based on (S)-carvone 2.55, 
which was reduced and cyclized to give 2.56.  Allylic oxidation followed by a 5-exo 
radical cyclization provided 2.57.  After extending the aldehyde chain to ketone 2.58, 
they converted the ketone to the alkylidene carbene which underwent the desired C-H 
insertion to form 2.59.  Subsequent dihydroxylation to 2.60 and diol cleavage afforded 
the ketoaldehyde previously reported by Eun Lee, which underwent a base catalyzed 
aldol condensation to give the core of platensimycin. 
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Scheme 2.11. Daesung Lee’s Synthesis of Platensimycin 
 
The next synthesis of platensimycin was achieved by the research group of Arun 
Ghosh, starting from carvone (Scheme 2.12) 22.  A key step was a Baeyer-Villiger 
oxidation of 2.61 to give the seven membered ring lactone 2.62, which subsequently 
isomerized to the 5,5-fused lactone 2.63.  Each ring of the fused bicyclic system was 
then elaborated to produce triene 2.64 necessary for the crucial intramolecular Diels-
Alder reaction.  Standard conditions failed to provide the Diels-Alder adduct, but by 
increasing the temperature and pressure (270oC, sealed tube) a reasonable yield of 
cycloaddition product 2.65 could be attained.  Ghosh et al. went on to elaborate their 
system to complete a total synthesis of (-)-platensimycin. 
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Scheme 2.12. Ghosh‘s Synthesis of Platensimycin 
 
Another report from the Nicolaou lab highlighted further development of the 
cycloisomerization reaction described in two of their previous routes (Scheme 2.1, 
Scheme 2.2) to platensimycin.23  This involved the use of a terminal alkyne in the 
cycloisomerization reaction to form 2.7 (Scheme 2.13).  Enyne precursor 2.68, was 
assembled using Stork-Danheiser chemistry and the core was completed in a similar 
fashion to their previous routes. 
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Scheme 2.13. Nicolaou‘s Fifth Synthesis of Platensimycin 
 
A platensimycin approach by Wang and coworkers (Scheme 2.14)24  utilized an 
intramolecular [3+2] cycloaddition of a cyclopropane 1,1-diester with a ketone to 
assemble the oxatropane via ylide 2.70.  Decarboxylation of 2.71 converged with 
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intermediate 2.72 from our synthesis to complete their formal synthesis of 
platensimycin. 
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Scheme 2.14. Wang‘s Synthesis of Platensimycin 
 
2.3 Our Synthetic Efforts25 
We envisioned a concise retrosynthetic plan for the total synthesis of 
platensimycin (Scheme 2.15).   Platensic acid (2.2) would serve as our immediate 
target as it represented a natural branch point for accessing all the other members of 
this natural product family.  We proposed that 2.2 could be made from 2.73 via a 
retro-Michael ring opening reaction followed by hydrolysis of the resulting ester.  
Radical cyclization of bromide 2.74 would be expected to afford the platensimycin 
carbocyclic core (2.73).  Oxidative dearomatization of 2.76 and in situ trapping of the 
ortho-quinone mono-ketal (2.75) with methyl acrylate was expected to provide 2.74 as 
the only cycloadduct.  In this one remarkable transformation, the aromatic core would 
be unraveled and primed for the following cyclization step.  At the same time, the 
quaternary center bearing the sidechain with the desired oxidation state would be 
32 
installed via a substrate and regiocontrolled Diels-Alder cycloaddition.  Oxatropane 
2.76 would originate from vinyl oxirane 2.77 using our newly described copper 
catalyzed ring expansion.26  Epoxidation of the diene obtained from enone 2.78 could 
also serve as the asymmetric entry point for this synthesis, which in turn would be 
assembled in two steps from 2.7927 and 2.80 using a Heck coupling followed by an 
intramolecular aldol condensation.  Although this design allows direct access to the 
platensimycin core including the propionic acid and methyl group, we decided to 
initially take a more conservative approach.  
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Scheme 2.15. Retrosynthetic Analysis of Platensimycin 
 
Our synthetic efforts commenced with vanillin, which was regioselectively 
brominated and protected to 2.81 following known procedures (Scheme 2.16).28  
Although 2.81 lacked the requisite methyl group in 2.79, its availability made it a nice 
model system.  This substrate was subjected to Heck coupling conditions in the 
presence of allylic alcohol 2.80, which furnished keto-aldehyde 2.82.29 The methyl 
branching was key to the rapid assembly of the fused ring system (2.83), ensuring that 
33 
under the thermodynamic conditions employed, only the seven membered ring enone 
could form.  Deprotonation30 of 2.83 and trapping of the resulting enolate with N-
phenyltriflamide afforded triflate 2.84.  Palladium mediated carbonylation afforded 
dienoate 2.85 in excellent yield.31  Regioselective epoxidation was accomplished using 
the highly reactive trityl hydroperoxide,32 and our new copper catalyzed ring 
expansion protocol formed oxatropane 2.87. 
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Scheme 2.16. Synthesis of the Functionalized Aryl Fused Oxatropane 
 
Ester 2.87 (Scheme 2.17) underwent stereoselective reduction using lithium 
triethyl borohydride to form alcohol 2.88, which formed bromide 2.89 using carbon 
tetrabromide and triphenylphosphine.  After hydrogenolysis of the benzyl ether 
oxidation of 2.90 using iodobenzene diacetate (IBDA) afforded dimethyl ketal 2.91 
which underwent a facile Diels-Alder dimerization.  This process was slow enough 
however to test the proposed cyclization.  Unfortunately, all efforts using either radical 
or anionic conditions did not form the desired core, instead giving only the product of 
34 
bromide reduction and no C-C bond formation.  Regardless, diene 2.91 could be 
trapped in-situ after oxidative dearomatization with methyl acrylate to give the desired 
cycloadduct 2.92. Our calculations had indicated that the structure of the new six 
membered ring would bring the radical accepting olefin in closer proximity with the 
primary radical compared to 2.91 and therefore make the cyclization more likely. 
Unfortunately all attempts to form 2.93 were unsuccessful, again giving only the 
product of bromine atom abstraction and subsequent radical quenching. 
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Scheme 2.17. Oxidative Dearomatization/Cyclization Attempts 
 
We decided to evaluate a slightly different substrate to determine whether our 
proposed C-C cyclization strategy to form the platensimycin core was feasible.  To 
this end oxatropane 2.87 was converted to 2.94 by alkene reduction and 
hydrogenolysis of the benzyl protecting group.  Deoxygenation was then 
accomplished by forming aryl triflate 2.95 followed by reductive cleavage using 
palladium and formic acid to give 2.72.  A mild phenolic silylation of the remaining 
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aryl methyl ether with triethylsilane and tris(pentafluorophenyl)borane furnished TES-
protected phenol 2.96.33  The ester was reduced with DIBAL-H to give primary 
alcohol 2.97, which was converted to the tosylate 2.98.  When this cyclization 
precursor was heated with tetrabutylammonium fluoride (TBAF) it rapidly underwent 
cyclization in excellent yield to form the platensimycin core (2.33).  The 1H and 13C 
NMR spectra of 2.33 were identical to those previously reported, thus completing our 
formal synthesis of platensimycin. 
 
O
MeO2C
MeO
OH
90%
O
MeO
OBn
MeO2C
2.942.87
H2
Pd/C
Pd(OAc)2
PPh3, Et3N
HCO2H
90%
O
MeO2C
MeO
2.72
Et3SiH
B(C6F5)3
88%
O
MeO2C
TESO
2.96
Dibal-H
O
TESO
2.97
HO90%
TsCl, Et3N
67%
O
TESO
2.98
TsO
TBAF
100°C
91%
O
O
2.33
Tf2O
Et3N
88%
O
MeO2C
MeO
OTf
2.95
 
Scheme 2.18. Intramolecular Alkylative Dearomatization 
 
This success inspired us to improve the synthetic approach using brominated 
anisaldehyde 2.99 (Scheme 2.19).  This route would circumvent with the late stage 
deoxygenation necessary in Scheme 2.18.  Commercially available bromide 2.99 was 
converted to 2.101 using Molander’s new trifluoroborate cross-coupling strategy.34  
Ketoaldehyde 2.101 cleanly underwent the analogous condensation, triflate formation, 
and carbonylation using the previously optimized conditions to give 2.103.  
Nucleophilic epoxidation with trityl hydroperoxide afforded vinyl oxirane 2.104, 
36 
which subsequently underwent ring expansion to oxatropane 2.105 when subjected to 
our Cu(hfacac)2 conditions.  Substrate controlled reduction afforded primary alcohol 
2.106 which was converted to the tosylate and again hydrosilated to give TES-
protected phenol 2.98.    The platensimycin core (2.33) was again accessed by 
alkylative dearomatization, this time completing the formal synthesis in only ten steps 
from commercially available precursor 2.99. 
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Scheme 2.19. Efficient Synthesis of the Platensimycin Core 
 
In summary, we have developed a very efficient route to the compact 
platensimycin core.  Our architectural assembly relied on the use of a new copper 
catalyzed oxirane ring expansion in combination with an alkylative dearomatization to 
complete the core.  Other notable features of this synthetic approach include an 
underutilized phenol ether deprotection, nucleophilic enoate epoxidation and a mild 
introduction of a substituted alkyl ketone using a trifluoroborate cross coupling. 
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3.1 Background and Significance 
In recent years a number of bridged bicyclic polyprenylated acylphloroglucinol 
natural products have been reported.1  The most famous being hyperforin, which is 
one of the main chemical constituents of the commonly used natural remedy St. 
John’s wort.  Recently, hyperforin has also shown promise as an anticancer agent.2  
We have established a research program focused on synthesizing and evaluating 
unique bridged bicyclic natural product anti-cancer agents.  The bridged 
phloroglucinol family drew our attention early on, but the catalyst for launching a 
synthetic program towards their synthesis was a report detailing the sirtuin 
inhibitory activity of hyperforin and guttiferone G (Figure 3.1).3  The sirtuins are 
considered high value targets for developing new anticancer agents and gaining 
more insight into improving longevity.4  Not surprisingly, there has been great 
interest in finding small molecule inhibitors, which selectively block the function 
of any of the seven known enzymes of the sirtuin family (SIRT1-7).5   
 
 
 
Figure 3.1. Guttiferone G and Hyperforin 
 
Hyperforin and guttiferone G share many structural similiarities in addition to 
the common [3.3.1] bridged bicyclic trione core and neither natural product has 
been synthesized to date.6  In our minds the most attractive difference is the bis-
prenyl bridgehead substitution of guttiferone G, which means that the fully 
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substituted trione part of the molecule is symmetrical.  This local symmetry opens 
the door for exciting synthetic designs and more importantly for late introduction 
of chirality.  We chose to limit our efforts to compounds containing stereocenters 
at both C5 and C6, thus excluding a number of symmetrically substituted 
compounds containing the C5 gem-dimethyl substitution pattern. Eight guttiferones 
sharing a symmetrical [3.3.1] bridged bicyclic core have been reported in the last 
twenty years since the first was discovered (guttiferone A).7  The only structural 
difference between members of this family are the substitution of the two adjacent 
stereocenters (C5 and C6), the benzoyl group oxidation state and the absolute 
configuration of the desymmetrized core (Figure 3.2).       
 A closer look at the published data for these eight compounds revealed that 
although there are four possible arrangements for each C5/C6 substitution pattern, 
it seems nature has prefered to place the two large groups (geranyl and prenyl) 
trans to each other.  Guttiferone A is the only member of this natural product class 
whose absolute configuration has been unambiguously established.8  The data 
suggests that guttiferone A and I belong to the same enantiomeric series9 and that 
the other six (guttiferones I, J, K, L, G and garcicowin B) belong to the opposite.10  
The latter six structures are remarkably similar, differing only in the benzoyl group 
and whether there is a prenyl or geranyl group at the C6-position. 
 Although this natural product collection has never been tested as one, each 
member has been shown to exhibit anti-cancer activity ranging from general 
cytotoxicity11 to potential protease inhibitors,12 antiapoptotic13 or antiproliferative 
agents.  In addition, several studies have been reported on their various biological 
functions beyond cancer.14  As stated above, we were most excited about the sirtuin 
inhibitory activity of guttiferone G and to learn how the other seven members of 
this family compare.  Such a study would provide important SAR clues on the 
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relative importance of the C5, C6 or benzoyl substitutions on sirtuin inhibition.       
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Figure 3.2. Guttiferones Containing Locally Symmetrical Bicyclic Cores 
 
3.2 Other Relevant Synthetic Work 
A considerable amount of synthetic effort has gone into this class of natural 
products due to their biological activity.  The first work was by the Nicolaou group 
which first published their efforts toward Garsubellin A in 1999 (Scheme 3.1).15  The 
first key step was a selenium-mediated cyclization to generate the bicyclic core 
(3.12).  They concluded their efforts by carrying out a [2+2] cycloaddition followed 
by Baeyer-Villager oxidation to assemble much of the garsubellin A core (3.16). 
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Scheme 3.1. Nicolaou’s Synthetic Efforts Toward Garsubellin A 
 
The research group of Brian Stoltz published a paper in 2002 detailing their work in 
this area (Scheme 3.2).16  After the straight-forward synthesis of the silyl enol ether 
3.17, treatment with malonyl chloride and base gave the desired bicyclic core.  The 
additional allyl group was installed by allylating 3.18 followed by a Claisen 
rearrangement in which the resulting enol was capped with diazomethane. 
 
 
 
Scheme 3.2. Stoltz’s Synthetic Approach to [3.3.1] Bicyclic Core 
 
The first total synthesis of a member of this family came from the group of 
Masakatsu Shibasaki17 in 2005 when they finished garsubellin A18  which was followed 
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up by an asymmetric total synthesis of ent-hyperforin (Scheme 3.3).19  The key step in 
assembling garsubellin A (3.21) was a ring closing metathesis, set up by an 
allylation/Claisen rearrangement similar to that used by Stoltz.  In their asymmetric 
approach to ent-hyperforin, the initial three stereocenters were set in an asymmetric 
Diels-Alder reaction promoted by a cationic iron complex to give 3.24.  The bicyclic 
core was made by an aldol addition/oxidation sequence to give the triketone 3.26 
which was carried forward to the enantiomer of hyperforin. 
 
 
 
Scheme 3.3. Shibasaki’s Synthesis of Garsubellin A and ent-Hyperforin 
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Danishefsky first published a total synthesis of garsubellin A in 200620 and a year 
later completed nemorosone and clusianone (Scheme 3.4).21  The synthesis of 
garsubellin A relied on an iodocarbocyclization to produce the bicyclic core (3.29).  
Iodocarbocyclization was also used in their syntheses of nemorosone and clusianone 
and a common intermediate (3.32) was diverted to each of the natural products. 
 
 
 
Scheme 3.4. Danishefsky’s Total Synthesis of Three Members of This Family 
 49 
 
A synthesis of clusianone was published by the Porco group in 2007 (Scheme 
3.5).22  The bicyclic core was constructed using a double alkylative dearomatization of 
a 1,3,5-trihydroxybenzene (phloroglucinol) derivative 3.38 with a versatile “double-
Michael acceptor”.  In this reaction the initial Michael addition causes elimination of 
the acetate group to generate another Michael acceptor which subsequently reacts in 
an intramolecular fashion to assemble the bicyclic core.  The synthesis was completed 
by converting the allyl group to a prenyl via metathesis and deprotection. 
 
OH
HO OH
O CHO
AcO
KHMDS
O
O OMe
O
OHC
1.
2. TMSCHN2
54%
O
O OMe
O
OAc
1. Pd(PPh3)4
HCO2NH4
2. Grubbs(II)
2-methyl-2-butene
3. LiOH
62% (3 Steps)
O
O OH
O
Clusianone (3.34)
3.38 3.39
3.40  
 
Scheme 3.5. Porco’s Synthesis of Clusianone 
 
Clusianone was recently synthesized by the Marazano group (Scheme 3.6).23  Their 
synthesis built off of the early success by Stoltz.  They were able to use an adequately 
functionalized 6-membered ring (3.41) with malonyl chloride to give the bicyclic core 
3.42.  An acylation of 3.42 completed their synthesis of clusianone. 
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Scheme 3.6. Marazano’s Synthesis of Clusianone 
 
Simpkins24 published syntheses of clusianone and garsubellin A (Scheme 3.7).25  
Malonyl chloride was used to assemble the bicyclic core of clusianone and a DMDO 
epoxidation followed by an intramolecular etherification generated the THF subunit 
(3.46) of garsubellin A.  They completed their formal synthesis by using a 
protection/allylation/deprotection sequence. 
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Scheme 3.7. Simpkins’s Synthesis of Clusianone and Garsubellin A 
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In addition to the approaches highlighted above, a number of groups have made 
noteworthy contributions to this area of research (Scheme 3.8).  The first are from the 
Mehta group and involve either a lactone opening/aldol addition sequence26 (3.48) or a 
palladium catalyzed ring closure (3.50).27  Nakada’s work involves the synthesis and 
in-situ opening of a methoxy cyclopropane to generate the core (3.53).28  Kraus uses a 
copper and manganese catalyzed cyclization to assemble the bicyclic core (3.55).29  
The final example is a Michael-based approach from 3.56 to assemble the core by the 
research group of Couladouros.30  
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Scheme 3.8. Other Synthetic Contributions 
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3.3 Our Synthetic Efforts 
  Our retrosynthetic analysis (Scheme 3.9) relies on the late stage 
desymmetrization of 3.59, which could be diverted to all eight targeted natural 
products.  This intermediate could be accessed via tandem 5-exo radical cyclizations 
(3.60) enabled by oxidative dearomatization of a para-hydroquinone, which is 
assembled from phenol 3.6131 and malonate derivative 3.62.  
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O
MeO O
O
PO
OP
3.58
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Br
EtO OEt
OO
+
3.61 3.62
 
 
Scheme 3.9. Guttiferone G Retrosynthesis 
 
Our synthetic efforts commenced with known diallyl ether 3.61, which was 
readily accessible from 4-methoxy phenol.  The free phenol was alkylated with 
diethyl 2-bromomalonate (3.62) to afford 3.63.  The esters were converted into 
bromomethyl groups (3.64) in two steps.  Selective deprotection of the methyl 
capped phenol using BCl3 and hypervalent iodine mediated oxidative 
deromatization yielded the desired dienone acetal radical cyclization precursor 
3.65.  Despite discouraging literature precedents,32 which suggested preferential 
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formation of 3.66 over 3.67 we decided to test the tandem 5-exo/5-exo radical 
cyclization thesis.  Cyclization proceeded smoothly and selectively affording only 
acetal 3.66 and no evidence of bridged bicyclic acetal 3.67.   
 
 
 
Scheme 3.10. Attempted Bis-Radical Cyclization 
 
We postulated that placing a large group between the two radical sites would 
force the two radicals to same face, which is critical for accessing the bicyclic 
motif.  This logic flows well with our synthetic design because an oxygenated 
phenacyl group resides in this exact position on the guttiferones.  Diester 3.63 was 
alkylated (3.68) and reduced to diol 3.69 (Scheme 3.11).  Bromination of the 
neopentyl alcohols was accomplished in two steps to give 3.70.  Selective 
deprotection of the methyl ether was accomplished using B(C6F5)3 in the presence 
of triethylsilane.33  Dearomatization proceeded as expected to produce acetal 3.72, 
which we were gratified to learn cyclized to form the desired symmetrical bridged 
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bicyclic product 3.73 as the only product.  Cross metathesis of 3.73 with 2-methyl 
propene in the presence of Grubbs second generation catalyst gave 3.74.34 To test 
the facial selectivity in the alkylation of the bicyclic ketone 3.74, the enolate 
generated with LHMDS was trapped as the silyl ether.  When this enol ether was 
treated with MeLi and MeI, the only product observed was determined to be that of 
methyl trapping on the exo face of the bicylic structure (3.75).  This exclusive bias 
for alkylation on the exo-face lends promise to being able to access any member of 
this natural product class by changing the order of the alkylation sequence.   
 
 
 
Scheme 3.11. Synthesis of the Bridged Bicyclic Core of the Guttiferones 
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In order to explain the profound reversal of selectivity in the cyclization of 3.65 
and 3.72, we performed density functional theory calculations (UB3LYP 6-
31G(d)).  The two possible transition states for the first radical cyclization  were 
found and the more stable in each case (3.78, 3.80) is depicted in Scheme 3.12.  
We see that in the case of R=H, the transition state having the methylene bromide 
on the exo face of the fused bicylic system is preferred by 2.8 kcal/mol.  
Alternatively with R=Bn, steric interactions with the benzyl group force it to the 
less hindered exo face and the methylene bromide to the endo which is competent 
for further cyclization.  These calculations are in complete agreement with 
experimental findings and explain the high selectivity attained in each case. 
 
 
 
Scheme 3.12. Rationalization of Stereochemical Outcome 
 
In order to assess our ability to carry out a late-stage desymmetrization to access 
either enantiomeric series of this natural product family, we employed chiral amide 
bases (Table 3.1).35  The asymmetry in the deprotonation was determined by trapping 
the enolate as a Mosher ester.  Both enantiomers of the enolate were trapped to give 
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the corresponding diastereomeric Mosher esters.  An increased selectivity was 
observed with LiCl being added prior to deprotonation. 
 
 
Base Additive Temp (oC) Yield dr 
LHMDS -- -78 85% 1.1:1 
RR-Amide -- -78 87% 3:1 
RR-Amide LiCl -78 83% 10:1 
SS-Amide LiCl -78 75% 1:6 
RR-Amide LiCl -100 72% 3:1 
 
Table 3.1. Asymmetric Desymmetrization of 3.74 
 
In conclusion, we have developed an efficient approach to this exciting class of 
natural products that takes advantage of the inherent local symmetry present in the 
bicyclic structure.  The complex core was accessed by employing a unique double 
radical cyclization of a p-quinone ketal derived from a simple aromatic precursor.  The 
shape of the molecule controls the facial selectivity during the ketone alkylation and 
the use of a chiral amide base provides access to either enantiomeric series.  
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APPENDIX 1 
 
A1.1 Experimental Procedures for Chapter 1 
 
General Information: Commercial reagents were purchased and used without further purification. All 
glassware was flame dried and reactions were performed under a nitrogen atmosphere, unless otherwise 
stated. Toluene, dichloromethane, diethyl ether, and THF were dried over a column of alumina. Flash 
chromatography was done with MP Silitech 32-63D 60Å silica, and thin layer chromatography (TLC) 
was performed with EMD 250 μm silica gel 60-F254
 
plates. 1H and 13C NMR data was acquired on a 
Varian Inova 400, 500, or 600 (400, 500 or 600 MHz) spectrometer and referenced to residual protic 
solvent or TMS. IR spectroscopy was done on a Nicolet Avatar 370 OTGS spectrometer. High-
resolution mass spectrometry was performed at the University of Illinois at Urbana-Champaign facility.  
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Br
1) Mg, Et2O, 50oC
2)                 
                      -10oC
O
OH
H
 
 
A mixture of magnesium turnings (1.600 g, 0.067 mol) and a crystal of I2 in diethyl ether (60.0 mL) was 
refluxed at 45°C.  Through a condenser 5-bromo-1-pentene (5.000 g, 0.034 mol) was added over 30 
minutes.  The reaction was refluxed an additional hour.  In a separate flask, a solution of methacrolein 
(3.9 mL, 47.5 mmol) in diethyl ether (5.0 mL) was cooled to -10°C.  The Grignard solution was 
cannulated into the solution of methacrolein over 30 min.  The reaction was stirred an additional 30 min 
at -10°C and then warmed to room temperature over 2.5 hr.  The reaction was subsequently quenched 
over ice with sat. NH4Cl followed by 2M HCl.  The aqueous layer was extracted with ethyl acetate (3 x 
30.0 mL).  The combined organic layers were dried over Na2SO4 and concentrated to give a residue, 
which was purified by column chromatography (15% EtOAc: hexanes) to give the allylic alcohol (4.200 
g, 90%) as a light yellow oil. 
 
FTIR (thin film/NaCl) 3368, 3075, 2976, 2935, 2861, 1641, 1442, 1066, 1029, 995 cm-1; 1H NMR 
(300 MHz, CDCl3)  5.78 (m, 1H), 4.98 (m, 1H), 4.92 (m, 1H), 4.90 (m, 1H), 4.80 (m, 1H), 4.02 (t, 
J=6.1 Hz, 1H), 2.05 (m, 2H), 1.95 (bs, 1H), 1.69 (s, 3H), 1.59-1.21 (m, 4H); 13C NMR (75 MHz, 
CDCl3)  147.5, 138.6, 114.5, 110.9, 75.7, 34.2, 33.5, 24.8, 17.3.   
 
 
 
 
 
 
A solution of the allylic alcohol (6.100 g, 0.044 mol), triethyl orthoacetate (39.7 mL, 217.7 mmol), and 
propionic acid (0.08 mL, 1.10 mmol) was refluxed at 140°C for 1.5 hr and then 145°C for 0.5 hr.  The 
low boiling components were collected in a sidearm flask cooled to -78°C.   The solution was then 
cooled to room temperature.  The reaction was quenched over ice with 2M HCl.  The aqueous layer was 
extracted with ethyl acetate (3 x 50.0 mL).  The combined organic layers were dried over Na2SO4.  
Concentration of the solvent in vacuo afforded a residue, which was purified by column 
chromatography (5% EtOAc: hexanes) to give ethyl ester (8.400 g, 92%) as a clear oil. 
 
FTIR (thin film/NaCl) 2980, 2928, 2850, 1737, 1440, 1156 cm-1; 1H NMR (300 MHz, CDCl3)  5.80 
(m, 1H), 5.15 (m, 1H), 4.99 (m, 1H), 4.94 (m, 1H), 4.12 (q, J=7.1 Hz, 2H), 2.46-2.23 (m, 4H), 2.12-1.90 
(m, 4H), 1.60 (s, 3H), 1.41 (m, 2H), 1.25 (t, J=7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3)  173.7, 139.2, 
133.8, 125.4, 114.6, 60.5, 34.9, 33.6, 33.5, 29.1, 27.5, 16.2, 14.5; HRMS (EI) m/z  210.1618 [calc'd for 
C13H22O2 (M+) 210.1620]. 
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Ethyl ester (4.400 g, 0.021 mol) in 95% n-hexane (175.0 mL) was cooled to -78°C. Diisobutyl 
aluminum hydride (22.0 mL, 1.0 M in hexanes) was added down the side of the cooled reaction flask 
over 1 hr.  After the addition, the solution was stirred an additional 30 min.  The reaction was quenched 
at -78°C with 20% sodium potassium tartrate (125.0 mL) and immediately warmed to room 
temperature.  Brine was added to help with the separation of the organic and aqueous layers. The 
aqueous layer was extracted with ethyl acetate (5 x 50.0 mL).  The combined organic layers were dried 
over Na2SO4.  Concentration of the solvent in vacuo afforded the aldehyde which was taken on crude. 
 
FTIR (thin film/NaCl) 3075, 2924, 2856, 1726, 1677, 1640, 1440, 1382, 1237, 992, 909 cm-1; 1H NMR 
(300 MHz, CDCl3)  9.76 (t, J=1.9 Hz, 1H), 5.80 (m, 1H), 5.16 (m, 1H), 4.99 (m, 1H), 4.95 (m, 1H), 
2.52 (m, 2H), 2.33 (m, 2H), 2.11-1.94 (m, 4H), 1.61 (s, 3H), 1.42 (m, 2H).   
 
 
 
 
 
 
The aldehyde (3.500 g, 0.021 mol) in 35 mL THF was cooled to -10°C.  Isopropenyl magnesium 
bromide (63.0 mL, 0.5 M in THF) was added over 1 hr via addition funnel.  The reaction stirred at -
10°C for an additional 15 min and then warmed to room temperature over 45 min.  The reaction was 
quenched with sat. NH4Cl and then acidified to pH 2.0 using 2 M HCl.  The aqueous layer was 
extracted with ethyl acetate (3 x 30.0 mL).  The combined organic layers were dried over Na2SO4.  
Concentration of the solvent in vacuo afforded a residue, which was purified by column 
chromatography (15% EtOAc: hexanes) to give the alcohol (2.500 g, 62%) as a yellow oil. 
 
FTIR (thin film/NaCl) 3364, 3075, 2974, 2920, 2855, 1640, 1441, 1374, 992, 907 cm-1; 1H NMR (300 
MHz, CDCl3)  5.81 (m, 1H), 5.17 (m, 1H), 5.00 (m, 1H), 4.95 (m, 1H), 4.94 (m, 1H), 4.84 (m, 1H), 
4.05 (dd, J=6.3, 10.1 Hz, 1H), 2.13-1.92 (m, 6H), 1.73 (s, 3H), 1.70-1.51 (m, 2H), 1.61 (s, 3H), 1.43 (m, 
2H); 13C NMR (75 MHz, CDCl3)  147.4, 138.8, 134.8, 124.6, 114.3, 110.9, 75.5, 35.6, 33.3, 33.1, 
28.9, 27.2, 17.4, 15.9; HRMS (EI) m/z  208.1826 [calc'd for C14H24O (M+) 208.1827]. 
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Sodium hydride (1.400 g, 0.035 mol, 60% in mineral oil) was washed with n-hexane (4 x 10.0 mL) and 
dried in vacuo.  The resultant residue was suspended in THF (8.0 mL).  Alcohol (1.600 g, 7.800 mmol) 
dissolved in THF (16.0 mL) was added to the NaH suspension and stirred for 1 hr.  A solution of 
bromoacetic acid (1.100 g, 8.200 mmol) in THF (5.0 mL) was added via reflux condenser over 20 min.  
The reaction refluxed at 85°C for 6 hr and subsequently cooled to room temperature.  The reaction was 
quenched dropwise with 2 M HCl and then acidified to pH 1.  The aqueous layer was extracted with 
ethyl acetate (4 x 30.0 mL).  The combined organic layers were dried over Na2SO4.  Concentration of 
the solvent in vacuo afforded the acid which was taken on crude to the next step.  
 
1H NMR (400 MHz, CDCl3)  5.81 (m, 1H), 5.14 (m, 1H), 5.04-4.92 (m, 4H), 4.06 (d, J=16.6 Hz, 1H), 
3.90 (d, J=16.6 Hz, 1H), 3.75 (m, 1H), 2.08-1.93 (m, 8H), 1.66 (dd, J=0.9, 1.5 Hz, 3H), 1.60 (s, 3H), 
1.42 (m, 2H).  
 
 
 
 
 
O
O OH
HO
O
OH
LDA, THF
 -78  C
 
 
Diisopropyl amine (3.9 mL, 28.1 mmol) in THF (20.0 mL) was cooled to -78°C.  To this solution, 
nBuLi (17.8 mL, 1.6 M in hexane) was added slowly.  The solution was warmed to 0°C over 1hr.  Upon 
cooling back down to -78°C, the crude acid in THF (9.0 mL) was slowly added.  The reaction was 
warmed to -45°C for 3.5 hr.  The reaction was quenched dropwise with 2 M HCl and then acidified to 
pH 1.  The aqueous layer was extracted with ethyl acetate (4 x 30.0 mL).  The combined organic layers 
were dried over Na2SO4.  Concentration of the solvent in vacuo afforded the new acid which was taken 
on crude to the next step.  
 
1H NMR (300 MHz, CDCl3)  5.81 (m, 1H), 5.27 (m, 1H), 5.12 (m, 1H), 5.00 (m, 1H), 4.94 (m, 1H), 
4.28 (dd, J=3.9, 9.1 Hz, 1H), 2.62 (dd, J=3.9, 13.7 Hz, 1H), 2.32 (dd, J=9.1, 13.7 Hz, 1H), 2.23-1.91 (m, 
8H), 1.67 (s, 3H), 1.59 (s, 3H), 1.51-1.35 (m, 2H). 
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A suspension of lithium aluminum hydride (0.750 g, 0.020 mol) in diethyl ether (25.0 mL) was stirred 
at room temperature.  The crude acid in diethyl ether (25.0 mL) was added via reflux condenser.  The 
reaction was refluxed at 50°C for 1.5 hr and was subsequently cooled to room temperature.  The 
reaction was quenched slowly over ice using 3M HCl (40.0 mL) and then stirred vigorously for 30 min 
at room temperature.  The mixture was filtered through Celite and washed with ethyl acetate (3 x 20.0 
mL).  The filtrate was washed with brine.  The aqueous layer was extracted with ethyl acetate (5 x 50.0 
mL).  The combined organic layers were dried over Na2SO4.  Concentration of the solvent in vacuo 
afforded a residue which was purified by column chromatography (gradient, 50% EtOAc: hexanes to 
100% EtOAc) to give the diol (1.700 g, 80% over 3 steps). 
 
FTIR (thin film/NaCl) 3368, 2920, 2840, 2800, 1640, 1441, 1380, 1100, 1040, 909 cm-1; 1H NMR 
(300 MHz, CDCl3)  5.80 (m, 1H), 5.20 (m, 1H), 5.11 (m, 1H), 4.98 (m, 1H), 4.93 (m, 1H), 3.78 (m, 
1H), 3.64 (m, 1H), 3.44 (dd, J=6.7, 11.2 Hz, 1H), 2.38 (bs, 1H), 2.25 (bs, 1H), 2.19-1.92 (m, 10H), 1.64 
(s, 3H), 1.58 (s, 3H), 1.41 (m, 2H); 13C NMR (75 MHz, CDCl3)  138.9, 134.8, 131.1, 128.5, 124.8, 
114.3, 69.1, 66.5, 43.6, 39.5, 33.3, 29.0, 27.3, 26.4, 16.1, 15.8; HRMS (EI) m/z  252.2088 [calc'd for 
C16H28O2 (M+) 252.2089]. 
 
 
 
 
 
 
A solution of lead tetraacetate (0.920 g, 2.100 mmol) and sodium carbonate (0.220 g, 2.100 mmol) in 
methylene chloride (15.0 mL) was cooled to 0°C.  The diol (0.500 g, 2.000 mmol) in methylene 
chloride (5.0 mL) was added to the solution at 0°C.  After an additional 10 min the reaction was 
warmed to room temperature over 1 hr.  The reaction was quenched with ethylene glycol (2.0 mL).  The 
mixture was filtered through Celite and rinsed with methylene chloride (3 x 15.0 mL).  The combined 
organic layers were washed with saturated sodium bicarbonate solution and then dried over Na2SO4. 
Concentration of the solvent in vacuo afforded aldehyde, which was taken on crude to the next step. 
 
FTIR (thin film/NaCl) 3075, 2924, 2856, 1726, 1677, 1640, 1440, 1382, 1237, 992, 909 cm-1; 1H NMR 
(600 MHz, C6D6)  9.28 (t, J=2.4 Hz, 1H), 5.78 (m, 1H), 5.16 (m, 1H), 5.07 (m, 1H), 5.04 (m, 1H), 4.99 
(m, 1H), 2.57 (s, 2H), 2.08-1.93 (m, 8H), 1.52 (s, 3H), 1.44-1.38 (m, 2H), 1.41 (s, 3H); 13C NMR (125 
MHz, C6D6) 198.8, 139.4, 135.1, 130.6, 127.3, 125.5, 115.1, 54.6, 40.0, 34.0, 29.8, 28.0, 27.3, 17.1, 
16.4; HRMS (ES+) m/z  220.1823 [calc'd for C15H24O (M+H+) 220.1827].   
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A tetrahydrofuran (16.0 mL) solution of enol ether (8.120 g, 0.048 mol) was added dropwise to a 
solution (64.0 mL THF) of freshly prepared LDA (0.051 mol) at -78°C.  This mixture was stirred at -
78°C for 1 hour before addition of allyl bromide (9.490 g, 0.058 mol) in 16.0 mL of THF.  [For 
preparation of allyl bromide see: a) Kim, S.; Park, J. H. J. Org. Chem. 1988, 53, 3111-3113; b) Gomez, 
L.; Gellibert, F.; Wagner, A.; Mioskowski, C. Tetrahedron Lett. 2000, 41, 6049-6052].  Stirring was 
continued at -78°C for an hour before warming to 0°C.  This mixture was diluted with water (100.0 mL) 
and ethyl acetate (60.0 mL).  The aqueous layer was extracted with ethyl acetate, dried over MgSO4 and 
concentrated.  This product was dissolved in 87.0 mL of dry THF and cooled to -78°C before MeLi 
(80.5 mL, 1.6M, 0.129 mol) was added.  This temperature was maintained for 30 minutes before 
warming to 0°C.  After an hour 2M HCl (65.0 mL) was added and stirring was continued for 12 hours 
before diluting with water (100.0 mL).  The aqueous layer was extracted with ethyl acetate (3 x 80.0 
mL) and dried over MgSO4, concentrated, and purified by silica gel chromatography (20% 
EtOAc/Hexanes) to give enone (6.700 g, 72%, 2 Steps). 
 
FTIR (thin film/NaCl) 2958, 2874, 1737, 1690, 1436, 1376, 1217, 968, 858 cm-1; 1H NMR (600 MHz, 
CDCl3)  5.79 (s, 1H), 5.46 (m, 1H), 5.33 (m, 1H), 2.39 (m, 1H), 2.32 (m, 1H), 2.29-2.19 (m, 2H), 2.10 
(m, 1H), 2.02-1.92 (m, 3H), 1.93 (s, 3H), 1.87 (m, 1H), 1.34 (m, 2H), 0.85 (t, J=7.4 Hz, 3H); 13C NMR 
(125 MHz, CDCl3) 199.4, 165.4, 133.2, 127.3, 126.8, 39.5, 34.5, 34.3, 33.7, 26.2, 23.0, 22.4, 13.5; 
HRMS (EI+) m/z  192.1512 [calc'd for C13H20O (M+) 192.1515]. 
 
 
 
 
 
 
An ethereal (14.0 mL) solution of CuI (0.700 g, 3.670 mmol) was cooled to -5°C before dropwise 
addition of MeLi (4.6 mL, 1.6M, 7.35 mmol).  After 30 minutes at -5°C enone (0.565 g, 2.940 mmol) in 
ether (4.3 mL) was added dropwise and stirred 90 minutes.  The reaction was cooled to -78°C before 
dropwise addition of distilled TMSCl (1.9 mL, 14.7 mmol), followed by dropwise addition of distilled 
Et3N (2.1 mL, 14.7 mmol).  This mixture was warmed to room temperature over 1 hour and poured 
slowly over ice, diluted with water (20.0 mL) and methylene chloride (20.0 mL).  The aqueous layer 
was extracted with methylene chloride (2 x 20.0 mL) and the combined organic extracts were dried over 
Na2SO4, concentrated, and purified with silica gel chromatography (92:4:4 hexane: EtOAc: Et3N) to 
give silyl enol ether (0.725 g, 88%). 
 
FTIR (thin film/NaCl) 2957, 2929, 2865, 1722, 1668, 1463, 1367, 1252, 1206, 1154, 966, 933, 823, 
805 cm-1; 1H NMR (600 MHz, C6D6)  5.44-5.34 (m, 2H), 4.75 (m, 1H), 2.26 (m, 1H), 2.06 (m, 2H), 
1.98 (dd, J=6.9, 13.4 Hz, 2H), 1.77 (m, 1H), 1.63 (m, 1H), 1.43-1.29 (m, 3H), 1.25 (m, 1H), 1.03 (s, 
1H), 0.88 (t, J=7.4 Hz, 3H), 0.86 (s, 3H), 0.18 (s, 9H); 13C NMR (125 MHz, C6D6) 149.4, 131.7, 
130.4, 116.4, 44.2, 35.2, 34.7, 33.6, 30.3, 24.4, 24.2, 23.2, 13.9; HRMS (EI+) m/z  280.2211 [calc'd for 
C17H32OSi (M+) 280.2223]. 
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TMS enol ether (0.422 g, 1.500 mmol) in diethyl ether (2.9 mL) was cooled to 0°C.  Methyl lithium 
(1.0 mL, 1.6 M in diethyl ether) was added dropwise.  The solution was warmed to room temperature 
over 1.25 hr.  The reaction was cooled to -10°C and zinc chloride (1.7 mL, 1.0 M in diethyl ether) was 
added dropwise over 15 min. The reaction stirred at -10°C for 20 min and then the bath was removed 
and allowed to sit at room temperature for 1 min before cooling to -45°C.  Aldehyde (0.166 g, 0.750 
mmol) in diethyl ether (1.3 mL) was added dropwise over 15 min.  The reaction was allowed to warm 
to -35°C over 1.5 hr.  The reaction was then poured onto saturated NH4Cl (15.0 mL).  The organic layer 
was diluted with ethyl acetate (10.0 mL) and then washed with sat. NH4Cl (2 x 10.0 mL) and brine (2 x 
10.0 mL).  The aqueous layers were extracted with ethyl acetate (3 x 10.0 mL).  The combined organic 
layers were dried over Na2SO4.  Concentrating the solvent in vacuo afforded the aldol adduct, which 
was taken on crude to the next step. 
 
 
 
 
 
 
 
Crude aldol product in methylene chloride (7.2 mL) and triethylamine (5.8 mL) was cooled to 0°C in a 
sealed tube.  Chlorotrimethylsilane (0.36 mL, 2.80 mmol) was added slowly.  The tube was sealed and 
warmed to room temperature over 18 hr.  The reaction was quenched by diluting with methylene 
chloride (10.0 mL) and brine (20.0 mL).  The aqueous layer was extracted with methylene chloride (3 x 
10.0 mL) and dried over Na2SO4.  Solvent was removed and residue filtered through Celite (2:5:93 
Et3N: EtOAc: hexanes, 50.0 mL).  Concentration of the solvent and silica purification (2:5:93 Et3N: 
EtOAc: hexanes) gave TMS aldol product (0.490 g, 65%).  
 
FTIR (thin film/NaCl) 2957, 2929, 2871, 1716, 1457, 1249, 968, 841 cm-1; 1H NMR (300 MHz, 
CDCl3)  5.81 (m, 1H), 5.39 (m, 2H), 5.12 (m, 2H), 4.99 (m, 1H), 4.93 (m, 1H), 4.34 (m, 1H), 2.44-
2.14 (m, 5H), 2.13-1.86 (m, 13H), 1.59 (s, 6H), 1.49-1.26 (m, 6H), 1.09 (s, 3H), 0.96 (s, 3H), 0.88 (t, 
J=7.3 Hz, 3H), 0.12 (s,9H); 13C NMR (75MHz,CDCl3) d 213.8, 139.0, 135.0, 132.0, 131.9, 129.4, 
128.3, 124.4, 114.3, 69.8, 61.7, 48.1, 44.1, 41.0, 40.0, 39.5, 34.7, 33.3, 32.0, 29.0, 27.3, 26.6, 26.2, 25.7, 
24.8, 22.7, 16.4, 16.0, 13.6, 0.8; HRMS (ES+) m/z  501.4119 [calc'd for C32H57O2Si (M+H+) 501.4128].
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TMS aldol adduct (0.580 g, 1.200 mmol) in THF (30.0 mL) was cooled to -78°C.  Lithium 
hexamethyldisilazide (3.5 mL, 1.0 M in THF) was added dropwise over 35 min.  A solution of Comin’s 
reagent (0.910 g, 2.300 mmol) in THF (5.0 mL) was added over 30 min.  The reaction was stirred at -
78°C for an additional 4.5 hr.  The reaction was quenched with brine (5.0 mL) and warmed to room 
temperature.  The mixture was washed with brine (30.0 mL) and NaOH (1 M, 30.0 mL).  The aqueous 
layer was extracted with ethyl acetate (3 x 30.0 mL).  The organics were dried over Na2SO4, 
concentrated and purified with silica (10% EtOAc: hexanes) to give vinyl triflate (0.702 g, 95%). 
 
FTIR (thin film/NaCl) 2960, 2927, 1690, 1641, 1419, 1247, 1200, 1146, 1087, 1024, 903, 841 cm-1; 1H 
NMR (300 MHz, CDCl3)  5.92-5.71 (m, 2H), 5.49-5.09 (m, 4H), 5.00 (m, 1H), 4.94 (m, 1H), 4.13 (m, 
1H), 2.40-2.15 (m, 5H), 2.14-1.89 (m, 12H), 1.63 (s, 3H), 1.60 (s, 2H), 1.51-1.30 (m, 5H), 1.16 (s, 3H), 
0.91 (s, 3H), 0.89 (t, J=7.2 Hz, 3H), 0.06 (s, 9H); 13C NMR (75 MHz, CDCl3) 

 HRMS (ES+) m/z  
655.3437 [calc'd for C33H55O4NaF3SSi (M+Na) 655.3440]. 
 
 
 
 
 
 
 
 
The TMS-protected vinyl triflate (0.050 g, 0.079 mmol) in THF (2.0 mL) and methanol (2.0 mL) was 
stirred at room temperature.  Approximately 10 pieces of Amberlyst 15 resin were added to the 
solution.  After 3 hr, the reaction was filtered through Celite using diethyl ether (15.0 mL).  
Triethylamine (2.0 mL) was added to the filtrate.  Concentration of the solvent in vacuo afforded a 
residue which was purified with silica (8% Et2O: hexanes) to give the alcohol (0.042 g, 95%). 
 
FTIR (thin film/NaCl) 3500, 2959, 2922, 2857, 1417, 1245, 1210, 1144, 1022, 915, 861 cm-1; 1H NMR 
(300 MHz, CDCl3)  5.89-5.74 (m, 2H), 5.49-5.20 (m, 3H), 5.12 (m, 1H), 5.00 (m, 1H), 4.94 (m, 1H), 
3.85 (m, 1H), 2.41-1.90 (m, 17H), 1.64 (s, 3H), 1.59 (s, 3H), 1.48-1.31 (m, 5H), 1.25 (bs, 1H), 1.12 (s, 
3H), 0.94 (s, 3H), 0.89 (t, J=7.4 Hz, 3H); 13C NMR (75 MHz, CDCl3) 149.3, 139.2, 134.9, 132.5, 
131.8, 129.8, 128.7, 125.2, 119.7, 114.5, 67.5, 55.8, 46.5, 39.7, 38.0, 37.5, 34.9, 33.6, 32.7, 29.2, 28.1, 
27.6, 26.6, 26.0, 22.9, 22.8, 16.1, 16.0, 13.9; HRMS (ES+) m/z  561.3249 [calc'd for C30H48O4F3S 
(M+H+) 561.3225]. 
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Palladium tetrakis (0.207 g, 0.180 mmol) was added to an 18 x 150 mm test tube with stir bar inserted 
into a Fisher-Porter bottle which was evacuated (100 torr) and backfilled with argon three times.  A 
degassed solution of vinyl triflate (0.400 g, 0.720 mmol) and triethylamine (0.30 mL, 2.2 mmol) in 
DMF (7.0 mL) was added.  The bottle was pressured to 62 psi CO then heated to 50°C for 15 hr.  Upon 
cooling, the CO was released and air bubbled through for 10 min.  Solvent was removed and the residue 
dissolved in methylene chloride (10.0 mL) and washed with H2O (20.0 mL) and HCl (1 M, 3.0 mL).  
The aqueous layer was extracted with 50:50 Et2O: hexanes (7 x 10.0 mL) and dried over Na2SO4.  The 
extracts were concentrated and purified by column chromatography (7% EtOAc: hexanes) to give 
lactone (0.289 g, 92%). 
 
FTIR (thin film/NaCl) 2958, 2925, 2872, 1740, 1686, 1428, 1320, 1215, 1141, 1000, 971 cm-1; 1H 
NMR (300 MHz, CDCl3)  6.82 (dd, J=3.4, 3.5 Hz, 1H), 5.81 (m, 1H), 5.47-5.05 (m, 4H), 4.99 (m, 
1H), 4.93 (m, 1H), 4.85 (m, 1H), 2.94 (m, 1H), 2.46-2.16 (m, 4H), 2.16-1.87 (m, 12H), 1.67 (s, 3H), 
1.58 (s, 3H), 1.52-1.23 (m, 5H), 1.15 (s, 3H), 0.98 (s, 3H), 0.88 (t, J=7.4 Hz, 3H); 13C NMR (75 MHz, 
CDCl3) 170.1, 139.3, 135.2, 135.0, 133.1, 130.8, 128.7, 127.9, 124.7, 114.5, 81.9, 46.9, 45.6, 44.2, 
40.0, 35.0, 34.9, 33.6, 32.6, 29.3, 27.6, 27.0, 26.9, 25.8, 24.9, 22.8, 16.6, 16.2, 13.9; HRMS (ES+) m/z  
439.3571 [calc'd for C30H47O2 (M+H+) 439.3576]. 
 
 
 
 
 
A solution of lactone (0.246 g, 0.560 mmol) in toluene (16.0 mL) was cooled to -78°C and treated with 
diisobutylaluminum hydride (4.5 mL, 1.0 M toluene) dropwise over 20 min.  After 5 min, the reaction 
was warmed to 0°C for 30 min and then 30°C for another 30 min.  The reaction was quenched with HCl 
(3 M, 8.0 mL) and stirred for 25 min at room temperature.  The mixture was saturated with NaCl and 
the aqueous layer was extracted with ethyl acetate (5 x 10.0 mL) and dried over Na2SO4.  Removal of 
solvent gave a residue which was purified with silica (25% EtOAc: hexanes) to give the diol (0.231 g, 
93%). 
 
FTIR (thin film/NaCl) 3285, 2940, 2871, 1667, 1640, 1438, 1384, 1052, 998, 969, 909 cm-1; 1H NMR 
(300 MHz, CDCl3)  5.87-5.66 (m, 2H), 5.48-5.22 (m, 2H), 5.17 (m, 1H), 5.09 (m, 1H), 4.98 (m, 1H), 
4.92 (m, 1H), 4.15-3.89 (m, 3H), 3.73 (bs, 1H), 2.55 (bs, 1H), 2.33-1.82 (m, 17H), 1.63 (s, 3H), 1.56 (s, 
3H), 1.50-1.22 (m, 5H), 1.07 (s, 3H), 0.86 (t, J=7.3 Hz, 3H), 0.79 (s, 3H); 13C NMR (75 MHz, CDCl3) 
138.9, 135.8, 134.7, 132.0, 131.4, 129.1, 128.9, 125.9, 124.9, 114.2, 68.6, 67.9, 53.7, 45.6, 39.4, 38.4, 
34.6, 33.6, 33.3, 29.5, 28.9, 27.3, 26.5, 26.3, 23.2, 22.6, 16.0, 15.8, 13.6; HRMS (ES+) m/z  443.3880 
[calc'd for C30H51O2 (M+H+) 443.3889]. 
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Pyridyl carbonate (0.029 g, 0.136 mmol) was added to the diol (0.050 g, 0.113 mmol) in dry toluene 
(2.5 mL).  This reaction mixture was heated at 110°C for 19 hours, cooled to room temperature, and 
concentrated in vacuo.  Purification using silica gel chromatography (20% EtOAc/hexanes) afforded 
carbonate (0.038 g, 73%).   
 
FTIR (thin film/NaCl) 2959, 2925, 2873, 1740, 1454, 1389, 1368, 1264, 1168, 1143, 1062, 969, 909 
cm-1; 1H NMR (300 MHz, CDCl3)  6.04 (m, 1H), 5.81 (m, 1H), 5.50-5.06 (m, 4H), 4.99 (m, 1H), 4.93 
(m, 1H), 4.75 (m, 1H), 4.41 (s, 2H), 2.50 (m, 1H), 2.38-2.13 (m, 4H), 2.13-1.86 (m, 10H), 1.70 (s, 3H), 
1.68-1.60 (m, 2H), 1.57 (s, 3H), 1.51-1.26 (m, 5H), 1.06 (s, 3H), 0.93-0.83 (m, 6H); 13C NMR (75 
MHz, CDCl3)   153.9, 139.1, 135.0, 132.1, 131.8, 129.2, 129.1, 128.7, 124.3, 114.2, 109.7, 80.1, 75.4, 
53.3, 53.3, 53.2, 42.0, 39.1, 34.7, 34.1, 33.3, 32.7, 29.0, 28.3, 27.3, 26.6, 24.4, 22.6, 16.0, 15.5, 13.7; 
HRMS (ES+) m/z  491.2500 [calc'd for C31H48O3Na (M+Na) 491.3501]. 
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The carbonate (0.008 g, 0.018 mmol) was dissolved in dry toluene (37.0 mL) and refluxed under 
nitrogen, before addition of Grubbs second generation catalyst (0.005 g, 0.005 mmol).  After 8 minutes 
the reaction was immediately cooled to 0oC in an ice bath and then warmed to room temperature.  The 
reaction mixture was filtered through a plug of silica.  The plug was thoroughly rinsed with 35% 
EtOAc/hexanes.  The solvent was evaporated and the residue was purified on silica using 20% 
EtOAc/hexanes affording diene (0.006 g, 95%). 
 
1H NMR (400 MHz, CDCl3)  6.09 (m, 1H), 5.47 (m, 1H), 5.20 (m, 1H), 4.72 (m, 1H), 4.38 (s, 2H), 
2.61 (m, 1H), 2.44-1.80 (m, 8H), 1.74-1.69 (m, 6H), 1.67 (m, 1H), 1.25 (m, 2H), 0.96 (s, 3H), 0.80 (s, 
3H); 13C NMR  154.7, 135.2, 133.2, 132.4, 131.1, 128.6, 125.0, 80.7, 75.7, 57.0, 42.8, 40.6, 33.6, 
32.1, 29.6, 28.0, 25.1, 24.2, 22.8, 22.4, 15.0; HRMS (EI+) m/z  330.2195 [calc'd for C21H30O3 (M+) 
330.2195].  Carbon shifts extracted from HSQC and HMBC spectra. 
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Titanium isopropoxide (0.07 mL, 0.23 mmol) in toluene (0.8 mL) was added to allylic alcohol (0.010 g, 
0.023 mmol) in toluene (46.0 mL) in a three neck round bottom flask with thermometer, reflux 
condenser, and nitrogen sparging tube.  The solution was heated to an internal temp of 80°C for 1 hr.  
The sparging tube was immersed in the mixture, and the internal temp was increased to 111°C.  A fresh 
solution of second generation Grubbs (0.006 g, 0.007 mmol) in toluene (0.4 mL) was added.  The 
reaction was stirred for 8 min then immersed in an ice bath.  NaOH (3 M, 5 mL) and an isocyanide 
(0.003 g, 0.027 mmol) in 0.5 mL of methanol was added to render the catalyst inactive by stirring 15 
min at room temp.  [For preparation and use of the isocyanide see: Diver, S.T. Org. Lett. 2007, 9, 
1203-1206]. The mixture was acidified with HCl (2 M, 8.0 mL), extracted with toluene (3 x 50.0 mL), 
and dried over Na2SO4.  Concentration of the solvent in vacuo and silica gel chromatography afforded 
triene diol (0.007 g, 95%). 
 
FTIR (thin film/NaCl) 3269, 2940, 2915, 1662, 1451, 1384, 1364, 1265, 1034, 1006, 952, 888, 807 cm-
1; 1H NMR (300 MHz, CDCl3)  5.88 (m, 1H), 5.41 (m, 1H), 5.10 (m, 1H), 4.18-4.07 (m, 2H), 3.92 (d, 
J=11.7 Hz, 1H), 2.52 (dd, J=8.7, 14.1 Hz, 1H), 2.37-1.77 (m, 9H), 1.72 (s, 3H), 1.70 (s, 3H), 1.51-0.99 
(m, 2H), 0.95 (s, 3H), 0.74 (s, 3H); 13C NMR  135.4, 134.9, 131.7, 129.9, 129.7, 124.2, 69.6, 69.3, 
59.8, 47.7, 40.4, 35.0, 34.0, 32.3, 26.8, 24.2, 23.4, 22.8, 21.8, 15.1;  HRMS (ES+) m/z  327.2306 [calc'd 
for C20H32O2Na (M+Na) 327.2300].  Carbon shifts extracted from HSQC and HMBC spectra.                                   
 
 
 
 
 
To a solution of diol (0.012 g, 0.039 mmol) in methylene chloride (0.4 mL) was added triethylamine 
(0.11 mL, 0.78 mmol), dimethylaminopyridine (0.010 g, 0.080 mmol) in methylene chloride (0.4 mL), 
and acetic anhydride (0.04 mL, 0.39 mmol) in methylene chloride (0.4 mL).  The reaction was stirred 
for 1 hr at room temperature.  Upon completion, the reaction was quenched with brine (3.0 mL).  The 
aqueous layer was extracted with ethyl acetate (3 x 2.0 mL) and dried over Na2SO4.  Concentration of 
the solvent in vacuo afforded a residue which was purified by column chromatography (25% EtOAc: 
hexanes) to give bis-acetate (0.014 g, 92%). 
 
1H NMR (600 MHz, CDCl3)  5.94 (m, 1H), 5.45-5.35 (m, 2H), 5.14 (m, 1H), 4.63 (d, J=12.5 Hz, 1H), 
4.52 (d, J=12.5 Hz, 1H), 2.48 (dd, J=14.2, 9.4 Hz, 1H), 2.36-2.06 (m, 6H), 2.05 (s, 3H), 2.01 (s, 3H), 
1.71 (s, 3H), 1.68-1.53 (m, 3H), 1.58 (s, 3H), 1.48-1.38 (m, 2H), 1.04 (s, 3H), 0.77 (s, 3H); 13C NMR  
170.8, 170.0, 132.6, 135.5, 131.3, 130.8, 130.7, 129.7, 72.9, 68.6, 54.0, 43.8, 42.2, 41.4, 36.7, 32.5, 
30.1, 26.3, 24.3, 23.0, 21.6, 21.6, 21.0, 15.1; HRMS (EI+) m/z  411.2511 [calc'd for C24H36O6Na 
(M+Na) 411.2492].   Carbon chemical shifts extracted from HSQC and HMBC data. 
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Triene (0.010 g, 0.026 mmol) was dissolved in acetone (0.3 mL) and treated with a freshly prepared 
dimethyl dioxirane solution (0.5 mL, 0.1M in acetone, 0.052 mmol).  The reaction is stirred 10 minutes 
while being monitored by TLC.  The solvent was evaporated to yield pure bis epoxide (0.010 g, 93%). 
  
1H NMR (600 MHz, CDCl3)  5.91 (m, 1H), 5.42 (d, J=7.6 Hz, 1H), 4.56 (d, J=12.6 Hz, 1H), 4.49 (d, 
J=12.6 Hz, 1H), 2.91 (dd, J=4.8, 9.6 Hz, 1H), 2.71 (d, 11.3 Hz, 1H), 2.23-2.11 (m, 2H), 2.06 (s, 3H), 
2.04 (s, 3H), 2.10-1.82 (m, 5H), 1.77-1.63 (m, 5H),  1.46 (s, 3H), 1.39 (s, 3H), 1.15 (s, 3H), 0.83 (s, 
3H); 13C NMR  170.5, 169.9, 132.3, 127.6, 71.1, 67.8, 65.9, 63.7, 59.7, 59.0, 53.4, 42.5, 35.4, 34.7, 
29.3, 28.5, 27.3, 26.7, 25.5, 22.1, 21.4, 21.3, 21.0, 16.4; HRMS (EI+) m/z  420.2519 [calc'd for 
C24H36O6 (M+) 420.2512]. Carbon chemical shifts extracted from HSQC and HMBC data. 
 
 
 
 
 
 
 
Bis-epoxide (0.008 g, 0.190 mmol) was dissolved in dry THF (1.9 mL) and treated consecutively with 
triethylamine and formic acid (26 L Et3N and 7.2 L HCOOH, 0.190 mmol each dissolved in 0.2 mL 
THF) and Pd(PPh3)4 (0.011 g, 0.008 mmol).  This reaction mixture was heated at 75°C for 15 hours 
before being evaporated to dryness.  Purification using silica gel chromatography (33% 
EtOAc/hexanes) afforded the desired exo-olefin containing product (0.006 g, 87%). 
 
1H NMR (600 MHz, CDCl3) 5.38 (dd, J = 2.3, 9.3 Hz, 1H), 5.03 (m, 1H), 4.71 (m, 1H), 3.07-2.95 (m, 
2H), 2.27-1.98 (m, 8H), 2.14 (s, 3H), 1.95-1.85 (m, 2H), 1.54 (s, 3H), 1.49-1.34 (m, 4H), 1.44 (s, 3H), 
1.14 (s, 3H), 0.84 (s, 3H); 13C NMR  170.4, 143.4, 116.1, 71.1, 65.9, 64.4, 60.0, 59.6, 59.2, 43.1, 38.0, 
35.7, 33.2, 28.5, 27.2, 27.0, 26.4, 25.3, 22.2, 22.2, 21.8, 16.7; HRMS (ES+) m/z  385.2355 [calc'd for 
C22H34O4Na (M+Na) 385.2355].  Carbon chemical shifts extracted from HSQC and HMBC data. 
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Exocyclic olefin product (0.001 g, 0.003 mmol) was dissolved in dry 50:50 DCM:MeOH (0.8 mL) and 
selenium dioxide was added in one portion. The reaction was then heated at 65oC for 15 hours.  The 
reaction was concentrated to remove the methanol and brought up in dry methylene chloride (0.8 mL). 
Freshly prepared Dess-Martin Periodinane was then added and the reaction was stirred for 1 hour.  The 
reaction was concentrated and purified using silica gel chromatography (33% EtOAc/hexanes) 
affording enone (0.0008 g, 77%). 
 
1H NMR (600 MHz, CDCl3)  (m, 1H), 5.40 (d, J = 7.8 Hz, 1H), 5.31 (m, 1H), 2.87 (m, 1H), 2.70 
(m, 1H), 2.59 (m, 1H), 2.53 (s, 1H), 2.31-1.99 (m, 4H), 2.07 (s, 3H), 1.86 (m, 1H), 1.47 (s, 3H), 1.39 (s, 
3H), 1.37-1.20 (m, 5H), 1.22 (s, 3H),  0.94 (s, 3H); 13C NMR  199.1, 169.8, 141.5, 127.7, 70.6, 65.7, 
62.7, 59.6, 59.2, 58.7, 42.3, 41.1, 36.2, 35.1, 26.3, 22.0, 21.5, 31.6, 27.2, 22.8, 21.4, 16.4; HRMS (ES+) 
m/z  399.2138 [calc'd for C22H32O5Na (M+Na) 399.2147].  Carbon chemical shifts extracted from 
HSQC and HMBC data. 
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Crude macrocycle (0.11 mmol) in methylene chloride (5.0 mL) was stirred at room temperature.  
Imidazole (0.068 g, 1.000 mmol) and tert-butylchlorodimethylsilane (0.050 g, 0.330 mmol) were added 
to the solution.  After 30 min, the mixture was filtered through a plug of silica and eluted with 20% 
EtOAc: hexanes (30.0 mL).  Concentration of the solvent in vacuo afforded a residue which was 
purified by column chromatography (9% EtOAc: hexanes) to give the protected alcohol (0.028 g, 62%). 
 
FTIR (thin film/NaCl) 3428, 2945, 2932, 2859, 1461, 1384, 1363, 1254, 1125, 1085, 1031, 1006, 860 
cm-1; 1H NMR (400 MHz, CDCl3)  5.82 (m, 1H), 5.41 (m, 1H), 5.09 (m, 1H), 4.12 (d, J=11.2 Hz, 1H), 
4.04-3.97 (m, 2H), 2.46 (dd, J=8.7, 14.0 Hz, 1H), 2.38-1.87 (m, 9H), 1.74 (s, 3H), 1.70 (s, 3H), 1.67-
1.50 (m, 2H), 0.95 (s, 3H), 0.89 (s, 9H), 0.72 (s, 3H), 0.09 (s, 6H); 13C NMR (75 MHz, CDCl3) 135.0, 
134.9, 134.8, 132.7, 130.0, 129.1, 70.7, 68.9, 60.4, 48.1, 40.3, 34.0, 32.3, 25.9, 25.8, 25.6, 24.2, 22.9, 
21.7, 18.3, 15.1, -3.6, -5.1, -5.4; HRMS (ES+) m/z  419.3343 [calc'd for C26H47O2Si (M+H+) 419.3345]. 
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To a mixture of N-methylmorpholine oxide (0.021 g, 0.180 mmol) and oven dried powdered 4Å sieves 
(0.060 g) was added TBS ether (0.050 g, 0.120 mmol) in methylene chloride (2.0 mL) and acetonitrile 
(0.4 mL).  Tetrapropylammonium perruthenate (0.002 g, 0.006 mmol) in methylene chloride (0.2 mL) 
was added and the reaction was stirred for 45 min at room temperature.  Concentration of the solvent in 
vacuo afforded a residue which was filtered through a plug of silica with ethyl acetate (20.0 mL).  
Concentration of the solvent in vacuo afforded the ketone which was taken on crude to the next step. 
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A solution of crude ketone (0.120 mmol) in THF (5.0 mL) was cooled to 0°C.  Lithium aluminum 
hydride (0.115 g, 3.000 mmol) was slowly added to the solution and stirred 10 min before warming to 
room temp (1 hr).  The reaction was quenched with ethyl acetate and then acidified to pH 1 with HCl (3 
M, 3.0 mL).  Solid NaCl (0.500 g) and brine (3.0 mL) were added followed by ethyl acetate extraction 
(5 x 5.0 mL).  The organics were dried over Na2SO4, concentrated, and purified by column 
chromatography (60% EtOAc: hexanes) to give diol (0.035 g, 96% over 2 steps). 
 
FTIR (thin film/NaCl) 3341, 2958, 2935, 2868, 1659, 1453, 1384, 1364, 1265, 1099, 1043, 1002, 883 
cm-1; 1H NMR (600 MHz, CDCl3)  5.75 (m, 1H), 5.44 (m, 1H), 5.22 (m, 1H), 4.37 (m, 1H), 4.11 (d, 
J=11.9, 1H), 3.98 (d, J=11.9 Hz, 1H), 2.54 (dd, J=8.4, 14.8 Hz, 1H), 2.46-1.91 (m, 9H), 1.81 (bs, 2H), 
1.75-1.69 (m, 6H), 1.68-1.59 (m, 2H), 1.16 (s, 3H), 0.76 (s, 3H); 13C NMR (125 MHz, CDCl3)  134.8, 
133.8, 130.1, 127.3, 126.9, 125.5, 75.1, 67.1, 57.9, 42.7, 40.7, 35.6, 32.0, 29.7, 29.3, 27.0, 26.8, 24.6, 
22.9, 17.6; HRMS (ES+) m/z  327.2328 [calc'd for C20H32O2Na (M+Na) 327.2300].  Carbon shifts 
extracted from HSQC and HMBC spectra. 
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To a solution of diol (0.023 g, 0.076 mmol) in methylene chloride (0.8 mL) was added triethylamine 
(0.21 mL, 1.50 mmol), dimethylaminopyridine (0.018 g, 0.150 mmol) in methylene chloride (0.8 mL), 
and acetic anhydride (0.07 mL, 0.76 mmol) in methylene chloride (0.8 mL).  The reaction was stirred 
for 1.5 hr at room temperature.  Upon completion, the reaction was quenched with brine (3.0 mL).  The 
aqueous layer was extracted with ethyl acetate (3 x 2.0 mL) and dried over Na2SO4.  Concentration of 
the solvent in vacuo afforded a residue which was purified by column chromatography (25% EtOAc: 
hexanes) to give the product (0.030 g, 98%). 
 
FTIR (thin film/NaCl) 2961, 2921, 2871, 1730, 1455, 1430, 1364, 1210, 1092, 1025 cm-1; 1H NMR 
(300 MHz, CDCl3)  5.88 (m, 1H), 5.50-5.40 (m, 2H), 5.19 (m, 1H), 4.63 (d, J=12.5 Hz, 1H), 4.44 (d, 
J=12.5 Hz, 1H), 2.59-2.11 (m, 7H), 2.08 (s, 3H), 2.05 (s, 3H), 2.03-1.84 (m, 3H), 1.74 (s, 3H), 1.72 (s, 
3H), 1.66-1.15 (m, 2H), 1.05 (s, 3H), 0.71 (s, 3H); HRMS (ES+) m/z  411.2521 [calc'd for C24H36O4Na 
(M+Na) 411.2511].  
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A solution of starting material (0.023 g, 0.059 mmol) in THF (3.0 mL) was cooled to 0°C.  Osmium 
tetroxide in t-butanol (0.662 g, 2.5 wt %) was diluted in THF (3.0 mL) and slowly added to the solution 
at 0°C.  After 15 min, the reaction was warmed to room temp over 3 h.  The reaction was quenched by 
stirring 48 h with saturated NaHSO3 (6.0 mL). The reaction was filtered through a plug of Celite with 
ethyl acetate (5 x 3.0 mL) and dried over Na2SO4.  Concentration of the solvent in vacuo afforded a 
residue which was purified by column chromatography (50% EtOAc: hexanes) to give diol (0.019 g, 
74%). 
 
FTIR (thin film/NaCl) 3452, 2925, 2874, 1735, 1671, 1451, 1376, 1220, 1079, 1029 cm-1; 1H NMR 
(400 MHz, CDCl3)  5.95 (m, 1H), 5.46 (m, 1H), 5.39 (m, 1H), 4.65 (d, J=12.4 Hz, 1H), 4.47 (d, 12.4 
Hz, 1H), 3.36 (m, 1H), 2.68 (m, 1H), 2.53 (dd, J=8.4, 15.0 Hz, 1H), 2.45-2.14 (m, 8H), 2.09 (s, 3H), 
2.06 (s, 3H), 1.88-1.75 (m, 2H), 1.73 (s, 3H), 1.35 (s, 3H), 1.05 (s, 3H), 0.71 (s, 3H); 13C NMR (125 
MHz, CDCl3) 170.9, 169.9, 135.5, 132.3, 132.3, 130.8, 95.0, 78.0, 74.2, 67.3, 55.0, 40.6, 38.9, 35.3, 
34.5, 32.4, 28.8, 26.0, 25.0, 22.7, 22.1, 21.6, 21.0, 17.1; HRMS (ES+) m/z  445.2583 [calc'd for 
C24H38O6Na (M+Na) 445.2566]. 
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Diol (0.005 g, 0.012 mmol) was dissolved in methylene chloride (1.2 mL) and cooled to 0°C.  Pyridine 
(0.019 g, 0.237 mmol) and methanesulfonyl chloride (0.020 g, 0.177 mmol) were added consecutively 
and the reaction was stirred for 15 minutes before being warmed to room temp for 2 hours.  Solvent was 
evaporated and residue was carried on to the next step. 
 
FTIR (thin film/NaCl) 3472, 2952, 2853, 1738, 1727, 1601, 1332, 1230, 1172, 1124, 1071, 1030, 919 
cm-1; 1H NMR (400 MHz, C6D6)  5.55 (m, 1H), 5.45 (m, 1H), 4.51 (m, 1H), 4.33 (m, 1H), 4.25-4.21 
(m, 1H), 2.84-2.63 (m, 2H), 2.50-2.39 (m, 2H), 2.31 (m, 1H), 2.20 (s, 3H), 2.14-2.01 (m, 3H), 1.90-1.78 
(m, 2H), 1.75 (s, 3H), 1.72-1.62 (m, 2H), 1.60 (s, 3H), 1.25 (s, 3H), 1.15 (s, 3H), 1.07 (s, 3H), 0.66 (s, 
3H); HRMS (ES+) m/z  523.2337 [calc'd for C25H40O8S (M+Na) 523.2342]. 
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Mesylate (0.003 g, 0.006 mmol) in dry THF (1.0 mL) was treated with excess NaH (0.002 g) and stirred 
at room temperature for 8 hours before quenching with sat NH4Cl (1.0 mL) and extraction with ethyl 
acetate (3 x 3.0 mL).  The organics were washed with brine, dried over MgSO4 and concentrated.  
Purification using silica gel (20% EtOAc: hexanes) afforded ketone.   
 
FTIR (thin film/NaCl) 2940, 2920, 2868, 1738, 1715, 1454, 1366, 1245, 1096, 1021, 954 cm-1; 1H 
NMR (400 MHz, CDCl3)  5.96 (m, 1H), 5.41 (m, 1H), 5.31 (m, 1H), 4.64 (m, 1H), 4.54 (m, 1H), 2.73-
2.15 (m, 8H), 2.14 (s, 3H), 2.07 (s, 3H), 2.02 (s, 3H), 1.74 (s, 3H), 1.72-1.52 (m, 5H), 1.00 (s, 3H), 0.78 
(s, 3H); 13C NMR (125 MHz, CDCl3) 134.3, 131.7, 130.2, 128.4, 72.6, 68.1, 
55.3, 51.2, 44.0, 34.5, 33.3, 33.0, 32.6, 30.0, 29.1, 28.0, 27.5. 26.5, 21.7, 21.0, 15.4; HRMS (ES+) m/z 
427.2476 [calc'd for C24H36O5 (M+Na) 427.2460]. 
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A dry methylene chloride (1.0 mL) solution of oxalyl chloride (0.03 mL, 0.34 mmol) was cooled to -
78°C before slow addition of dimethyl sulfoxide (0.05 mL, 0.70 mmol) in methylene chloride (0.5 mL).  
Ten min later a solution of diol (0.015 g, 0.037 mmol) in methylene chloride (1.5 mL) was added 
dropwise and stirred 15 minutes.  Triethylamine (0.2 mL, 1.4 mmol) was added and the mixture was 
warmed to 0°C over 30 minutes.  The reaction was quenched with sat NH4Cl and extracted with 
methylene chloride (3 x 5.0 mL).  The extracts were dried over MgSO4 and evaporated.  Purification 
using silica gel (10%-25% EtOAc/hexanes) afforded ketone (0.012 g, 80%). 
 
FTIR (thin film/NaCl) 3483, 2930, 2877, 1738, 1432, 1375, 1241, 1028, 930 cm-1; 1H NMR (400 
MHz, CDCl3)  5.87 (m, 1H), 5.45 (m, 1H), 5.03 (m, 1H), 4.63 (d, J=12.6 Hz, 1H), 4.48 (d, J=12.6 Hz, 
1H), 3.22 (m, 1H), 2.76 (m, 1H), 2.58-2.15 (m, 7H), 2.08 (s, 3H), 2.06 (s, 3H), 1.95-1.78 (m, 2H), 1.71 
(s, 3H), 1.27 (s, 3H), 1.17 (s, 3H), 0.74 (s, 3H); 13C NMR (125 MHz, CDCl3) 217.5, 170.8, 169.8, 
135.4, 132.3, 130.6, 130.1, 79.2, 73.7, 67.1, 54.0, 38.1, 35.4, 35.0, 34.6, 31.7, 29.7, 28.3, 26.5, 22.9, 
22.4, 21.6, 21.0, 17.1; HRMS (ES+) m/z  443.2413 [calc'd for C24H36O6Na (M+Na) 443.2410]. 
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To a methanol (3.0 mL) solution of ketone (0.012 g, 0.029 mmol) was added NaBH4 (0.011 g, 0.290 
mmol).  This reaction mixture was stirred at room temperature for 30 minutes before being quenched 
with 1M HCl (3.0 mL) and stirred for additional 30 minutes.  At this point brine (4.0 mL) was added 
and the reaction mixture was extracted with ethyl acetate (3 x 5.0 mL).  The combined organic layers 
were dried over MgSO4 and concentrated in vacuo.  Purification using silica gel chromatography (50% 
EtOAc/hexanes) afforded 0.010 g of the product (80%).   
 
FTIR (thin film/NaCl) 3482, 2921, 2851, 1737, 1454, 1376, 1245, 1078, 1027, 956 cm-1; 1H NMR 
(400 MHz, CDCl3)  5.83 (m, 1H), 5.50 (m, 1H), 5.17 (m, 1H), 4.67 (d, J=12.8 Hz, 1H), 4.46 (d, J=12.8 
Hz, 1H), 3.62 (m, 1H), 3.04-2.91 (bs, 2H), 2.77-2.13 (m, 8H), 2.08 (s, 3H), 2.07 (s, 3H), 2.01-1.84 (m, 
2H), 1.75 (s, 3H), 1.64-1.37 (m, 2H), 1.25 (s, 3H), 1.17 (s, 3H), 0.73 (s, 3H); HRMS (ES+) m/z  
445.2577 [calc'd for C24H38O6Na (M+Na) 445.2566]. 
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Diol (0.007 g, 0.017 mmol) was dissolved in methylene chloride (1.5 mL), and then treated with DMAP 
(0.081 g, 0.663 mmol) and thiophosgene (0.020 g, 0.174 mmol) dissolved in 0.5 mL methylene 
chloride.  This reaction mixture was heated at 45°C for 20 hours at which point SiO2 was added (color 
of solution changes from red to yellow) and stirring was continued for additional 10 minutes before 
passing the crude reaction mixture through a silica plug using 50% EtOAc/hexanes as the eluent.  
Further purification using silica gel chromatography (33% EtOAc/hexanes) afforded thiocarbonate 
(0.007 g, 91%).    
 
FTIR (thin film/NaCl) 2953, 2884, 1800, 1734, 1436, 1368, 1300, 1240, 1096, 1025, 951, 917, 852 cm-
1; 1H NMR (600 MHz, CDCl3)  5.77 (m, 1H), 5.45 (m, 1H), 5.21 (m, 1H), 4.78 (m, 1H), 4.63 (m, 1H), 
4.46 (m, 1H), 2.60 (m, 1H), 2.43-2.18 (m, 7H), 2.08 (s, 3H), 2.06 (s, 3H), 2.04-1.98 (m, 2H), 1.89-1.75 
(m, 2H), 1.72 (s, 3H), 1.45 (s, 3H), 1.22 (s, 3H), 0.77 (s, 3H); HRMS (ES+) m/z  487.2125 [calc'd for 
C25H36O6NaS (M+Na) 487.2130]. 
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Thiocarbonate (0.007 g, 0.015 mmol), dissolved in neat triethyl phosphate (1.5 mL, 7.7 mmol) was 
heated at 160°C for 15 hours.  The reaction mixture was cooled to room temperature and all excess 
triethyl phosphate was removed in vacuo.  Purification using silica gel chromatography (12% 
EtOAc/hexanes) afforded 0.005 g of product (86%).   
 
FTIR (thin film/NaCl) 2921, 2854, 1735, 1661, 1434, 1371, 1240, 1021, 957, 803, 737 cm-1; 1H NMR 
(600 MHz, CDCl3)  5.65 (m, 1H), 5.38 (m, 1H), 5.23 (m, 1H), 5.10 (m, 1H), 4.53 (m, 1H), 4.40 (m, 
1H), 2.75 (m, 1H), 2.46-2.08 (m, 7H), 2.05 (s, 3H), 2.04 (s, 3H), 1.92-1.73 (m, 4H), 1.72 (s, 3H), 1.54 
(s, 3H), 1.30 (s, 3H), 0.79 (s, 3H); 13C NMR  171.0, 170.0, 137.4, 134.3, 132.1, 129.6, 128.7, 127.8, 
78.6, 68.6, 54.8, 44.6, 42.8, 39.2, 36.6, 33.3, 29.5, 28.7, 26.3, 23.9, 21.9, 21.3, 16.5, 15.0; HRMS (EI) 
m/z  411.2524 [calc'd for C24H36O4 (M+Na) 411.2511]. Carbon shifts extracted from HSQC and 
HMBC spectra. 
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Triene starting material (0.002 g, 0.005 mmol) was dissolved in acetone (1.0 mL) and treated with a 
freshly prepared DMDO solution (0.05 mL, 0.1M in acetone, 0.005 mmol).  The C5-C6 olefin is rapidly 
consumed (5 minutes), while the C9-C12 olefin takes another 4 hours to be oxidized.  The solvent was 
evaporated the crude reaction mixture was carried on to the next step. 
 
1H NMR (600 MHz, CDCl3)  5.96 (m, 1H), 5.58 (m, 1H), 4.67 (d, J=12.4 Hz, 1H), 4.58 (d, J=12.4 Hz, 
1H), 2.95 (dd, J=4.9, 8.2 Hz, 1H), 2.84 (dd, 3.0, 7.4 Hz, 1H), 2.49-2.27 (m, 3H), 2.13 (m, 1H), 2.06 (s, 
3H), 2.05 (s, 3H), 2.04-2.00 (m, 2H), 1.95-1.85 (m, 2H), 1.78 (m, 1H), 1.69 (m, 1H), 1.46 (m, 2H), 1.35 
(s, 3H), 1.31 (s, 3H), 1.09 (s, 3H), 0.76 (s, 3H); HRMS (ES+) m/z  443.2402 [calc'd for C24H36O6 
(M+Na) 443.2410].  
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Bis-epoxide starting material was dissolved in dry THF (0.6 mL) and treated consecutively with 
Et3N/HCOOH (0.005 g Et3N and 0.002 g HCOOH, 0.050 mmol dissolved in 0.2 mL THF) and 
Pd(PPh3)4 (0.006 g, 0.005 mmol dissolved 0.1 mL THF).  This reaction mixture was heated at 75°C for 
15 hours before being evaporated to dryness.  Purification using silica gel chromatography (33% 
EtOAc/hexanes) afforded exo-olefin product (0.001 g, 55%). 
 
FTIR (thin film/NaCl) 2993, 2920, 2854, 1734, 1600, 1462, 1451, 1248, 1235, 1078, 1018, 957, 889 
cm-1; 1H NMR (400 MHz, C6D6) 5.52 (m, 1H), 4.70 (m, 1H), 4.58 (m, 1H), 3.09-3.01 (m, 2H), 2.62-
2.50 (m, 1H), 2.28-2.02 (m, 8H), 1.97 (s, 3H), 1.93 (m, 1H), 1.79-1.65 (m, 2H), 1.51 (s, 3H), 1.31 (s, 
3H), 1.26 (s, 3H), 0.98-0.85 (m, 2H), 0.83 (s, 3H); 13C NMR  168.6, 127.9, 111.7, 70.4, 65.1, 64.7, 
61.2, 60.4, 58.8, 43.2, 40.0, 37.6, 36.8, 32.9, 31.3, 30.4, 30.2, 30.1, 24.5, 20.7, 18.7, 15.9; HRMS (ES+) 
m/z  363.2538 [calc'd for C22H35O4 (M+H) 363.2535].  Carbon chemical shifts extracted from HSQC 
and HMBC data. 
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Diene starting material (0.014 g, 0.036 mmol) was dissolved in dry DCM and cooled to 0oC.  A freshly 
prepared solution of mCPBA (0.013 g, 0.072 mmol) in 2.0 mL of DCM was added drop-wise over  10 
minutes and the reaction was stirred an additional 20 minutes.  The reaction was then quenched by 
adding 3.0 mL of saturated sodium thiosulfate, extracted with DCM, and dried over sodium sulfate.  
Purification using silica gel chromatography (20% EtOAc/hexanes) afforded monoepoxide (0.006 g, 
40%). 
 
1H-NMR (400 MHz, CDCl3)  5.92 (m, 1H), 5.47 (m, 1H), 5.36 (m, 1H), 4.66 (d, J=12.4 Hz, 1H), 4.48 
(d, J=12.4 Hz, 1H), 2.90 (m, 1H), 2.81 (m, 1H), 2.60-2.14 (m, 9H), 2.09 (s, 3H), 2.07 (s, 3H), 2.04-1.88 
(m, 2H), 1.74 (s, 3H), 1.37 (s, 3H), 0.98 (s, 3H), 0.73 (s, 3H). 
 
_____________________________________________________________________ 
 
 
 
 
 
Bis-acetate epoxide (0.024 g, 0.059 mmol) was dissolved in THF (3.0 mL) and cooled to 0oC.  Freshly 
distilled pyridine (0.065 g) was added followed by OsO4 in THF (0.693 g, 1.15 eq, 0.9 mL) and the 
reaction was stirred for 10 min and then the bath was removed.  After 18 hours at room temperature, 
NaHSO3 (2.0 mL) and MeSO2NH2 were added and stirred 24 hours to ensure complete quenching of 
the osmium.  The reaction was then concentrated and purified with silica gel chromatography (50% 
EtOAc/hexanes) to give epoxy-diol (0.024 g, 93%). 
 
1H-NMR (400 MHz, CDCl3)  5.90 (m, 1H), 5.48 (m, 1H), 4.69 (d, J = 12.7 Hz, 1H),  4.58 (d, J = 12.7 
Hz, 1H), 3.74 (m, 1H), 2.95 (dd, J = 15.8, 9.3, 1H), 2.86 (m, 1H), 2.35-2.11 (m, 4H), 2.10 (s, 3H), 2.04 
(s, 3H), 1.99-1.76 (m, 5H), 1.65-1.48 (m, 2H), 1.33 (s, 3H), 1.28 (s, 3H), 1.14 (s, 3H). 
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Diol starting material (0.024 g, 0.055 mmol) was dissolved in dry DCM (1.2 mL) and cooled to 0oC.  
Freshly distilled pyridine (0.086 g, 20 eq.) was added followed by MsCl (0.093 g, 15 eq.) in DCM (0.3 
mL).  The reaction was maintained 10 minutes before the bath was removed and stirred 2 additional 
hours.  The volatiles were then removed and the residue was purified using silica gel chromatography 
(50% EtOAc/hexanes) to give mono mesylate (0.028 g, 99%). 
 
1H-NMR (500 MHz, CDCl3)  5.88 (m, 1H), 5.47 (d, J = 9.42 Hz, 1H), 4.76 (d, J = 13.2 Hz, 1H), 4.62 
(m, 1H), 4.53 (d, J = 13.2 Hz, 1H), 3.07 (s, 3H), 2.85 (m, 1H), 2.32-2.02 (m, 5H), 2.11 (s, 3H), 2.06 (s, 
3H), 1.95-1.80 (m, 3H), 1.65-1.51 (m, 3H), 1.41 (s, 3H), 1.26 (s, 3H), 1.13 (s, 3H), 0.76 (s, 3H). 
 
_____________________________________________________________________ 
 
 
 
 
 
 
Mono mesylate (0.028 g, 0.054 mmol) was dissolved in dry CH3CN (1.2 mL) at room temperature.  
Excess DBU (0.058 g, 7 eq.) was then added and the reaction was stirred 12 hours until starting material 
was consumed.  The solvent was removed and the residue was purified using silica gel chromatography 
(50% EtOAc/hexanes) to give desired bis epoxide (0.007 g, 33%). 
 
1H-NMR (300 MHz, CDCl3)  5.96 (m, 1H), 5.58 (m, 1H), 4.68 (d, J = 11.9 Hz, 1H), 4.58 (d, J = 11.9 
Hz, 1H), 2.95 (m, 1H), 2.85 (m, 1H), 2.56-2.25 (m, 5H), 2.06 (s, 3H), 2.05 (s, 3H), 1.97-1.61 (m, 4H), 
1.53-1.39 (m, 2H), 1.35 (s, 3H), 1.31 (s, 3H), 1.10 (s, 3H), 0.76 (s, 3H); 13C NMR  170.8, 170.0, 
131.0, 130.7, 70.7, 67.2, 64.4, 62.6, 59.8, 58.5, 51.5, 34.1, 33.3, 32.6, 29.8, 28.4, 27.3, 25.0, 22.9, 22.3, 
22.3, 22.2, 21.5, 20.9. Carbon chemical shifts extracted from HSQC and HMBC data. 
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Bis-epoxide (0.004 g, 0.008 mmol) was added to a flame dried flask along with freshly prepared 
Pd(PPh3)4 and degassed THF (1.2 mL).  To this solution was added a solution of formic acid (3.2 L, 
0.08 mmol), triethylamine (0.01 mL, 0.08 mmol) and THF (0.6 mL).  This mixture was heated at 75oC 
for 18 hours.  The solvent was then removed and the residue was purified using silica gel 
chromatography (30% EtOAc/hexane) to give pure exo olefin (0.003 g, 98%).   
 
1H-NMR (400 MHz, C6D6)  5.63 (m, 1H), 4.73 (m, 1H), 4.65 (m, 1H), 2.85-2.69 (m, 2H), 2.59 (dd, J 
= 3.4, 16.2 Hz, 1H), 2.35 (dd, J = 4.5, 9.9 Hz, 1H), 2.13 (dd, J = 6.0, 15.1 Hz, 1H), 2.00-1.89 (m, 2H), 
1.87-1.76 (m, 1H), 1.74 (s, 3H), 1.71-1.16 (m, 8H), 1.13 (s, 3H), 1.04 (s, 3H),  0.88 (s, 3H), 0.67 (s, 
3H). 
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Exo-olefin (0.003 g, 0.008 mmol) was dissolved in dry benzene (3.5 mL) and then freshly distilled 
pyridine (0.07 mL, 0.83 mmol) was added at room temperature.  To this was added pentafluorobenzene 
selenic acid and the reaction was heated at 80oC for 2 hrs.  The solvent was then removed and the 
residue was purified using silica gel chromatography (50% EtOAc/hexanes) to yield an isomer of 
hypoestoxide (0.001 g). 
 
1H-NMR (600 MHz, CDCl3)  6.32 (m, 1H), 5.53 (m, 1H), 5.35 (m, 1H), 2.92 (m, 1H), 2.82 (m, 1H), 
2.76 (d, J = 4.8 Hz, 1H), 2.70-2.62 (m, 2H), 2.50 (dd, J = 1.7, 15.2 Hz, 1H), 2.23 (m, 1H), 2.15-2.00 (m, 
2H), 2.06 (s, 3H), 1.95-1.81 (m, 3H), 1.78-1.59 (m, 2H), 1.33 (s, 3H), 1.21 (s, 3H), 1.17 (s, 3H), 0.86 (s, 
3H); ); 13C NMR  198.7, 169.9, 144.4, 127.1, 75.7, 63.8, 61.9, 60.4, 58.5, 55.5, 42.1, 35.5, 34.3, 33.3, 
29.2, 27.5, 26.1, 24.1, 23.9, 23.4, 22.9, 21.7.  HRMS (ES+) m/z  399.2159 [calc'd for C22H32O5Na 
(M+Na) 399.2147].  Carbon chemical shifts extracted from HSQC and HMBC data. 
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Ketone starting material (0.058 g, 0.120 mmol) was dissolved in dry THF (2.5 mL), cooled to 0°C when 
an ethereal solution of MeMgBr (0.43 mL, 3.0M, 1.28 mmol) was added dropwise.  After 15 minutes 
the reaction was allowed to warm to room temperature over an hour.  This mixture was quenched with 
sat. NH4Cl, acidified to pH 1 (HCl), and stirred 10 minutes.  Addition of NaCl and extraction with 
EtOAc (8 x 8.0 mL) followed by drying over MgSO4 and concentration gave yellow oil that was 
purified over silica gel (15% EtOAc/hexanes) to give product (0.060 g, 60%). 
 
FTIR (thin film/NaCl) 3392, 2957, 2940, 2871, 1453, 1386, 1180, 1102, 1043, 993, 968, 910 cm-1;    
1H NMR (300 MHz, CDCl3)  5.81 (m, 1H), 5.35 (m, 2H), 5.23 (m, 1H), 5.12 (m, 1H), 4.99 (m, 1H), 
4.94 (m, 1H), 4.37 (m, 1H), 2.51 (dd, J=10.8, 13.4 Hz, 1H), 2.32-1.77 (m, 16H), 1.64 (s, 3H), 1.59 (s, 
3H), 1.51-1.37 (m, 7H), 1.35 (s, 3H), 1.33 (s, 3H), 1.05 (s,3H),0.88(t, J=7.3 Hz,3H); 13C NMR 
(75MHz,CDCl3) 
; HRMS 
(ES+) m/z 467.3867 [calc'd for C30H52O2Na (M+Na+) 467.3865].

_____________________________________________________________________ 
 
 
 
 
 
Pyridine (0.17 mL, 2.03 mmol) was added to the diol (0.060 g, 0.140 mmol) dissolved in methylene 
chloride (5.0 mL).  This mixture was cooled to -78°C and a methylene chloride (3.0 mL) solution of 
triphosgene (0.040 g, 0.140 mmol) was added slowly.   The reaction was warmed to room temperature 
(1 hour) and stirred for 18 hours.  The reaction mixture was quenched with sat. NH4Cl (2.0 mL), and 
acidified using 1M HCl (1.0 mL).  The organic layer was separated and the aqueous layer was extracted 
using ethyl acetate (6 x 5.0 mL).  The combined organic layers were dried over MgSO4, filtered and 
concentrated in vacuo.  Purification with silica gel (16% EtOAc/hexanes) afforded the carbonate 
product (0.048 g, 75%). 
 
FTIR (thin film/NaCl) 2955, 2926, 2872, 1735, 1451, 1368, 1294, 1215, 1166, 1085, 969, 909, 770 cm-
1; 1H NMR (300 MHz, CDCl3)  5.82 (m, 1H), 5.51-5.18 (m, 3H), 5.12 (m, 1H), 4.99 (m, 1H), 4.94 (m, 
1H), 2.59 (m, 1H), 2.42-2.17 (m, 3H), 2.19-1.73 (m, 12H), 1.69 (s, 3H), 1.59 (s, 1H), 1.54 (s, 3H), 1.52-
1.23 (m, 9H), 1.18 (s, 3H), 1.09 (s, 3H), 0.88 (m, 3H); 13C NMR  150.3, 139.0, 135.2, 132.2, 131.0, 
129.0, 128.3, 124.9, 114.5, 79.5, 79.1, 43.6, 39.5, 39.2, 35.9, 34.7, 33.6, 32.9, 31.0, 30.3, 29.9, 29.3, 
27.5, 26.9, 25.6, 24.0, 23.7, 22.9, 16.7, 16.1, 13.9; HRMS (ES+) m/z  471.3853 [calc'd for C31H51O3 
(M+H+) 471.3838].  
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The metathesis precursor (0.046 g, 0.098 mmol) was dissolved in dry toluene (204.0 mL).  This mixture 
was brought to reflux, with a stream of nitrogen constantly bubbling through the solution, before 
addition of Grubbs second generation catalyst (0.025 g, 0.030 mmol).  After 8 minutes the crude 
reaction mixture was immersed in an ice-water bath and the before mentioned isocyanide (0.006 g, 
0.054 mmol) in 0.5 mL of methanol was added to render the catalyst inactive by stirring 15 min at room 
temp.  The cold toluene solution was then filtered through a plug of silica washing with 30% 
EtOAc/hexanes.  The solvent was evaporated and the crude mixture was purified on silica using 10% 
EtOAc/hexanes affording the macrocycle (0.013 g, 40%). 
 
1H NMR (600 MHz, CDCl3)  5.55 (m, 1H), 5.38 (m, 1H), 4.60 (m, 1H), 3.03 (dd, J=14.1, 11.7 Hz, 
1H), 2.52 (d, 14.1 Hz, 1H), 2.38-1.89 (m, 13H), 1.74 (s, 3H), 1.61 (s, 3H), 1.26 (s, 3H), 0.99 (s, 3H), 
0.98 (s, 3H); 13C NMR  154.5, 135.9, 132.8, 128.8, 125.2, 86.1, 77.34, 56.4, 44.1, 43.8, 38.2, 35.6, 
33.5, 32.0, 30.5, 29.7, 27.6, 25.3, 24.2, 24.1, 15.2; HRMS (EI+) m/z  332.2347 [calc'd for C21H32O3 
(M+) 332.2352].  Carbon chemical shifts extracted from HSQC and HMBC data.  
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To a dioxane (1.5 mL) solution of the carbonate (0.024 g, 0.074 mmol) was added 1M NaOH (1.5 mL).  
This mixture was stirred vigorously at room temperature for 6 hours, at which point it was diluted with 
brine (2.0 mL), saturated with solid NaCl and extracted with ethyl acetate (5 x 3.0 mL).  The combined 
organic layers were dried over MgSO4, filtered and concentrated. Purification using silica gel 
chromatography (30% EtOAc/hexanes) gave diol product (0.018 g, 71%).   
 
FTIR (thin film/NaCl) 3316, 2947, 2927, 2870, 1653, 1558, 1540, 1457, 1341, 1109, 1000, 913, 801 
cm-1; 1H NMR (600 MHz, CDCl3)  5.50 (m, 1H), 5.31 (m, 1H), 4.12 (d, J=9.7 Hz, 1H), 3.13 (dd, 
J=14.2, 9.7 Hz, 1H), 2.41-1.79 (m, 15H), 1.74 (s, 3H), 1.72 (s, 3H), 1.48 (s, 3H), 0.96 (s, 3H), 0.94 (s, 
3H); 13C NMR (125 MHz, CDCl3)  135.2, 132.3, 129.9, 125.8, 75.8, 71.7, 63.0, 47.9, 44.8, 41.0, 36.4, 
35.9, 32.2, 29.7, 24.8, 24.5, 24.4, 24.1, 22.9, 15.3; HRMS (ES+) m/z  329.245 [calc'd for C20H34O2 
(M+Na) 329.2457]. 
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To a dichloromethane (1.5 mL) solution of the diol (0.005 g, 0.016 mmol) was added dimethyl amino 
pyridine (0.002 g, 0.016 mmol) and pyridine (0.013 g, 0.163 mmol).  A stock solution of mesyl chloride 
(0.019 g, 0.163 mmol) was next added at room temperature and was stirred 20 hours.  The reaction 
mixture was concentrated in vacuo and purified using silica gel chromatography (30% EtOAc/hexanes) 
afforded mesylate (0.003 g, 51%).   
 
1H NMR (500 MHz, CDCl3)  5.51 (m, 1H), 5.42-5.36 (m, 2H), 3.45 (dd, J=10.1, 14.9 Hz, 1H), 2.49-
1.83 (m, 15H), 1.80 (s, 3H), 1.73 (s, 3H), 1.47 (s, 3H), 1.07 (s, 3H), 0.98 (s, 3H).  
 
_____________________________________________________________________ 
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A solution of naphthalene (1.300 g, 0.010 mol) and THF (10 mL) was stirred at 23oC for 10 minutes.  
Freshly cleaned lithium wire was next added to the reaction and allowed to stir 2 hours at which point it 
had assumed a dark green color.  An aliquot of this was transferred to a fresh vial and cooled to -78oC 
under nitrogen.  Next starting mesylate (0.002 g, 0.005 mmol) was dissolved in dry THF (0.5 mL) and 
added slowly to the reaction mixture over 3 minutes.  The reaction was allowed to stir 10 minutes and 
then it was quenched with saturated ammonium chloride.  The reaction was brought to room temp and 
extracted with ethyl acetate (4 x 2.0 mL) and dried over MgSO4.  The extracts were concentrated and 
purified with silica gel chromatography to give pure deoxygenated product (1.4 mg, 93%). 
 
1H NMR (500 MHz, CDCl3)  5.54 (m, 1H), 5.26 (m, 1H), 2.50-1.77 (m, 17H), 1.75 (s, 3H), 1.67 (s, 
3H), 1.42 (s, 3H), 1.28 (s, 3H), 0.92 (s, 3H); 13C NMR  135.0, 134.9, 128.6, 125.7, 73.4, 57.8, 44.6, 
40.6, 37.4, 36.5, 34.6, 32.2, 29.7, 29.6, 27.2, 24.9, 24.6, 24.0, 22.9, 15.2; HRMS (EI+) m/z  290.2613 
[calc'd for C20H34O (M+) 290.2610].  Carbon chemical shifts extracted from HSQC and HMBC 
data.   
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Spectral Confirmation of Incorrect C12, 
Olefin Geometery (Z) and Atropisomer 
 
 
 
HSQC (1.37) 
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HMBC (1.37) 
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Carbon and Proton Assignments From HSQC and HMBC Data (1.37): 
 
All carbons chemical shifts and the chemical shifts of the protons that are attached to 
them have been mapped out using both HSQC and HMBC techniques.  These values 
can then be used to map out stereochemical relationships given NOE correlations. 
 
 
C ppm HMQC ( ppm) HMBC ( ppm) 
1 57.0 2.32 6.07,4.70,2.59,0.95,0.79 
2 33.6  2.32,2.24,0.95,0.79 
3 40.6 2.07 6.07,2.32,1.70,0.95,0.79 
4 24.2 2.28,1.99 1.70 
5 125.0 5.45 1.70 
6 135.2  2.28,1.70 
7 32.1 2.21,1.92 5.45,2.28,1.70 
8 28.0 2.24,1.69 6.07 
9 132.4 5.18 2.59,2.38,1.71 
10 131.1  2.59,1.69 
11 42.8 2.59,2.38 5.18,4.70,2.32,1.69 
12 80.7 4.70 2.59,2.32,0.95,0.79 
15 22.8 1.70 5.45 
16 15.0 1.71 5.18,2.59 
17 29.6 1.24  
18 133.2 6.07 4.34,2.32 
19 128.6  4.70,4.34,2.59,2.38,2.32 
20 75.7 4.39,4.34 6.07 
21 22.4 0.79 0.95 
22 25.1 0.95 0.79 
23 154.7  4.70,4.34 
 
 
Table A1.1 2D-NMR Data for 1.37 
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NOESY (1.37) 
 
 
 
 
Important NOE Correlations For Proving Stereochemical Assignments: 
 
Pictured are the relevant NOE correlations to prove the stereochemical assignments 
for the metathesis product. 
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O
C9-C10 = E-olefin
C5-C6 = Z-olefin
C1-C12 = axial
C3-C4 = equatorial
Incorrect atropisomer C12 = incorrect
H
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ppm HMBC ( ppm) 
135.4 4.13,3.95,2.13 
134.9 4.16,2.52,1.71 
131.7 2.15,1.73 
129.9 4.13,3.95,2.13 
129.7 2.13,1.73 
124.2 1.73 
69.6 0.76 
69.3 2.35 
59.8 0.96,0.76 
47.7 2.12,1.73 
40.4 2.13,1.71,0.96,0.76 
35.0 1.09,0.76 
34.0 2.12,0.96,0.76 
32.3 1.71,0.96 
26.8 0.76 
24.2 1.71 
23.4 1.60,0.96 
22.8 0.76 
21.8 2.13,0.96 
15.1 5.10 
 
Table A1.2 2D-NMR Data for 1.38 
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C ppm HSQC ( ppm) HMBC ( ppm) 
1 54.0 2.08 4.51 
2 36.7  0.77 
3 42.2 1.41  
4 30.1 1.04  
5 130.7 5.13  
6 135.5  1.71 
7 41.7 2.06,1.77  
8 24.3 2.36,2.28 1.71 
9 130.8 5.35  
10 132.6  5.37 
11 43.8 2.48,2.09  
12 72.9 5.37 2.48 
13 170.0  5.37,2.01 
14 21.6 2.01  
15 23.0 1.71  
16 15.1 1.75 2.48 
17 32.5 2.30,1.73  
18 129.7 5.94  
19 131.3  1.73 
20 68.6 4.62,4.51  
21 21.6 0.77  
22 26.3 0.97 5.37 
23 170.8  4.62,4.51,2.05 
24 21.0 2.05  
 
 
Table A1.3 2D-NMR Data for 1.38-(Bis-Acetate) 
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C ppm HSQC ( ppm) HMBC ( ppm) 
 29.3 2.18,1.89  
 28.5 1.72,1.35 2.90 
 27.3 1.98,1.38  
 26.7 1.14  
 25.5 2.09,1.46 2.70 
 22.1 1.38  
 21.3 0.83  
 16.4 1.46 1.72 
1 53.4 2.09 4.49,1.14 
2 34.7  1.14,0.73 
3 35.4 1.66  
5 65.9 2.70 1.72,1.46 
6 59.0  1.37 
9 63.7 2.90 1.73 
10 59.7  5.41,1.45 
11 42.5 2.07,1.73  
12 71.1 5.41  
13 169.9  2.03,5.41 
14 21.4 2.03  
18 127.6 5.91  
19 132.3  5.41 
20 67.8 4.55,4.49  
23 170.5  2.05,4.49 
24 21.0 2.05 1.14 
 
Table A1.4 2D-NMR Data for 1.39 
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C ppm HSQC ( ppm) HMBC ( ppm) 
1 60.0 2.15 1.95,1.50 
2 35.7  1.10, 0.80 
3 38.0 1.77 2.96,1.10,0.80 
4 25.3 2.10,1.49  
5 64.4 2.98 1.68,1.40 
6 59.2  1.40 
7 27.0 1.96,1.43 1.40 
8 28.5 1.67,1.34  
9 65.9 2.96 2.15,1.50 
10 59.6  1.10, 0.80 
11 43.1 2.15,1.95 1.50 
12 71.1 5.35 2.15,1.95 
13 170.4  2.05 
14 21.8 2.05  
15 22.2 1.40  
16 16.7 1.50 1.95 
17 26.4 1.74,1.39  
18 33.2 2.42,2.36 4.99,4.68 
19 143.4  2.15,5.35 
20 116.1 4.99,4.68  
21 22.2 0.8 1.10 
22 27.2 1.10 0.80 
 
Table A1.5 2D-NMR Data for 1.40 
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C ppm HSQC ( ppm) HMBC ( ppm) 
1 58.7 2.53 1.86,1.22,0.94 
2 36.2  1.22,0.94 
3 35.1 1.86 1.22,0.94 
4 31.6 1.26 1.29 
5 62.7 2.87 1.39 
6 59.2  1.39 
7 27.2 2.01,1.37 1.39 
8 22.8 1.29  
9 65.7 2.71 2.06,1.47 
10 59.6  2.06,1.47 
11 42.3 2.06,1.26  
12 70.6 5.40  
13 169.8  2.08 
14 21.4 2.07  
15 22.0 1.39  
16 16.4 1.47  
17 41.1 2.60,2.24  
18 199.1  6.22,5.31,2.53 
19 141.5  5.40,2.53 
20 127.7 6.22,5.31  
21 21.5 0.94 1.22 
22 26.3 1.22 0.94 
 
Table A1.6 2D-NMR Data for 1.41 
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C ppm HSQC ( ppm) HMBC ( ppm) 
 134.8  1.72 
 133.8  2.25, 2.51 
 130.1   
 127.3 5.76 2.01, 1.72 
 125.5  1.72 
 57.9  1.16, 0.74 
 42.7   
 40.7  1.16, 0.74 
 35.6  1.16, 0.74 
 32.0  1.72 
 29.7 1.26  
 29.3   
 27.0   
 26.8 1.16 0.76 
 24.6 0.76  
 22.9 1.72  
 17.6 1.81 2.25 
12 75.1 4.37 2.51 
18 126.9  3.98 
20 67.1 4.10,3.98  
 
Table A1.7 2D-NMR Data for 1.42 
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Spectral Confirmation for Correction of: C12 and Olefin Geometry (EE)  
 
 
HSQC-AD (1.45) 
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HMBC-AD (1.45)  
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Carbon and Proton Assignments From HSQC and HMBC Data: 
 
All carbons chemical shifts and the chemical shifts of the protons that are attached to 
them have been mapped out using both HSQC and HMBC techniques.  These values 
can then be used to map out stereochemical relationships given NOE correlations. 
 
 
C ppm HSQC ( ppm) HMBC ( ppm) 
1 54.8 2.00 0.77 
2 36.6  0.77 
3 42.8 1.65 1.52,0.77 
4 29.5 1.80,1.76 5.36,1.52 
5 129.6 5.36  
6 134.3  2.16,2.04,1.52 
7 39.2 2.16,2.04 5.36,2.12,1.52 
8 26.3 2.35,2.12 1.69,1.52 
9 127.8 5.08 1.69 
10 132.1  5.22,2.73,2.11,1.69 
11 44.6 2.73,2.11 1.69 
12 78.6 5.22  
13 170.0  5.22,2.04,2.01 
14 21.9 2.01  
15 15.0 1.52 5.36 
16 16.5 1.69  
17 33.3 2.24,1.77  
18 128.7 5.63 4.51,4.38,2.24,2.00 
19 137.4  5.22,4.51,4.38,2.00 
20 68.6 4.51,4.38  
21 23.9 0.77  
22 28.7 1.28 0.77 
23 171.0  4.51.4.38,2.02 
24 21.3 2.02  
 
Table A1.8 2D-NMR Data for 1.45 
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NOESY (1.45) 
 
 
 
 
Important NOE Correlations For Proving Stereochemical Assignments: 
 
Pictured are the relevant NOE correlations to prove the stereochemical assignments.  
This shows correct C12 and olefin geometries (EE). 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C9-C10 = E-olefin
C5-C6 = E-olefin
C1-C12 = axial
C3-C4 = equatorial
Incorrect atropisomer C12 = correct
H H
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C ppm HSQC ( ppm) HMBC ( ppm) 
 40.0  0.89,0.61 
 36.8  0.89.0.61 
 31.3 1.23,1.20  
 30.2 1.98,1.36  
 30.1 1.56,1.31  
1 61.2 1.86 0.89,0.61 
5 64.7 2.76 1.02 
6 58.8  1.02 
9 65.1 2.81 2.25,1.56 
10 60.4  1.56 
11 43.2 2.25,2.15 1.54 
12 70.4 5.60 2.25 
13 168.6  1.68 
14 20.7 1.68  
15 15.9 1.02  
16 18.7 1.53  
17 32.9 1.78,0.82  
18 37.6 1.93,1.04  
19 127.9  4.64 
20 111.7 4.64,4.53  
21 24.5 0.61 0.89 
22 30.4 0.89 0.61 
 
 
Table A1.9 2D-NMR Data for 1.46 
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Spectral Confirmation for Correction of C12 
and the Unnatural Epoxide Geometries (ZZ) 
 
 
 
 
 
 
Carbon Chemical Shifts Extracted 
From HSQC and HMBC Spectra 
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HSQC-AD (1.49) 
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HMBC-AD (1.49) 
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Carbon and Proton Assignments From HSQC and HMBC Data: 
 
All carbons chemical shifts and the chemical shifts of the protons that are attached to 
them have been mapped out using both HSQC and HMBC techniques.  These values 
can then be used to map out stereochemical relationships given NOE correlations. 
 
C ppm HSQC  ( ppm) HMBC ( ppm) 
1 51.5 2.11 5.94,5.56,4.65,4.56 
2 34.1  5.56 
3 32.6 2.42 5.94,2.93 
4 28.4 1.64,1.43 2.93,1.33 
5 64.4 2.93 1.33 
6 59.8  2.93,1.33 
7 27.3 1.87,1.46 2.82,1.33 
8 22.9 2.00 2.82 
9 62.6 2.82 1.29 
10 58.5  5.56,1.29 
11 33.3 2.37,1.90 1.29 
12 70.7 5.56  
13 170.0  5.56,2.04 
14 21.5 2.04  
15 22.3 1.33 2.93 
16 22.3 1.29 2.82 
17 29.8 2.32,1.76 5.94 
18 131.0 5.94 5.56,4.56,1.43,1.08 
19 130.7  5.56 
20 67.2 4.65,4.56 5.94 
21 22.2 0.74  
22 25.0 1.08  
23 170.8  2.05,4.65,4.56 
24 20.9 2.04  
 
Table A1.10 2D-NMR Data for 1.49 
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NOESY (1.49) 
 
 
Important NOE Correlations For Proving Stereochemical Assignments: 
 
Pictured are the relevant NOE correlations to prove the stereochemical assignments.  
This shows correct C12 and the unnatural epoxide geometries (ZZ). 
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Incorrect atropisomer
H
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C5,C6,C9,C10 relative
stereochemistry correct
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C ppm HSQC ( ppm) HMBC ( ppm) 
1 55.5 2.76 6.33,5.53,1.85,1.16,0.85 
2 35.5  2.76,2.65,1.16,0.85 
3 33.3 2.67 2.76,2.24,1.16,0.85 
4 29.2 1.72,1.63 2.92,2.24 
5 63.8 2.92 1.32 
6 60.4  1.32 
7 27.5 1.87,1.51 1.88,1.32 
8 23.9 2.09,1.88 1.51 
9 61.9 2.82 1.21 
10 58.5  2.49,1.85,1.21 
11 34.3 2.49,1.85 2.76,1.21 
12 75.7 5.35 2.76,2.49,1.85 
13 169.9  2.05 
14 21.7 2.05  
15 23.4 1.32 1.51 
16 22.9 1.21 2.49 
17 42.1 2.65,2.24 1.63 
18 198.7  6.33,5.53,2.65,2.24 
19 144.4  6.33,2.76 
20 127.1 6.33,5.53 2.76,2.09 
21 24.1 0.85 2.76,1.16 
22 26.1 1.16 0.85 
 
 
Table A1.11 2D-NMR Data for 1.50 
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C ppm HSQC ( ppm) HMBC ( ppm) 
 135.9  1.72,1.43 
 132.8 5.38  
 128.8  2.19,1.73 
 125.2 5.54  
 43.8 3.03,2.52  
 38.2 2.05  
 33.5 1.61  
 32.0 2.26,1.95  
 30.5 1.43  
 29.7 1.26  
 27.6 1.00  
 25.3 2.16  
 24.2 0.98  
 24.1 2.34,2.08  
 15.2 1.72  
1 56.4 2.16  
2 35.6  0.98 
3 44.1 2.14  
12 77.3 4.60  
19 86.1  1.61 
23 154.5  4.60 
 
Table A1.12 2D-NMR Data for 1.52-(Carbonate) 
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Spectral Confirmation of Verticillol Diol Stereochemistry 
 
HSQC-AD (1.52) 
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HMBC-AD (1.52) 
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Carbon and Proton Assignments From HSQC and HMBC Data: 
 
All carbons chemical shifts and the chemical shifts of the protons that are attached to 
them have been mapped out using both HSQC and HMBC techniques.  These values 
can then be used to map out stereochemical relationships given NOE correlations. 
 
C ppm HSQC ( ppm) HMBC ( ppm) 
1 62.0 1.91 3.06,2.29,1.42,0.88 
2 43.7  1.91,0.88 
3 34.8 2.09 1.91,0.88 
4 24.3 1.11,2.04 5.44,1.91 
5 124.7 5.44 1.66 
6 134.2  2.26,1.66 
7 31.3 2.18,1.86 5.44 
8 23.0 2.26,1.97 1.68 
9 128.8 5.24 3.06,2.29 
10 131.2  3.06,2.29 
11 47.0 2.29,3.06 5.24,1.91 
12 70.7 4.06 3.06,2.29,1.91,0.88 
15 21.9 1.66 5.44 
16 14.3 1.68 5.24 
17 35.6 1.61,1.12 1.96 
18 40.3 1.66,1.96 1.91,1.42 
19 74.9  1.91,1.66,1.42 
21 23.8 0.88 0.90 
22 28.5 0.90 0.88 
24 35.4 1.42 1.96,1.91 
 
Table A1.13 2D-NMR Data for 1.52 
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NOESY (1.52) 
 
 
Important NOE Correlations For Proving Stereochemical Assignments: 
 
Pictured are the relevant NOE correlations to prove the stereochemical assignments.  
This shows incorrect C19 and C12 stereochemistry and incorrect olefin geometry 
(EZ).   
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Carbon Chemical Shifts Extracted
From HSQC and HMBC Spectra
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C ppm HSQC ( ppm) HMBC ( ppm) 
 135.0  1.65 
 134.9  1.73 
 128.6 5.24 1.65 
 125.7 5.52 1.73 
 40.6 1.80,1.72 1.40 
 37.4 2.43,2.17 1.65 
 32.2 2.87,1.91 1.73 
 29.7 0.92  
 29.6 1.32,1.26 0.91 
 27.2 2.01  
 24.9 0.91 0.92 
 24.6 2.33,2.05  
 24.0 2.08,1.79  
 22.9 1.73  
 15.2 1.65  
1 57.8 1.51 1.40,0.91 
2 36.5  0.91,0.92 
3 44.6 2.14 0.92 
19 73.4  1.40 
24 34.6 1.40  
 
 
Table A1.14 2D-NMR Data for 1.53 
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Spectral Data for Authentic Hypoestoxide 
 
2-D NMR analysis of Hypoestoxide is consistent with previously published crystal 
structure from isolation paper. 
 
Hypoestoxide HSQC-AD (1.1) 
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Hypoestoxide HMBC-AD (1.1) 
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Carbon and Proton Assignments From HSQC and HMBC Data: 
 
All carbons chemical shifts and the chemical shifts of the protons that are attached to 
them have been mapped out using both HSQC and HMBC techniques.  These values 
can then be used to map out stereochemical relationships given NOE correlations. 
 
C ppm HSQC ( ppm) HMBC ( ppm) 
1 46.7 2.51 6.05,5.66,1.15,1.04 
2 37.3  2.62,2.51,1.90,1.15,1.04 
3 45.0 1.98 2.86,2.62,1.90,1.15,1.04 
4 31.6 1.90,1.90 2.86,2.62 
5 62.2 2.59 1.27 
6 62.3   
7 36.2 2.18,1.20 1.98,1.27 
8 24.1 1.98,1.43 2.45,2.19 
9 63.7 2.44 1.98,1.43 
10 59.9  1.80,1.43 
11 42.3 2.19,1.80 1.42 
12 69.1 5.47 2.19,1.80 
13 170.2  2.05 
14 21.7 2.05  
15 16.3 1.27  
16 16.9 1.42 1.80 
17 43.0 2.86,2.62 1.90 
18 203.0  6.04,5.66,2.86,2.62 
19 143.3  6.05,2.52 
20 124.1 6.04,5.66 2.51 
21 24.9 1.04 2.52,1.15 
22 27.6 1.15 1.04 
 
Table A1.15 2D-NMR Data for Authentic Hypoestoxide 1.1 
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Hypoestoxide NOESY (1.1) 
 
 
 
Important NOE Correlations For Proving Stereochemical Assignments: 
Pictured are the relevant NOE correlations to prove the stereochemical assignments 
for Hypoestoxide. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hypoestoxide (1)
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C9-C10 = E-epoxide
C5-C6 = E-epoxide
C1-C12 = equatorial
C3-C4 = axial
Atropisomer defined
C12 stereochemistry defined
C5,C6,C9,C10 relative
stereochemistry defined
10
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6
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Hypoestoxide Isomer Comparison 
 
Authentic Hypoestoxide (1.1) Z,Z-Atrop-Hypoesotoxide (1.50) E,Z-epi-Atrop-Hypoestoxide (1.41) 
C ppm 1H  ppm  C ppm 1H  ppm  C ppm 1H  ppm 
18 203.0    18 198.7    18 199.1   
13 170.2    13 169.9    13 169.8   
19 143.3    19 144.4    19 141.5   
20 124.1 6.04,5.66  20 127.1 6.33,5.53  20 127.7 6.22,5.31 
12 69.1 5.47  12 75.7 5.35  12 70.6 5.4 
9 63.7 2.44  5 63.8 2.92  9 65.7 2.71 
6 62.3    9 61.9 2.82  5 62.7 2.87 
5 62.2 2.59  6 60.4    10 59.6   
10 59.9    10 58.5    6 59.2   
1 46.7 2.51  1 55.5 2.76  1 58.7 2.53 
3 45.0 1.98  17 42.1 2.65,2.24  11 42.3 2.06,1.26 
17 43.0 2.86,2.62  2 35.5    17 41.1 2.60,2.24 
11 42.3 2.19,1.80  11 34.3 2.49,1.85  2 36.2   
2 37.3    3 33.3 2.67  3 35.1  1.86 
7 36.2 2.18,1.20  4 29.2 1.72,1.63  4 31.6 1.26 
4 31.6 1.90,1.90  7 27.5 1.87,1.51  7 27.2 2.01,1.37 
22 27.6 1.15  22 26.1 1.16  22 26.3 1.22 
21 24.9 1.04  21 24.1 0.85  8 22.8 1.29 
8 24.1 1.98,1.43  8 23.9 2.09,1.88  15 22 1.39 
14 21.7 2.05  15 23.4 1.32  21 21.5 0.94 
16 16.9 1.42  16 22.9 1.21  14 21.4 2.07 
15 16.3 1.27  14 21.7 2.05  16 16.4 1.47 
 
 
 
 
 
 
 
 
 
 
 
Table A1.16 Hypoestoxide Isomer Analysis 
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Proton Spectra Overlay For Isomers of Hypoestoxide 
Z,Z-Atrop
Hypoestoxide
E,Z-epi-Atrop
Z,Z-Atrop
Hypoestoxide
E,Z-epi-Atrop
 
 
 
Figure A1.1 NMR Overlay of Hypoestoxide Isomers 
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A1.3  DFT Calculations for Chapter 1 
 
Coordinates and calculated energies 
DFT calculations were performed with the program Gaussian03[1] by using the WebMO interface (WebMO, 
version 6.0.003; www.webmo.net) for importing and constructing models. 
 
[1]Gaussian 03 (Revision C.02); M. J. Frisch,G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, J. A. 
Montgomery, Jr., T. Vreven, K. N. Kudin, J. C. Burant, J. M. Millam, S. S. Iyengar, J. Tomasi, V. Barone, B. Mennucci, M. 
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Structure Method Basis Set 
Uncorrected 
Energy  
(hartrees) 
 
Corrected 
Energy 
(hartree) 
 
Corrected 
Energy 
(kcal/mol) 
 
Relative  
E(kcal/ 
mol) 
 
Freq. 
(cm-1) 
Hypoestoxide  B3LYP 6-311+G(d,p) -1233.994224 -1233.54252 -774059.7832 0  
Atrop-hypo  B3LYP 6-311+G(d,p) -1233.986218 -1233.535978 -774055.678 4.11  
TS-1 B3LYP 6-311+G(d,p) -1233.892363 -1233.438121 -773994.2718 65.51 
 
-112.6 
 
Table A1.17 Calculated Energies for Atropisomers of Hypoestoxide 
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Hypoestoxide  B3LYP/6-311+G(d,p) 
C1     0.00000000  0.00000000  0.00000000 
C2     0.02583700 -0.68570800  1.36209000 
C3    -1.00160500 -1.76657500  1.57880400 
C4    -1.30489700 -2.65823700  0.38634200 
C5    -1.26270600 -1.97804200 -0.99899100 
C6    -0.00330600 -1.05954400 -1.16546100 
C7     1.26101300 -1.94691600 -1.13775000 
H8     1.18400600 -2.73110800 -1.89734800 
H9     1.42012400 -2.42556300 -0.17028200 
H10    2.15400600 -1.36089300 -1.35681300 
C11   -0.05894100 -0.37172100 -2.54407400 
H12    0.89460800  0.09349400 -2.80189500 
H13   -0.27504800 -1.11046100 -3.32190500 
H14   -0.83198500  0.39865000 -2.59612400 
C15   -2.64686800 -1.38090900 -1.37423000 
C16   -3.33080200 -0.42096900 -0.41339500 
C17   -3.87752000  0.92770900 -0.72834300 
O18   -4.73466300 -0.23090700 -0.66319100 
C19   -4.17911300  1.90004400  0.40836000 
C20   -3.29032400  3.14722900  0.55151800 
C21   -1.88084400  2.87467400  1.03336600 
C22   -0.61787600  3.17402000  0.31095100 
C23    0.64565600  2.41397600  0.69775700 
C24    0.96267800  1.18984300 -0.17995000                      
O25    2.33445200  0.76947000  0.08633300 
C26    3.31667500  1.31368300 -0.67164500 
C27    4.67311100  0.83887700 -0.21781800 
H28    5.41511800  1.08325400 -0.97539200 
H29    4.66438300 -0.23376800 -0.01921700 
H30    4.93494400  1.34589600  0.71522600 
O31    3.11687100  2.08361500 -1.57990600 
H32    0.93494800  1.50530100 -1.22007900 
H33    1.48637700  3.11002700  0.60998600 
H34    0.56768900  2.13083700  1.74725800 
C35   -0.59694700  3.83655900 -1.04973200 
H36   -1.48132900  4.45313600 -1.20517000 
H37   -0.53449000  3.10441800 -1.85939100 
H38    0.28114000  4.48397900 -1.12627700 
O39   -1.08968800  4.02529500  1.37542800 
H40   -1.82286600  2.09005100  1.79063200 
H41   -3.75307200  3.79547600  1.30423600 
H42   -3.28242100  3.72682500 -0.37393800 
H43   -4.18833700  1.34027500  1.34910300 
H44   -5.20978900  2.23867600  0.25077400 
C45   -3.75933500  1.53938900 -2.10694000 
H46   -3.71740000  0.77238200 -2.87968900 
H47   -4.63521800  2.16404900 -2.30810500 
H48   -2.87229200  2.17183400 -2.19188100 
H49   -3.13079200 -0.60706800  0.64174500 
H50   -3.32976800 -2.23558200 -1.44890700 
H51   -2.61091600 -0.95442800 -2.37709900 
H52   -1.11982500 -2.78038200 -1.73218000 
H53   -0.54156100 -3.44498400  0.42651900 
H54   -2.26182000 -3.15385200  0.56548700 
O55   -1.50150600 -1.97526800  2.66685900 
C56    0.87829800 -0.47285300  2.36985800 
H57    0.75587400 -1.02977100  3.29190800 
H58    1.70373400  0.22079500  2.30622700 
H59   -0.98533900  0.47891900 -0.07214600 
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Atrop-Hypoestoxide B3LYP/6-311+G(d,p) 
C1     0.00000000  0.00000000  0.00000000 
C2     1.10411800 -0.59353600 -0.86334300 
C3     0.71417600 -1.31819300 -2.12907100 
C4    -0.72958100 -1.79619500 -2.27902400 
C5    -1.77518100 -1.22374300 -1.30100600 
C6    -1.15622100 -1.06967300  0.12576500 
C7    -2.19790500 -0.68579400  1.19202800 
H8    -2.83900800  0.13783900  0.89667000 
H9    -2.84345900 -1.53994300  1.41068300 
H10   -1.70380900 -0.41134100  2.12882700 
C11   -0.54655400 -2.40072000  0.63535700 
H12   -0.11986300 -2.25493400  1.63238500 
H13    0.24540000 -2.80308300  0.00560200 
H14   -1.32464000 -3.16374600  0.72251800 
C15   -3.11001400 -2.00335200 -1.42061600 
C16   -4.34387800 -1.15163100 -1.17154600 
C17   -4.86631600 -0.12760100 -2.10919200 
O18   -5.51364100 -1.41438200 -1.96512100 
C19   -5.70851900  1.02026000 -1.56192400 
C20   -5.00312300  2.38115800 -1.38466400 
C21   -3.86913600  2.34789700 -0.37460300 
C22   -2.50113000  2.90185700 -0.55377600 
C23   -1.33396800  2.30973700  0.23953700 
C24   -0.40079700  1.39520100 -0.59213500 
O25    0.83263900  2.15351000 -0.78408100 
C26    1.27297900  2.36680000 -2.04919100 
C27    2.58912500  3.09760600 -2.04159600 
H28    2.81380800  3.45107700 -3.04587300 
H29    3.37426100  2.40825500 -1.71953200 
H30    2.56662500  3.92973000 -1.33624600 
O31    0.67955400  2.01142500 -3.03841600 
H32   -0.81361300  1.24636700 -1.58602300 
H33   -0.72640700  3.14027500  0.61094200 
H34   -1.72160000  1.80353800  1.12005300 
C35   -2.12681500  3.68275100 -1.79650100 
H36   -1.64863000  3.05916000 -2.55486600 
H37   -1.42153400  4.47449300 -1.52533900 
H38   -3.00257400  4.16092800 -2.23391000 
O39   -3.47888500  3.57515700  0.26553200 
H40   -3.97424900  1.54261900  0.34971100 
H41   -5.74581800  3.09917500 -1.02116700 
H42   -4.66094800  2.76259000 -2.34951800 
H43   -6.13664700  0.70247200 -0.60592700 
H44   -6.55496700  1.15799300 -2.24448600 
C45   -4.24338700  0.10920100 -3.46899000 
H46   -3.74076800 -0.78233100 -3.84158900 
H47   -5.02380400  0.37644700 -4.18826400 
H48   -3.51992400  0.92841600 -3.44324000 
H49   -4.59169700 -0.99602100 -0.12358000 
H50   -3.12799000 -2.87099600 -0.75215300 
H51   -3.18853900 -2.40825400 -2.43231200 
H52   -2.01453200 -0.21667900 -1.64692300 
H53   -1.02074900 -1.60692100 -3.31584400 
H54   -0.68268800 -2.88799100 -2.18298000 
O55    1.53038700 -1.58564400 -2.98730900 
C56    2.39720100 -0.55727100 -0.53186400 
H57    3.13905400 -1.01214900 -1.17847600 
H58    2.73593200 -0.08409100  0.38317900 
H59    0.40750000  0.17824700  1.00140000 
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TS-1 B3LYP/6-311+G(d,p) 
C1     0.00000000  0.00000000  0.00000000 
C2     0.86000300  1.21988600  0.21682300 
C3     0.20772900  2.46099500 -0.37573600 
C4    -1.29889700  2.36345400 -0.68497400 
C5    -2.01031000  1.67561000  0.49703400 
C6    -1.38161800  0.25278100  0.71439400 
C7    -1.29442400  0.00481100  2.22861200 
H8    -0.99311900 -1.00931000  2.48818600 
H9    -0.57313600  0.68791300  2.68631400 
H10   -2.26443400  0.18553700  2.69937900 
C11   -2.22269300 -0.72573700 -0.04480100 
H12   -1.59423300 -1.45590900 -0.46996800 
H13   -2.66685000 -0.26152100 -0.91234700 
H14   -2.95836100 -1.20995100  0.56613400 
C15   -3.60961300  1.69854800  0.50223100 
C16   -4.42509900  0.66601000 -0.30533200 
C17   -4.99990200 -0.60291500  0.20484900 
O18   -5.85244700  0.51542100 -0.17844000 
C19   -5.01765000 -1.87480600 -0.69358400 
C20   -4.17383700 -3.16766600 -0.31425000 
C21   -2.69592700 -3.26033600 -0.75674900 
C22   -1.48427100 -3.41643200  0.09530900 
C23   -0.12102800 -2.77685600 -0.34712600 
C24    0.56493300 -1.45538900  0.27684600 
O25    1.86948100 -1.45929000 -0.37157400 
C26    2.90795500 -2.04810900  0.26908300 
C27    4.15364200 -1.99500000 -0.57576600 
H28    4.33782500 -0.97408200 -0.91551900 
H29    4.01757100 -2.61682500 -1.46432600 
H30    4.99989800 -2.36252500  0.00082100 
O31    2.82486600 -2.54308000  1.36720400 
H32    0.72966200 -1.61096400  1.34189000 
H33    0.63113200 -3.55055400 -0.16325100 
H34   -0.15249400 -2.63466400 -1.43206300 
C35   -1.59212800 -3.74516200  1.56817700 
H36   -1.59320400 -2.85236600  2.19454300 
H37   -0.73760500 -4.35907000  1.86763300 
H38   -2.49834300 -4.31560900  1.77197000 
O39   -1.96964600 -4.50319800 -0.73652600 
H40   -2.53089100 -2.74214400 -1.70257600 
H41   -4.68096200 -3.99874200 -0.81624700 
H42   -4.26713800 -3.37413000  0.75436300 
H43   -4.78223800 -1.58169200 -1.72184400 
H44   -6.06120500 -2.20714500 -0.71200500 
C45   -5.13764000 -0.88264300  1.69138700 
H46   -5.19345300  0.04404000  2.26100500 
H47   -6.07181700 -1.42777900  1.86003200 
H48   -4.32469900 -1.49127800  2.09332400 
H49   -4.16468100  0.65735900 -1.36351200 
H50   -3.90937500  2.69559000  0.15987500 
H51   -3.92539700  1.64292500  1.54637100 
H52   -1.75978100  2.29067100  1.36942700 
H53   -1.66129400  3.37843300 -0.85668700 
H54   -1.43532300  1.80766600 -1.62159700 
O55    0.82414000  3.48874300 -0.56169600 
C56    1.98947400  1.35351000  0.91486600 
H57    2.44392600  2.33256600  1.01792100 
H58    2.48030900  0.51740900  1.39743800 
H59   -0.22016000 -0.00019700 -1.07508200 
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APPENDIX 2 
 
A2.1 Experimental Procedures for Chapter 2 
 
General Information: Commercial reagents were purchased and used without further purification. All 
glassware was flame dried and reactions were performed under a nitrogen atmosphere, unless otherwise 
stated. Toluene, dichloromethane, diethyl ether, and THF were dried over a column of alumina. Flash 
chromatography was done with MP Silitech 32-63D 60Å silica, and thin layer chromatography (TLC) 
was performed with EMD 250 μm silica gel 60-F254
 
plates. 1H and 13C NMR data was acquired on a 
Varian Inova 400, 500, or 600 (400, 500 or 600 MHz) spectrometer and referenced to residual protic 
solvent or TMS. IR spectroscopy was done on a Nicolet Avatar 370 OTGS spectrometer. High-
resolution mass spectrometry was performed at the University of Illinois at Urbana-Champaign facility. 
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The known bromoaldehyde (10.000 g, 0.031 mol), was added to a flame-dried round bottom flask and 
dissolved in dry DMF (311.4 mL).  Triethyl amine (5.4 mL, 38.9 mmol) was added followed by 
palladium acetate (0.350 g, 0.002 mol) and triphenylphosphine (0.820 g, 0.003 mol).  Then the allylic 
alcohol (13.400 g, 0.156 mol) was added and the reaction was heated at 100oC for 12 hours.  Upon 
completion, the reaction mixture was quenched with one molar hydrochloric acid (100.0 mL) and 
extracted with ether.  The combined ether extracts were subsequently washed with distilled water and 
dried with sodium sulfate.  The ethereal solution was concentrated and purified with silica gel (70% 
hexanes, 30% ethyl acetate) to yield keto-aldehyde (7.900 g, 78%).  
 
FTIR (thin film/NaCl) 2958, 2930, 1708, 1677, 1597, 1511, 1354, 1270, 1108 cm-1; 1H NMR (400 
MHz, C6D6) δ = 10.02 (s, 1H), 7.27-7.21 (m, 3H), 7.14-7.01 (m, 3H), 6.63 (s, 1H), 4.82-4.70 (m, 2H), 
3.32 (s, 3H), 3.28 (dd, J=7.1, 13.2, 1H), 2.76 (dd, J=7.1, 13.2, 1H), 2.61-2.58 (m, 1H), 1.68 (s, 3H), 
0.86 (d, J=7.1, 3H); 13C NMR (126 MHz, C6D6) δ = 210.2, 190.2, 153.3, 149.3, 137.7, 137.1, 129.1, 
128.7, 128.1, 127.9, 117.0, 115.0, 71.0, 55.8, 49.3, 35.4, 29.1, 16.8; HRMS (EI) m/z 349.1408 [calc'd 
for C20H22O4Na (M+Na) 349.1416]. 
 
 
 
 Potassium tert-butoxide (2.020 g, 0.017 mol) was added to a flame-dried round bottom flask 
and dry THF (300.0 mL) was added under a nitrogen atmosphere at -78oC.  The starting material (5.070 
g, 0.016 mol) was dissolved in dry THF (11.0 mL) and added drop-wise to the butoxide slurry.  Upon 
complete addition, the reaction was allowed to stir for an additional 30 minutes at -78oC at which time 
the bath was removed and the reaction allowed to warm to room temperature.  The reaction was 
neutralized with saturated sodium bicarbonate and extracted with ether.  The combined extracts were 
dried over sodium sulfate, concentrated, and purified by column chromatography (70% hexanes, 30% 
ethyl acetate) to yield enone (4.310 g, 90%).   
 
FTIR (thin film/NaCl) 2964, 2933, 1651, 1567, 1519, 1455, 1354, 1268, 1164, 1098 cm-1;      1H 
NMR (400 MHz, CDCl3) δ = 7.41-7.30 (m, 5H), 6.95 (d, J=12.6, 1H), 6.84 (s, 1H), 6.76 (s, 1H), 6.04 
(d, J=12.6, 1H), 5.18 (s, 2H), 3.88 (s, 3H), 2.89-2.72 (m, 2H), 2.66 (m, 1H), 1.07 (d, J=7.1, 3H); 13C 
NMR (75 MHz, CDCl3) δ = 203.5, 149.4, 148.2, 142.0, 136.6, 134.2, 128.8, 128.2, 127.5, 127.4, 
127.4, 115.9, 115.3, 71.1, 56.4, 44.7, 37.0, 15.7; HRMS (EI) m/z 309.1483 [calc'd for C20H21O3 (M+H) 
309.1491]. 
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 Freshly distilled diisopropyl amine (2.50 mL, 0.02 mol) was added to a flame-dried flask and 
diluted with dry THF (60.0 mL) and cooled to -78oC under nitrogen.  Butyl lithium (2.5M, 6.5 mL, 0.02 
mol) was then added and allowed to react for 30 minutes.  Starting material (2.500 g, 0.008 mol) was 
then dissolved in THF (10.0 mL) and added drop-wise to the LDA solution over 1 minute and allowed 
to stir for an additional 15 minutes.  A stock solution of N-phenyl triflimide (3.190 g, 8.900 mmol) was 
then added and the bath removed as the reaction warmed to room temperature.  After 1 hour the 
reaction was diluted with ether (500.0 mL) and washed with NaOH solution (0.1M, 200.0 mL).  The 
ethereal solution was then dried over sodium sulfate, concentrated, and purified with column 
chromatography (70% hexanes, 30% ethyl acetate) to yield vinyl triflate (3.100 g, 87%).   
 
FTIR (thin film/NaCl) 3033, 2963, 2840, 1736, 1657, 1603, 1561, 1512, 1413, 1211, 1141, 1029 cm-1; 
1H NMR (400 MHz, CDCl3) δ = 7.48-7.30 (m, 5H), 7.04 (d, J=11.8, 1H), 6.84 (s, 1H), 6.68 (s, 1H), 
6.26 (d, J=11.8, 1H), 5.18 (s, 2H), 3.88 (s, 3H), 2.97 (s, 2H), 2.03 (s, 3H);   13C NMR (75 MHz, 
CDCl3) δ = 150.2, 148.4, 140.5, 136.9, 134.7, 128.8, 128.5, 128.3, 128.2, 127.6, 127.4, 121.1, 116.5, 
113.1, 111.5, 71.3, 56.3, 38.1, 18.8; HRMS (EI) m/z 440.0901 [calc'd for C21H19F3O5S (M+) 440.0905].   
 
 
 
 Palladium acetate (0.087 g, 0.390 mmol) and triphenylphosphine (0.203 g, 0.780 mmol) were 
added to a flame-dried flask at room temperature under nitrogen.  Dry DMF (30.0 mL) was added 
followed by triethylamine (0.54 mL, 3.86 mmol) and methanol (6.2 mL, 0.154 mol).  Starting triflate 
(1.700 g, 3.860 mmol) was dissolved in dry DMF (9.0 mL) and added to the reaction and a balloon of 
carbon monoxide was attached via needle through a septum.  The reaction was heated at 80oC for 3 
hours until the starting material was consumed.  The reaction was then diluted with ethyl acetate (300.0 
mL) and washed with distilled water (3 x 50.0 mL).  The organics were then dried over sodium sulfate 
and purified with silica gel chromatography (70% hexanes, 30% ethyl acetate) to yield enoate (1.110 g, 
82%). 
 
FTIR (thin film/NaCl) 3029, 2936, 1713, 1602, 1509, 1453, 1222 cm-1; 1H NMR (400 MHz, CDCl3) δ = 7.47-7.30 (m, 5H), 7.02 (d, J=11.6, 1H), 6.83 (s, 1H), 6.80 (d, J=11.6, 1H), 6.70 (s, 1H), 5.17 (s, 
2H), 3.87 (s, 3H), 3.74 (s, 3H), 2.94 (s, 2H), 2.31 (s, 3H); 13C NMR (126 MHz, CDCl3) δ = 168.2, 
149.6, 148.3, 146.9, 137.1, 131.6, 128.9, 128.7, 128.1, 127.8, 127.6, 127.2, 124.0, 112.7, 110.8, 71.3, 
56.3, 51.7, 43.2, 22.8; HRMS (EI) m/z 351.1584 [calc'd for C22H23O4 (M+H) 351.1596]. 
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 Triphenylmethyl hydroperoxide (0.166 g, 0.600 mmol) was added to a flame-dried flask and 
dissolved in dry THF (7.0 mL) under nitrogen and then cooled to -78oC.   Methyl lithium (1.6M, 0.33 
mL, 0.52 mmol) was added and the reaction was stirred for 10 minutes.  Starting diene (0.140 g, 0.400 
mmol) was then dissolved in dry THF (1.0 mL), added to the reaction, and allowed to stir at -78oC for 1 
hour.  The reaction was then warmed to room temperature and quenched with saturated ammonium 
chloride (50.0 mL) and extracted with ethyl acetate (3 x 100.0 mL).  The organics were then dried over 
sodium sulfate, concentrated, and purified by silica gel chromatography (80% hexanes, 20% ethyl 
acetate) to yield epoxide (0.129 g, 89%).  
 
FTIR (thin film/NaCl) 2953, 2935, 1747, 1604, 1518, 1267, 1099, 1064, 1454 cm-1; 1H NMR (300 
MHz, CDCl3) δ = 7.51-7.28 (m, 5H), 6.81 (s, 1H), 6.74 (s, 1H), 6.68 (d, J=11.4, 1H), 6.16 (d, J=11.4, 
1H), 5.17 (s, 2H), 3.89 (s, 3H), 3.72 (s, 3H), 2.97 (d, J=13.6, 1H), 2.78 (d, J=13.6, 1H), 1.36 (s, 3H); 
13C NMR (126 MHz, CDCl3) δ = 169.6, 148.8, 147.9, 137.1, 134.1, 128.9, 128.8, 128.5, 128.2, 127.6, 
124.2, 115.7, 113.6, 71.6, 71.4, 62.9, 56.4, 52.9, 43.4, 18.7; HRMS (EI) m/z 367.1541 [calc'd for 
C22H23O5 (M+H) 367.1545]. 
 
 
 
 
 
 Starting epoxide (0.120 g, 0.330 mmol) was dissolved in dry toluene (0.33 mL) and dry 
Cu(hfacac)2 (0.008 g, 0.017 mmol, dried on vacuum pump for 2 hours prior to use) was added at room 
temperature.  The vial was sealed well and the reaction heated at 100oC for 12 hours.  After allowing 
the reaction to cool to room temperature, it was filtered through neutral alumina (activity grade 1), 
concentrated and purified with silica gel chromatography (80% hexanes, 20% ethyl acetate) to give the 
ring expansion product (0.118 g, 99%). 
 
FTIR (thin film/NaCl) 2952, 2935, 1714, 1611, 1506, 1452, 1307, 1261, 1100, 1070, cm-1;     1H 
NMR (600 MHz, CDCl3) δ = 7.44-7.28 (m, 5H), 7.21 (s, 1H), 6.63 (s, 1H), 6.61 (s, 1H), 5.27 (d, J=2.0, 
1H), 5.08 (s, 2H), 3.85 (s, 3H), 3.71 (s, 3H), 2.85 (d, J=17.1, 1H), 2.70 (d, J=17.1, 1H), 1.70 (s, 3H); 
13C NMR (126 MHz, CDCl3) δ = 164.2, 148.3, 147.8, 147.6, 137.3, 135.2, 128.8, 128.8, 128.1, 127.5, 
126.3, 116.4, 108.4, 84.2, 79.7, 71.4, 56.5, 51.7, 34.7, 23.6; HRMS (EI) m/z 367.1531 [calc'd for 
C22H23O5 (M+H) 367.1545]. 
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Methyl enoate (0.080 g, 0.219 mmol) was dissolved in dry THF (4.4 mL) and the solution 
cooled to -78oC under nitrogen.  Lithium triethylborohydride (1M, 0.88 mL, 0.88 mmol) was added 
drop-wise and the reaction stirred for 90 minutes.  The bath was then removed and when the reaction 
had come to room temperature it was quenched with saturated ammonium chloride and extracted with 
DCM.  The organics were dried over sodium sulfate, concentrated, and chromatographed (50% 
hexanes, 50% ethyl acetate) to give the alcohol (0.065 g, 88%). 
 
FTIR (thin film/NaCl) 2922, 2939, 1509, 1454, 1333, 1257, 1223, 1117, 1073, 1015 cm-1;      1H 
NMR (400 MHz, CDCl3) δ = 7.46-7.28 (m, 5H), 6.59 (s, 1H), 6.51 (s, 1H), 5.09 (s, 2H), 4.93 (d, J=6.9, 
1H), 3.84 (s, 3H), 3.62-3.56 (m, 1H), 3.49-3.42 (m, 1H), 2.89 (d, J=17.0, 1H), 2.75 (d, J=17.0, 1H), 
2.58-2.44 (m, 1H), 2.38-2.20 (m, 1H), 1.52 (s, 3H), 1.51-1.46 (m, 1H); 13C NMR (126 MHz, CDCl3) δ 
= 148.1, 147.4, 137.4, 134.4, 128.7, 128.0, 127.5, 124.4, 114.6, 107.9, 81.8, 77.3, 71.5, 64.9, 56.3, 49.8, 
40.1, 36.5, 28.4; HRMS (EI) m/z 341.1758 [calc'd for C21H25O4(M+H) 341.1753]. 
 
 
 
 
 
Primary alcohol (0.010 g, 0.030 mmol) was dissolved in dry DCM (0.6 mL) at room 
temperature.  Triphenyl phosphine (0.012 g, 0.045 mmol) was then added followed by carbon 
tetrabromide (0.015 g, 0.045 mmol) and the reaction was stirred for 4 hours until the starting material 
was consumed.  The crude reaction mixture was concentrated and directly purified by silica gel 
chromatography (30% ethyl acetate, 70% hexanes) to give bromide (0.010 g, 84%). 
 
FTIR (thin film/NaCl) 2953, 2917, 1653, 1507, 1457, 1338, 1257, 1225, 1012 cm-1; 1H NMR (600 
MHz, CDCl3) δ = 7.45-7.29 (m, 5H), 6.60 (s, 1H), 6.51 (s, 1H), 5.14-5.06 (m, 2H), 4.91 (d, J=6.7, 1H), 
3.85 (s, 3H), 3.31-3.22 (m, 2H), 2.88 (d, J=17.1, 1H), 2.77 (d, J=17.1, 1H), 2.68-2.60 (m, 1H), 2.56-
2.48 (m, 1H), 1.62 (dd, J=3.8, 12.3, 1H), 1.55 (s, 3H); 13C NMR (126 MHz, CDCl3) δ = 148.4, 147.6, 
137.3, 134.0, 128.8, 128.1, 127.6, 123.8, 114.6, 108.0, 82.2, 76.6, 71.5, 56.4, 50.2, 43.3, 36.1, 35.1, 
28.1; HRMS (EI) m/z 403.0908 [calc'd for C21H24O3Br (M+H) 403.0909]. 
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Benzyl-protected phenol (0.011 g, 0.027 mmol) was dissolved in dry acetone (2.7 mL) at room 
temperature.  10% Pd/C (0.020 g) was added followed by ammonium formate (0.009 g, 0.135 mmol).  
The reaction was sealed in a vial and heated at 60oC for 4 hours.  The reaction was filtered through 
Celite and concentrated to yield pure phenol (0.008 g, 94%). 
 
FTIR (thin film/NaCl) 2967, 2880, 1591, 1451, 1247, 1099, 1070, 1024 cm-1; 1H NMR (400 MHz, 
CDCl3) δ = 6.64 (s, 1H), 6.47 (s, 1H), 4.90 (d, J=6.6, 1H), 3.86 (s, 3H), 3.32-3.26 (m, 2H), 2.91 (d, 
J=17.2, 1H), 2.80 (d, J=17.2, 1H), 2.69-2.59 (m, 1H), 2.58-2.49 (m, 1H), 1.64-1.58 (m, 1H), 1.55 (s, 
3H); 13C NMR (126 MHz, CDCl3) δ = 145.1, 144.9, 132.8, 124.6, 114.4, 106.7, 82.2, 76.7, 56.2, 50.2, 
43.4, 36.0, 35.1, 28.1; HRMS (EI) m/z 312.0356 [calc'd for C14H17O3Br (M+) 312.0361]. 
 
 
 
Starting phenol (0.005 g, 0.016 mmol) was dissolved in anhydrous methanol (2.0 mL) and 
stirred at room temperature.  Iodobenzene diacetate (0.006 g, 0.018 mmol) was added to the reaction 
and after a few seconds, the reaction turned a bright yellow.  The reaction was stirred for 10 minutes 
before being concentrated and directly purified using silica gel chromatography (30% ethyl acetate, 
70% hexanes) to give dearomatized product (0.005 g, 91%).  This ortho-quinone mono-ketal was 
dissolved in dry toluene (2.0 mL) and tributyltin hydride (0.01 mL, 0.03 mmol) was added at -78oC, 
followed by active triethylborane (1M, 0.01 mL, 0.01 mmol).  The reaction was warmed to room 
temperature and was diluted with ethyl acetate and washed with brine, dried over sodium sulfate, and 
the organics were concentrated.  The product was purified using silica gel chromatography to give the 
quenched, dimerized product (0.003 g, 55%). 
 
Monomer:  1H NMR (400 MHz, CDCl3) δ = 5.97 (s, 1H), 5.87 (s, 1H), 4.74 (d, J=7.8, 1H), 3.38 (s, 
3H), 3.37-3.33 (m, 2H), 3.30 (s, 3H), 2.80-2.68 (m, 3H), 2.51-2.40 (m, 1H), 1.52-1.48 (m, 1H), 1.47 (s, 
3H). 
Dimer:  1H NMR (600 MHz, C6D6) δ = 5.78-5.75 (m, 1H), 4.50 (d, J=6.5, 1H), 4.31 (d, J=7.5, 1H), 
3.78 (s, 1H), 3.14 (s, 3H), 3.13 (s, 3H), 3.13 (s, 3H), 2.98-2.95 (m, 1H), 2.88 (s, 3H), 2.61-2.57 (m, 1H), 
2.39-2.35 (m, 1H), 2.28-2.22 (m, 1H), 2.15-2.06 (m, 2H), 1.92-1.88 (m, 1H), 1.88-1.82 (m, 1H), 1.80-
1.65 (m, 2H), 1.24 (s, 3H), 1.17 (s, 3H), 0.94-0.82 (m, 2H), 0.83 (d, J=7.3, 3H), 0.70 (d, J=7.1, 3H); 
HRMS (EI) m/z 513.24973 [calc'd for C29H37O8 (M (–CH3) +) 513.24883]. 
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Phenol (0.004 g, 0.013 mmol) was dissolved in dry methanol (0.2 mL) at room temperature.  
Solid iodobenzene diacetate (0.005 g, 0.014 mmol) was added and the reaction turned a bright yellow 
over the course of five minutes.  The reaction was concentrated and filtered through a plug of silica to 
give the crude oxidation product.  This product was next dissolved in dry toluene (0.2 mL) and methyl 
acrylate (0.01 mL, 0.13 mmol) was added.  The reaction was stirred at 50oC for five hours at which time 
the solvent was evacuated and the crude oil subjected to silica gel chromatography to give the product 
(0.005 g, 91%). 
 
1H NMR (400 MHz, CDCl3) δ = 4.36 (d, J=6.5, 1H), 3.69 (s, 3H), 3.36 (s, 3H), 3.30 (s, 3H), 3.18-3.12 
(m, 1H), 3.06-3.00 (m, 1H), 2.94-2.85 (m, 1H), 2.53-2.28 (m, 6H), 2.18 (d, J=18.0, 1H), 2.00 (d, 
J=11.9, 1H), 1.80-1.71 (m, 1H), 1.47 (s, 3H); HRMS (EI) m/z 429.0896 [calc'd for C19H26O6Br (M+H) 
429.0913]. 
 
 
 
 
A solution of Diels-Alder product (0.010 g, 0.023 mmol) and dry toluene (2.3 mL) was purged 
with nitrogen and cooled to -78oC.  To this was added tributyltin hydride (10% in toluene, 0.07 mL, 
0.03 mmol) followed by triethyl borane (1M, 0.02 mL) that had been activated by addition of dry air.  
The reaction was allowed to stir for 10 minutes and the bath was removed.  After 30 minutes, the 
reaction was concentrated and purified using silica gel chromatography to give quenched product 
(0.007 g, 86%). 
 
FTIR (thin film/NaCl) 2966, 2950, 1734, 1456, 1437, 1202, 1135, 1096, 1055, 750 cm-1; 1H NMR 
(600 MHz, CDCl3) δ = 4.35-4.28 (m, 1H), 3.68 (s, 3H), 3.34 (s, 3H), 3.30 (s, 3H), 3.04-2.99 (m, 1H), 
2.94-2.88 (m, 1H), 2.42-2.31 (m, 1H), 2.29-2.23 (m, 1H), 2.17 (s, 1H), 2.10-2.02 (m, 1H), 1.80-1.75 (m, 
1H), 1.75-1.69 (m, 1H), 1.64-1.56 (m, 2H), 1.34 (s, 3H), 0.94-0.88 (m, 3H);  HRMS (EI) m/z 351.1813 
[calc'd for C19H27O6 (M+H) 351.1808]. 
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 Starting material (0.035 g, 0.096 mmol) was dissolved in dry methanol (1.9 mL) at room 
temperature under nitrogen.  Palladium on carbon (10%, 0.030 g) was added to the reaction and the 
nitrogen was replaced by a balloon of hydrogen gas.  The reaction was heated at 50oC for 12 hours and 
then filtered through a plug of Celite.  The reaction was concentrated and loaded directly onto a silica 
gel column for purification yielding deprotected product (0.024 g, 90%). 
 
FTIR (thin film/NaCl) 2973, 2939, 1736, 1509, 1343, 1284, 1199, 1108 cm-1; 1H NMR (400 MHz, 
CDCl3) δ = 6.55 (s, 1H), 6.49 (s, 1H), 5.48 (bs, 1H), 4.98 (d, J=6.8, 1H), 3.85 (s, 3H), 3.64 (s, 3H), 
3.02-2.86 (m, 1H), 2.90 (d, J=17.0, 1H), 2.56 (d, J=17.0, 1H), 2.52-2.43 (m, 1H), 2.42-2.34 (m, 1H), 
1.64 (s, 3H); 13C NMR (126 MHz, CDCl3) δ = 172.9, 144.9, 144.8, 132.0, 124.4, 114.3, 106.5, 82.4, 
77.7, 56.1, 53.6, 52.1, 38.9, 37.6, 28.0; HRMS (EI) m/z 278.1154 [calc'd for C15H18O5 (M+) 278.1154]. 
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 Starting phenol (0.034 g, 0.122 mmol) was dissolved in dry DCM (2.5 mL) at 0oC under 
nitrogen.  To this was added freshly distilled triethylamine (0.04 mL, 0.24 mmol) and then triflic 
anhydride (0.02 mL, 0.14 mmol).  The reaction was stirred for 10 minutes until the reaction was 
complete.  The solvent was partially removed and the residue purified by silica gel chromatography to 
yield the triflate (0.044 g, 88%). 
 
FTIR (thin film/NaCl) 2982, 2957, 1737, 1614, 1508, 1421, 1206, 1141, 1082 cm-1; 1H NMR (600 
MHz, CDCl3) δ = 6.85 (s, 1H), 6.67 (s, 1H), 5.04 (d, J=7.1, 1H), 3.88 (s, 3H), 3.63 (s, 3H), 3.03-3.00 
(m, 1H), 2.93 (d, J=17.2, 1H), 2.62 (d, J=17.2, 1H), 2.55-2.48 (m, 1H), 2.40 (dd, J=4.1, 12.5, 1H), 1.65 
(s, 3H); 13C NMR (126 MHz, CDCl3) δ = 172.6, 157.8, 149.6, 141.3, 137.7, 124.7, 122.2, 108.8, 82.4, 
56.4, 54.8, 53.7, 52.2, 38.7, 37.2, 27.8.; HRMS (EI) m/z 410.06474 [calc'd for C16H17F3O7S (M+) 
410.06471]. 
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 Starting triflate (0.026 g, 0.063 mmol) was dissolved in anhydrous DMF (1.3 mL) at room 
temperature.  To this was added freshly distilled triethylamine (0.09 mL, 6.30 mmol), palladium acetate 
(0.001 g, 0.006 mmol), and triphenylphosphine (0.003 g, 0.012 mmol).  Upon addition of formic acid 
(0.02 mL, 0.63 mmol), a white smoke was observed and the reaction was sealed and heated at 100oC for 
15 hours.  After cooling to room temperature the reaction was quenched with saturated sodium 
bicarbonate (10.0 mL) and extracted with ethyl acetate (3 x 50.0 mL).  The extracts were dried over 
sodium sulfate, concentrated and purified with silica gel chromatography to give the product (0.015 g, 
90%).  
 
FTIR (thin film/NaCl) 2950, 2902, 1736, 1613, 1503, 1433, 1251, 1198, 1164, 1035 cm-1;      1H 
NMR (400 MHz, CDCl3) δ = 6.90 (d, J=8.5, 1H), 6.70 (dd, J=2.6, 8.5, 1H), 6.55 (d, J=2.6, 1H), 5.01 
(d, J=6.9, 1H), 3.77 (s, 3H), 3.63 (s, 3H), 3.02-2.97 (m, 1H), 2.93 (d, J=17.0, 1H), 2.62 (d, J=17.0, 1H), 
2.55-2.46 (m, 1H), 2.42-2.37 (m, 1H), 1.65 (s, 3H); 13C NMR (75 MHz, CDCl3) δ = 172.9, 157.9, 
141.3, 129.3, 123.7, 113.0, 109.1, 82.6, 78.0, 55.4, 53.7, 52.1, 38.7, 37.4, 28.0; HRMS (EI) m/z 
262.12055 [calc'd for C15H18O4 (M+) 262.12051]. 
 
 
 
 
 
 
 Starting material (0.009 g, 0.031 mmol) was dissolved in DCM (0.62 mL) at room 
temperature.  The tris(pentafluorophenyl)borane (0.002 g, 0.003 mmol) was then added followed by a 
10% stock solution of triethylsilane (0.06 mL, 0.034 mmol) and the reaction was allowed to stir at room 
temperature for 1 hour.  After starting material was consumed, the reaction was quenched with 3 drops 
of triethyl amine and filtered through a Celite plug before being purified by silica gel chromatography 
(80% hexanes, 20% ethyl acetate) to give the TES-ether (0.011 g, 88%). 
 
FTIR (thin film/NaCl) 3014, 2993, 1770, 1374, 1241, 1057, 914 cm-1; 1H NMR (400 MHz, CDCl3) δ 
= 6.83 (d, J=8.2, 1H), 6.64 (dd, J=8.2, 2.3, 1H), 6.50 (d, J=2.3, 1H), 4.97 (d, J=7.0, 1H), 3.61 (s, 3H), 
3.05-2.95 (m, 1H), 2.92 (d, J=17.1, 1H), 2.62 (d, J=17.1, 1H), 2.55-2.43 (m, 1H), 2.41-2.32 (m, 1H), 
1.65 (s, 3H), 0.98 (t, J=7.9, 9H), 0.72 (q, J=7.9, 6H); 13C NMR (126 MHz, CDCl3) δ = 172.8, 153.7, 
141.3, 129.2, 124.3, 118.9, 115.2, 82.6, 77.8, 53.7, 52.0, 38.7, 37.4, 28.0, 6.9, 5.2; HRMS (EI) m/z 
362.1911 [calc'd for C20H30O4Si (M+) 362.1913]. 
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 Starting ester (0.006 g, 0.018 mmol) was dissolved dry DCM (0.9 mL) under nitrogen at -
78oC.  To this was added 20% by weight DIBAL-H in THF (0.04 mL, 0.05 mmol) drop-wise and the 
reaction was then maintained at -78oC for 30 minutes. The bath was removed and when the reaction 
reached room temperature, saturated sodium potassium tartrate (0.2 mL) was added followed by ethyl 
acetate (0.2 mL) to quench remaining DIBAL-H.  The reaction was extracted with ethyl acetate, dried 
over sodium sulfate, concentrated, and purified with silica gel chromatography to give the primary 
alcohol (0.005 g, 90%). 
 
FTIR (thin film/NaCl) 2958, 2922, 2875, 1499, 1279, 1264, 1015, 974, 905 cm-1; 1H NMR (300 MHz, 
CDCl3) δ = 6.90 (d, J=8.3, 1H), 6.64 (dd, J=8.3, 2.7, 1H), 6.47 (d, J=2.7, 1H), 4.91 (d, J=7.2, 1H), 
3.65-3.42 (m, 2H), 2.90 (d, J=17.0, 1H), 2.85 (d, J=17.0, 1H), 2.60-2.44 (m, 1H), 2.37-2.18 (m, 1H), 
1.54 (s, 3H), 1.50-1.43 (m, 1H), 0.98 (t, J=7.8, 9H), 0.72 (q, J=7.8, 6H);      13C NMR (600 MHz 
HSQCAD/gHMBCAD, CDCl3) δ = 152.4, 141.3, 128.5, 123.4, 113.0, 109.4, 80.7, 75.9, 63.7, 48.4, 
38.8, 34.9, 27.2, 5.6, 3.9; HRMS (EI) m/z 334.1964 [calc'd for C19H30O3Si (M+) 334.1964]. 
 
 
 
 
 
 Starting alcohol (0.002 g, 0.007 mmol) was dissolved in dry DCM (0.3 mL) at 0oC under 
nitrogen.  Freshly distilled triethylamine (0.01 mL, 0.07 mmol) was added followed by p-
toluenesulfonyl chloride (0.006 g, 0.032 mmol).  The bath was removed and the reaction stirred for 16 
hours.  The reaction was quenched with water (1.0 mL) and extracted with DCM (3 x 5.0 mL).  The 
organics were dried with sodium sulfate, concentrated and purified with silica gel chromatography to 
give the tosylate (0.002 g, 67%). 
 
FTIR (thin film/NaCl) 2954, 2915, 1674, 1622, 1497, 1457, 1372, 1243, 1177, 1156, 1124, 1062, 1011 
cm-1; 1H NMR (600 MHz, CDCl3) δ = 7.72 (d, J=8.0, 1H), 7.33 (d, J=8.0, 1H), 6.69 (d, J=8.2, 1H), 
6.59 (dd, J=2.5, 8.2, 1H), 6.38 (d, J=2.5, 1H), 4.85 (d, J=6.9, 1H), 4.01-3.94 (m, 1H), 3.79-3.73 (m, 
1H), 2.86 (d, J=17.1, 1H), 2.54 (d, J=17.1, 1H), 2.51-2.45 (m, 1H), 2.47 (s, 3H), 2.40-2.35 (m, 1H), 
1.47 (s, 3H), 1.31 (dd, J=3.9, 12.3, 1H), 0.97 (t, J=7.8, 9H), 0.71 (q, J=7.8, 6H); 13C NMR (600 MHz 
HSQCAD/gHMBCAD, CDCl3) 153.7, 144.9, 141.6, 130.8, 129.9, 129.1, 128.0, 124.0, 118.8, 115.1, 
81.8, 76.8, 71.4, 46.0, 39.7, 35.9, 27.9, 21.5, 6.7, 4.8; HRMS (EI) m/z 489.2151 [calc'd for C26H37O5SiS 
(M+H) 489.2131]. 
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 Starting tosylate (0.016 g, 0.033 mmol) was dissolved in dry THF (2.0 mL) at room 
temperature.  A 10% stock solution of TBAF (0.4 mL, 0.04 mmol) was added and the reaction allowed 
to stir for 1 hour at 100oC.  The reaction was then concentrated and purified with silica gel to yield 
known dienone (0.006 g, 91%). 
 
FTIR (thin film/NaCl) 2963, 2942, 1659, 1626, 1149 cm-1; 1H NMR (600 MHz, CDCl3) δ = 6.66 (d, 
J=10.0, 1H), 6.32 (dd, J=1.6, 10.0, 1H), 6.12 (d, J=1.6, 1H), 4.71 (d, J=4.3, 1H), 2.59 (t, J=6.2, 1H), 
2.27-2.21 (m, 1H), 2.20-2.15 (m, 1H), 2.01-1.92 (m, 2H), 1.78 (d, J=11.4, 1H), 1.56-1.50 (m, 1H), 1.51 
(s, 3H); 13C NMR (600 MHz HSQCAD/gHMBC, CDCl3) 187.1, 160.4, 150.9, 130.1, 121.9, 87.1, 
80.0, 54.9, 49.9, 48.7, 44.4, 42.6, 22.2; HRMS (EI) m/z 202.0993 [calc'd for C13H14O2 (M+) 202.0994]. 
 
 
 
 Starting bromide (1.000 g, 4.650 mmol) was mixed with keto-boronate (1.790 g, 9.300 mmol), 
K2CO3 (1.930 g, 0.014 mol), palladium acetate (0.026 g, 0.120 mmol), and RuPhos (2-
dicyclohexylphosphino-2’,6’-diisopropoxybiphenyl) (0.108 g, 0.230 mmol) under an atmosphere of 
nitrogen.  Freshly degassed dry toluene (18.6 mL) and freshly degassed distilled water (4.7 mL) were 
sequentially added and the reaction was heated at 85oC for 16 hours.  The reaction was then quenched 
with pH 7.5 phosphate buffer and extracted with ethyl acetate.  The organics were dried over sodium 
sulfate, concentrated and purified with silica gel to give the keto-aldehyde (0.725 g, 71%). 
 
FTIR (thin film/NaCl) 2970, 2935, 1706, 1608, 1572, 1499, 1263, 1164, 1037 cm-1; 1H NMR (400 
MHz, CDCl3) δ = 10.20 (s, 1H), 7.34 (d, J=2.9, 1H), 7.17 (d, J=8.4, 1H), 7.05 (dd, J=2.9, 8.4, 1H), 
3.86 (s, 3H), 3.42-3.30 (m, 1H), 2.90-2.77 (m, 2H), 2.11 (s, 3H), 1.11-1.08 (m, 3H);  13C NMR (75 
MHz, CDCl3) δ = 212.3, 192.5, 158.7, 134.8, 134.7, 133.6, 120.3, 116.9, 55.7, 48.9, 34.8, 29.3, 16.5; 
HRMS (EI) m/z 220.1099 [calc'd for C13H16O3 (M+) 220.1100]. 
 
Synthesis of keto-boronate: 
 
 Copper chloride (0.035 g, 0.360 mmol), sodium tert-butoxide (0.103 g, 1.070 mmol), and 
DPEPhos (0.192 g, 0.360 mmol) were mixed under nitrogen.  THF (15.0 mL) was added at room 
temperature and the mixture was stirred for 30 minutes.  Bispinacolato diboron (3.170 g, 0.013 mol) in 
THF (9.0 mL) was added and the reaction was stirred for 15 minutes.  3-methyl-3-butene-2-one (1.000 
g, 0.012 mol) was then added followed by anhydrous methanol (0.9 mL) and the reaction was stirred for 
2 hours.  This mixture was then filtered through Celite, concentrated to an oil, and subsequently 
dissolved in acetonitrile (60.0 mL) and cooled to 0oC.  Saturated KHF2 (3.710 g, 0.047 mol, 10 mL 
H2O) was added drop-wise and the reaction was stirred 2 hours.  The solvent was then removed.  The 
solids were triturated with hot acetone and the acetone washings combined and concentrated to 10% of 
the original volume.  The product was precipitated by adding diethyl ether and recrystallized with 
acetone (1.950 g, 85%, mp=110-112oC). 
 
1H NMR (400 MHz, (CD3)2CO) δ = 2.49-2.40 (m, 1H), 2.03-1.98 (m, 2H), 1.95 (s, 3H), 0.94 (d, J=6.8, 
3H); 13C NMR (75 MHz, (CD3)2CO) δ = 205.6, 44.9, 29.2, 26.1, 18.3. 
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Potassium tert-butoxide (3.240 g, 0.027 mol) was added to a flame-dried round bottom flask 
and dry THF (360.0 mL) was added under a nitrogen atmosphere at -78oC.  The starting material (4.010 
g, 0.018 mol) was dissolved in dry THF (10.0 mL) and added drop-wise to the butoxide slurry.  Upon 
complete addition, the reaction was allowed to stir for an additional 30 minutes at -78oC at which time 
the bath was removed and the reaction allowed warming to room temperature.  The reaction was 
neutralized with saturated sodium bicarbonate and extracted with ether.  The combined extracts were 
dried over sodium sulfate, concentrated, and purified by column chromatography (70% hexanes, 30% 
ethyl acetate) to yield enone (3.420 g, 93%).   
 
FTIR (thin film/NaCl) 2970, 2935, 1657, 1600, 1569, 1504, 1275, 1175, 1327 cm-1;   1H NMR (400 
MHz, CDCl3) δ = 7.20 (d, J=7.2, 1H), 7.02 (d, J=12.8, 1H), 6.90-6.84 (m, 2H), 6.15 (d, J=12.8, 1H), 
3.83 (s, 3H), 2.96-2.84 (m, 2H), 2.75-2.62 (m, 1H), 1.12 (d, J= 7.1, 3H); 13C NMR (126 MHz, CDCl3) δ = 203.7, 158.7, 142.0, 135.3, 132.7, 131.1, 129.4, 117.5, 115.5, 55.7, 45.3, 36.5, 15.9; HRMS (EI) 
m/z 202.0993 [calc'd for C13H14O2 (M+) 202.0994]. 
 
 
 
 
 
 
 
Freshly distilled diisopropyl amine (5.2 mL, 0.037 mol) was added to a flame-dried flask and 
diluted with dry THF (160.0 mL) and cooled to -78oC under nitrogen.  Butyl lithium (1.6M, 21.0 mL, 
0.034 mol) was then added and allowed to react for 30 minutes.  Starting enone (3.400 g, 0.017 mol) 
was then dissolved in THF (8.0 mL) and added drop-wise to the LDA solution over 1 minute and 
allowed to stir for an additional 15 minutes.  A stock solution of N-phenyl triflimide (6.610 g, 0.019 
mol) was then added and the bath removed as the reaction warmed to room temperature.  After 1 hour 
the reaction was diluted with ether (250.0 mL) and washed with NaOH solution (0.1M, 100.0 mL).  The 
ethereal solution was then dried over sodium sulfate, concentrated, and purified with column 
chromatography (70% hexanes, 30% ethyl acetate) to yield the vinyl triflate (3.240 g, 58%).   
 
FTIR (thin film/NaCl) 2945, 2838, 1498, 1414, 1206, 1139, 1032 cm-1; 1H NMR (400 MHz, CDCl3) δ = 7.10-7.02 (m, 2H), 6.93 (dd, J=2.6, 8.3, 1H), 6.83 (d, J=2.6, 1H), 6.32 (d, J=11.9, 1H), 3.79 (s, 3H), 
3.05 (s, 2H), 2.07 (s, 3H); 13C NMR (75 MHz, CDCl3) δ = 158.5, 140.3, 135.8, 135.0, 129.5, 128.9, 
128.5, 122.9, 120.8, 116.3, 112.8, 55.6, 37.8, 18.9; HRMS (EI) m/z 335.0558 [calc'd for C14H14O4F3S 
(M+H) 335.0565]. 
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Palladium acetate (0.046 g, 0.210 mmol) and triphenylphosphine (0.108 g, 0.420 mmol) were 
added to a flame-dried flask at room temperature under nitrogen.  Dry DMF (21.0 mL) was added 
followed by triethylamine (0.8 mL, 6.200 mmol) and methanol (3.4 mL, 0.083 mol).  Starting triflate 
(0.690 g, 2.070 mmol) was dissolved in dry DMF (3.0 mL) and added to the reaction and a balloon of 
carbon monoxide was attached via needle through a septum.  The reaction was heated at 80oC for 3 
hours until the starting material was consumed.  The reaction was then diluted with ethyl acetate (250.0 
mL) and washed with distilled water (3 x 50.0 mL).  The organics were then dried over sodium sulfate 
and purified with silica gel chromatography (70% hexanes, 30% ethyl acetate) to yield the enoate 
(0.485 g, 96%). 
 
FTIR (thin film/NaCl) 2952, 1716, 1604, 1495, 1434, 1257, 1221 cm-1; 1H NMR (400 MHz, CDCl3) δ = 7.09 (d, J=8.4, 1H), 7.03 (d, J=11.8, 1H), 6.90 (dd, J=2.7, 8.4, 1H), 6.86 (d, J=11.8, 1H), 6.82 (d, 
J=2.7, 1H), 3.78 (s, 3H), 3.72 (s, 3H), 3.03 (s, 2H), 2.36 (s, 3H); 13C NMR (75 MHz, CDCl3) δ = 
168.1, 158.2, 148.9, 136.4, 131.9, 128.8, 128.3, 128.2, 124.0, 115.6, 111.7, 55.6, 51.7, 42.9, 22.9; 
HRMS (EI) m/z 244.1097 [calc'd for C15H16O3 (M+) 244.1100]. 
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Triphenylmethyl hydroperoxide (0.153 g, 0.554 mmol) was added to a flame-dried flask and 
dissolved in dry THF (7.0 mL) under nitrogen and then cooled to -78oC.   Methyl lithium (1.6M, 0.3 
mL, 0.480 mmol) was added and the reaction was stirred for 10 minutes.  Starting diene (0.090 g, 0.368 
mmol) was then dissolved in dry THF (0.4 mL), added to the reaction, and allowed to stir at -78oC for 1 
hour.  The reaction was then warmed to room temperature and quenched with saturated ammonium 
chloride (5.0 mL) and extracted with ethyl acetate (3 x 50.0 mL).  The organics were then dried over 
sodium sulfate, concentrated, and purified by silica gel chromatography (80% hexanes, 20% ethyl 
acetate) to yield the epoxide (0.086 g, 90%). 
  
FTIR (thin film/NaCl) 2957, 1749, 1605, 1572, 1503, 1435, 1266, 1045 cm-1; 1H NMR (400 MHz, 
CDCl3) δ = 7.01-6.96 (m, 2H), 6.77 (dd, J=2.7, 8.3, 1H), 4.23 (d, J=4.3, 1H), 4.18 (d, J=4.3, 1H), 3.96 
(d, J=13.6, 1H), 3.80 (s, 3H), 3.75 (s, 3H), 3.26 (d, J=13.6, 1H), 2.24 (s, 3H); 13C NMR (75 MHz, 
CDCl3) δ = 169.5, 158.9, 136.9, 134.2, 130.6, 127.9, 125.7, 115.1, 113.6, 71.6, 62.7, 55.5, 52.9, 42.8, 
18.6; HRMS (EI) m/z 260.1050 [calc'd for C15H16O4 (M+) 260.1049]. 
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Starting epoxide (0.062 g, 0.238 mmol) was dissolved in dry toluene (0.5 mL) and dry 
Cu(hfacac)2 (0.035 g, 0.071 mmol, dried on vacuum pump for 2 hours prior to use) was added at room 
temperature.  The vial was sealed well and the reaction heated at 150oC for 30 minutes.  After allowing 
the reaction to cool to room temperature, it was filtered through neutral alumina (activity grade 1), 
concentrated and purified with silica gel chromatography (80% hexanes, 20% ethyl acetate) to give the 
ring expanded product (0.050 g, 81%). 
 
FTIR (thin film/NaCl) 2947, 2933, 1714, 1598, 1494, 1437, 1253 cm-1; 1H NMR (300 MHz, CDCl3) 
δ = 6.98 (d, J=8.5, 1H), 6.76 (dd, J=8.5, 2.6, 1H), 6.63 (d, J=2.6, 1H), 5.30 (d, J=1.8, 1H), 3.77 (s, 3H), 
3.71 (s, 3H), 2.92 (d, J=17.0, 1H), 2.78 (d, J=17.0, 1H), 1.72 (s, 3H); 13C NMR (151 MHz, CDCl3) δ = 
164.1, 157.6, 147.4, 137.0, 135.7, 131.3, 126.1, 113.4, 110.0, 84.5, 80.2, 55.6, 51.7, 34.6, 23.6; HRMS 
(EI) m/z 261.1129 [calc'd for C15H17O4 (M+H) 261.1127]. 
 
 
 
 
 
Methyl enoate (0.135 g, 0.520 mmol) was dissolved in dry THF (26.0 mL) and the solution 
cooled to -78oC under nitrogen.  Lithium triethylborohydride (1M, 2.08 mL, 2.08 mmol) was added 
drop-wise and the reaction stirred for 90 minutes.  The bath was then removed and when the reaction 
had come to room temperature it was quenched with saturated ammonium chloride and extracted with 
DCM.  The organics were dried over sodium sulfate, concentrated, and chromatographed (50% 
hexanes, 50% ethyl acetate) to give the primary alcohol (0.118 g, 97%). 
 
FTIR (thin film/NaCl) 2953, 2922, 1610, 1502, 1451, 1382, 1258, 1155, 1034 cm-1;  1H NMR (400 
MHz, CDCl3) δ = 6.97 (d, J=8.1, 1H), 6.70 (dd, J=2.5, 8.1, 1H), 6.51 (d, J=2.5, 1H), 4.95 (d, J=7.2, 
1H), 3.77 (s, 3H), 3.64-3.55 (m, 1H), 3.54-3.44 (m, 1H), 2.94 (d, J=17.0, 1H), 2.83 (d, J=17.0, 1H), 
2.60-2.50 (m, 1H), 2.33-2.24 (m, 1H), 1.54 (s, 3H), 1.50 (dd, J=4.2, 12.2, 1H);    13C NMR (600 MHz 
HSQCAD/gHMBC, CDCl3) δ =157.7, 142.3, 129.3, 124.3, 112.7, 109.0, 81.8, 77.1, 64.8, 55.4, 49.5, 
40.0, 36.2, 28.3; HRMS (EI) m/z 234.1259 [calc'd for C14H18O3 (M+) 234.1256].. 
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Starting alcohol (0.049 g, 0.210 mmol) was dissolved in dry DCM (4.2 mL) at 0oC under 
nitrogen.  Freshly distilled triethylamine (0.3 mL, 2.1 mmol) was added followed by p-toluenesulfonyl 
chloride (0.060 g, 0.315 mmol).  The bath was removed and the reaction stirred for 10 hours.  The 
reaction was quenched with water (2.0 mL) and extracted with DCM (3 x 5.0 mL).  The organics were 
dried with sodium sulfate, concentrated and purified with silica gel chromatography to give the tosylate 
(0.078 g, 96%). 
 
FTIR (thin film/NaCl) 2970, 2929, 1612, 1503, 1452, 1360, 1253, 1176, 1096, 1017, 950 cm-1 ; 1H 
NMR (400 MHz, CDCl3) δ = 7.73 (d, J=8.2, 2H), 7.33 (d, J=8.2, 2H), 6.77 (d, J=8.3, 1H), 6.66 (dd, 
J=2.6, 8.3, 1H), 6.43 (d, J=2.6, 1H), 4.90 (d, J=6.8, 1H), 4.00-3.94 (m, 1H), 3.82-3.76 (m, 1H), 3.76 (s, 
3H), 2.87 (d, J=17.0, 1H), 2.56 (d, J=17.0, 1H), 2.53-2.35 (m, 2H), 2.47 (s, 3H), 1.48 (s, 3H), 1.34 (dd, 
J=3.7, 12.1, 1H); 13C NMR (600 MHz HSQCAD/gHMBC, CDCl3) δ =157.8, 144.9, 141.7, 132.7, 
129.7, 129.0, 127.6, 123.1, 112.6, 108.7, 81.5, 76.5, 71.2, 55.0, 45.7, 39.4, 35.6, 27.6, 21.3; HRMS (EI) 
m/z 389.1417 [calc'd for C21H25O5S (M+H) 389.1423]. 
 
 
 
 
  
 
Starting tosylate (0.034 g, 0.088 mmol) was dissolved in DCM (1.8 mL) at room temperature.  
The tris(pentafluorophenyl)borane (0.005 g, 0.009 mmol) was then added followed by a 10% stock 
solution of triethylsilane (0.15 mL, 0.097 mmol) and the reaction was allowed to stir at room 
temperature for 1 hour.  After the starting material was consumed, the reaction was purified by silica gel 
chromatography (80% hexanes, 20% ethyl acetate) to give pure TES-ether (0.036 g, 84%). 
 
FTIR (thin film/NaCl) 2954, 2915, 1674, 1622, 1497, 1457, 1372, 1243, 1177, 1156, 1124, 1062, 1011 
cm-1; 1H NMR (600 MHz, CDCl3) δ = 7.72 (d, J=8.0, 1H), 7.33 (d, J=8.0, 1H), 6.69 (d, J=8.2, 1H), 
6.59 (dd, J=2.5, 8.2, 1H), 6.38 (d, J=2.5, 1H), 4.85 (d, J=6.9, 1H), 4.01-3.94 (m, 1H), 3.79-3.73 (m, 
1H), 2.86 (d, J=17.1, 1H), 2.54 (d, J=17.1, 1H), 2.51-2.45 (m, 1H), 2.47 (s, 3H), 2.40-2.35 (m, 1H), 
1.47 (s, 3H), 1.31 (dd, J=3.9, 12.3, 1H), 0.97 (t, J=7.8, 9H), 0.71 (q, J=7.8, 6H); 13C NMR (600 MHz 
HSQCAD/gHMBCAD, CDCl3) 153.7, 144.9, 141.6, 130.8, 129.9, 129.1, 128.0, 124.0, 118.8, 115.1, 
81.8, 76.8, 71.4, 46.0, 39.7, 35.9, 27.9, 21.5, 6.7, 4.8; HRMS (EI) m/z 489.2151 [calc'd for C26H37O5SiS 
(M+H) 489.2131]. 
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A2.2 NMR Data for Chapter 2 
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APPENDIX 3 
 
A3.1 Experimental Procedures for Chapter 3 
 
General Information: Commercial reagents were purchased and used without further purification. All 
glassware was flame dried and reactions were performed under a nitrogen atmosphere, unless otherwise 
stated. Toluene, dichloromethane, diethyl ether, and THF were dried over a column of alumina. Flash 
chromatography was done with MP Silitech 32-63D 60Å silica, and thin layer chromatography (TLC) 
was performed with EMD 250 μm silica gel 60-F254
 
plates. 1H and 13C NMR data was acquired on a 
Varian Inova 400, 500, or 600 (400, 500 or 600 MHz) spectrometer and referenced to residual protic 
solvent or TMS. IR spectroscopy was done on a Nicolet Avatar 370 OTGS spectrometer. High-
resolution mass spectrometry was performed at the University of Illinois at Urbana-Champaign facility. 
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Starting phenol (3.480 g, 0.017 mol) was dissolved in dry acetone (34.8 ml) and anhydrous potassium 
carbonate (4.800 g, 0.035 mol) was added.  Diethyl bromomalonate (14.6 ml, 0.087 mol) was then 
added and a reflux condenser was attached to the flask.  The reaction was refluxed for 14 hours until 
starting material was consumed.  The potassium carbonate was filtered off and the reaction was diluted 
with diethyl ether and subsequently washed with brine and dried over sodium sulfate.  The solvent was 
removed and the residue was purified with silica gel chromatography to give the malonyl ether (4.300 
g, 70%). 
 
FT-IR (thin film/NaCl) 2917, 1743, 1595, 1466, 1195, 1078, 915 cm-1; 1H NMR (400 MHz, CDCl3) δ 
= 6.54 (s, 2H), 5.89 (ddt, J=6.4, 10.2, 16.6, 2H), 5.07 – 4.98 (m, 4H), 4.75 (s, 1H), 4.32 – 4.15 (m, 4H), 
3.70 (s, 3H), 3.38 (d, J=6.4, 4H), 1.27 – 1.23 (t, J=7.1, 6H); 13C NMR (101 MHz, CDCl3) δ = 166.3, 
156.3, 148.3, 136.9, 133.9, 116.5, 113.8, 81.9, 62.3, 55.5, 34.3, 14.1; HRMS (EI) m/z 362.1741 [calc’d 
for C20H26O6 (M+) 362.1729]. 
_____________________________________________________________________ 
 
 
 
 
Lithium aluminum hydride (1.570 g, 0.041 mol) was placed in a flask and ether (37.0 mL) was added 
slowly at room temperature.  To this slurry was added drop-wise a solution of starting material (3.740 g, 
0.010 mol) and ether (4.0 mL) over ten minutes and the reaction was allowed to stir an additional 2 
hours.  The reaction was quenched by slow addition of ethyl acetate followed by water and 1 M HCl.  
The reaction was then diluted with ether and washed with brine.  The ether was concentrated and the oil 
was purified with silica gel chromatography to give diol (2.680 g, 93%). 
 
FT-IR (thin film/NaCl) 3406, 2938, 1602, 1466, 1323, 1197, 1050, 915 cm-1; 1H NMR (400 MHz, 
CDCl3) δ = 6.58 (s, 2H), 5.97 – 5.83 (m, 2H), 5.11 – 5.01 (m, 4H), 3.96 – 3.90 (m, 1H), 3.87 (dd, J=4.7, 
11.6, 2H), 3.79 (dd, J=4.1, 11.4, 2H), 3.72 (s, 3H), 3.41 – 3.38 (m, 4H), 2.64 (bs, 2H); 13C NMR (101 
MHz, CDCl3) δ = 155.8, 146.8, 137.0, 134.1, 116.5, 113.9, 82.1, 62.3, 55.6, 34.5; HRMS (EI) m/z 
278.1521 [calc’d for C16H22O4 (M+) 278.1518]. 
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Starting diol (0.318 g, 1.140 mmol) and triphenylphosphine (1.050 g, 0.004 mol) were dissolved in dry 
dichloromethane (11.4 ml) at 0oC and carbon tetrabromide (1.330 g, 0.004 mol) was then added.  The 
ice bath was removed and the reaction was allowed to stir 12 hours to ensure completion.  The reaction 
mixture was then concentrated and purified directly with silica gel chromatography to give pure 
dibromide (0.427 g, 92%). 
 
FT-IR (thin film/NaCl) 2937, 1638, 1602, 1465, 1327, 1186, 1052, 915 cm-1; 1H NMR (400 MHz, 
CDCl3) δ = 6.59 (s, 2H), 5.92 (m, 2H), 5.20 – 4.97 (m, 4H), 4.21 (m, 1H), 3.74 (s, 3H), 3.73 (dd, J=3.7, 
10.4, 2H), 3.64 (dd, J=3.7, 10.4, 2H), 3.40 (m, 4H); 13C NMR (126 MHz, CDCl3) δ = 156.2, 145.8, 
136.7, 134.2, 116.8, 114.1, 79.5, 55.6, 34.7, 32.4; HRMS (EI) m/z 401.98379 [calc’d for C16H20O2Br2 
(M+) 401.98303]. 
_____________________________________________________________________ 
 
 
 
 
 
Dibromide (0.019 g, 0.048 mmol) was dissolved in dichloromethane (0.24 ml) and tetrabutylammonium 
iodide (0.020 g, 0.053 mmol) was added.  The reaction was cooled to -78oC and boron trichloride 
solution (0.06 ml, 1M, 0.06 mmol) was added slowly.  The reaction was then placed in a -10oC bath and 
stirred two hours.  When complete, the reaction was quenched with saturated sodium bicarbonate and 
extracted with dichloromethane.  The organics were dried over sodium sulfate, concentrated and 
purified with silica gel chromatography to give phenol (0.015 g, 80%). 
 
FT-IR (thin film/NaCl) 3387, 2917, 1598, 1454, 1322, 916 cm-1; 1H NMR (400 MHz, CDCl3) δ = 6.53 
(s, 2H), 5.90 (m, 2H), 5.10 (m, 4H), 4.20 (m, 1H), 3.72 (dd, J=6.2, 10.4, 2H), 3.63 (dd, J=6.2, 10.4, 
2H), 3.37 (m, 4H); 13C NMR (101 MHz, CDCl3) δ = 152.2, 145.8, 136.6, 134.5, 116.9, 115.5, 79.5, 
34.5, 32.3; HRMS (EI) m/z 387.9670 [calc’d for C15H18O2Br2 (M+) 387.9674]. 
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Dibromide phenol (1.000 g, 2.560 mmol) was dissolved in dry methanol (23.3 ml) and cooled to 0oC.  
Iodobenzene diacetate (0.908 g, 2.820 mmol) was added and the reaction turned bright yellow 
immediately.  The reaction was concentrated and purified with a plug of silica gel to give pure 
dearomatized product (1.010 g, 94%).   
 
FT-IR (thin film/NaCl) 2977, 2944, 1675, 1640, 1427, 1294, 1102, 1061, 1037, 923 cm-1; 1H NMR 
(400 MHz, CDCl3) δ = 6.33 (s, 2H), 5.84 (m, 2H), 5.35 – 5.19 (m, 4H), 3.83 (tt, J=3.3, 6.5, 1H), 3.62-
3.50 (m, 4H), 3.30 – 3.17 (m, 2H), 3.09 (s, 3H), 3.10 – 2.99 (m, 2H); 13C NMR (101 MHz, CDCl3) δ = 
184.5, 157.2, 132.3, 130.5, 120.1, 98.4, 72.0, 51.6, 33.4, 33.0; HRMS (EI) m/z 417.9782 [calc’d for 
C16H20O3Br2 (M+) 417.9780]. 
_____________________________________________________________________ 
 
 
 
 
 
Starting material (0.046 g, 0.110 mmol) was dissolved in freshly distilled toluene (11.0 ml) and was 
cooled to -78o C.  Tributyltin hydride (0.09 ml, 0.330 mmol) was added to the reaction followed by 
triethylborane (0.01 ml, 0.01 mmol).  The reaction was allowed to stir 30 minutes and the bath was 
removed.  After 30 additional minutes at room temperature, the reaction was concentrated and purified 
with silica gel chromatography to give mono cyclized product (0.025 g, 87%).     
 
FT-IR (thin film/NaCl) 2970, 2935, 1678, 1262, 1122, 1026, 669 cm-1; 1H NMR (400 MHz, CDCl3) δ 
= 5.85 (s, 1H), 5.85 – 5.65 (m, 2H), 5.21 – 5.05 (m, 4H), 4.33 (m, 1H), 3.48 (s, 3H), 3.11 – 3.05 (m, 
2H), 2.56 – 2.36 (m, 3H), 2.19 (dd, J=7.8, 13.9, 1H), 2.10 (m, 1H), 1.92 – 1.71 (m, 2H), 1.36 (d, J=6.2, 
4H); 13C NMR (126 MHz, CDCl3) δ = 198.1, 159.5, 133.9, 133.9, 127.2, 119.3, 118.8, 105.3, 75.2, 
52.6, 52.3, 44.3, 43.2, 39.3, 35.3, 21.4; HRMS (EI) m/z 262.1566 [calc’d for C16H22O3 (M+) 
262.1569]. 
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Potassium iodide (1.260 g, 7.620 mmol) and sodium hydride (0.112 g, 2.790 mmol) were mixed and 
dry DMF (25.4 ml) was added and cooled to -10oC.  The starting material (0.920 g, 2.540 mmol) was 
dissolved in dry DMF (2.0 ml) and added slowly to the slurry.  After complete addition, benzyl chloride 
(0.44 ml, 3.81 mmol) was added and the bath was removed.  After 4 hours the reaction was diluted with 
ether and washed with distilled water.  The ethereal solution was dried over sodium sulfate, 
concentrated and purified with silica gel chromatography to give benzylated product (0.980 g, 85%). 
 
FT-IR (thin film/NaCl) 3073, 2981, 2838, 1741, 1602, 1463, 1247, 1195, 1055, 914, 700 cm-1; 1H 
NMR (300 MHz, CDCl3) δ = 7.21 – 7.05 (m, 5H), 6.52 (s, 2H), 5.97 – 5.79 (m, 2H), 5.14 – 5.00 (m, 
4H), 4.05 – 3.94 (m, 4H), 3.73 (s, 3H), 3.49 (s, 2H), 3.42 (d, J=6.8, 4H), 1.06 (t, J=7.2, 6H); 13C NMR 
(101 MHz, CDCl3) δ = 168.2, 156.5, 145.6, 136.8, 134.8, 130.5, 128.3, 128.1, 127.2, 116.7, 112.9, 88.6, 
62.0, 55.5, 41.1, 35.4, 13.8. HRMS (EI) m/z 452.2198 [calc’d for C27H32O6 (M+) 452.2199]. 
_____________________________________________________________________ 
 
 
 
 
Lithium aluminum hydride (0.147 g, 3.870 mmol) was added to a flask and dry ether (8.7 ml) was 
added carefully.  Starting material (0.875 g, 1.940 mmol) was dissolved in ether (1.0 ml) and added 
drop-wise to the LAH solution over twenty minutes.  The reaction was allowed to stir 1 hour and then 
quenched with ethyl acetate followed by water and 1 M HCl.  The product was extracted with ether, 
dried over sodium sulfate and concentrated to an oil.  The oil was purified with silica gel 
chromatography to give pure diol (0.700 g, 98%).       
   
FT-IR (thin film/NaCl) 3460, 2938, 1638, 1602, 1461, 1320, 1197, 1052, 915 cm-1; 1H NMR (400 
MHz, CDCl3) δ = 7.30 – 7.15 (m, 5H), 6.63 (s, 2H), 5.91 (m, 2H), 5.16 – 5.06 (m, 4H), 3.76 – 3.75 (m, 
7H), 3.48 (d, J=6.4, 4H), 3.05 (s, 2H). 13C NMR (101 MHz, CDCl3) δ = 155.9, 145.3, 136.9, 136.5, 
135.9, 130.7, 128.5, 128.3, 116.9, 113.9, 86.4, 65.0, 55.5, 39.1, 35.7; HRMS (EI) m/z 368.1987 [calc’d 
for C23H28O4 (M+) 368.1988]. 
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Starting diol (0.075 g, 0.200 mmol) was dissolved in dry dichloromethane at 0oC.  Freshly distilled 
triethylamine (0.11 ml, 0.80 mmol) was added followed by drop-wise addition of methane sulfonyl 
chloride (0.04 ml, 0.44 mmol).  The reaction was stirred ten minutes and then neutralized with saturated 
sodium bicarbonate and extracted with dichloromethane.  The combined extracts were dried over 
sodium sulfate, concentrated and subjected to silica gel chromatography to yield bis-mesylate (0.081 g, 
76%). 
 
FT-IR (thin film/NaCl) 3028, 2938, 1639, 1602, 1464, 1367, 1343, 1175, 1053 cm-1; 1H NMR (400 
MHz, CDCl3) δ = 7.42 – 7.13 (m, 5H), 6.63 (s, 2H), 5.89 (m, 2H), 5.18 – 5.09 (m, 4H), 4.34 (m, 4H), 
3.76 (s, 3H), 3.40 (d, J=6.3, 4H), 3.02 (s, 2H), 2.88 (s, 6H); 13C NMR (75 MHz, CDCl3) δ = 156.4, 
144.5, 136.6, 135.8, 134.1, 130.9, 128.8, 127.7, 117.4, 114.0, 81.8, 68.1, 55.7, 39.5, 37.5, 35.3; HRMS 
(ESI) m/z 547.1437 [calc’d for C25H32O8S2Na (M+Na) 547.1436]. 
 
___________________________________________________________________________________ 
 
 
 
 
 
Starting material (0.080 g, 0.150 mmol) and tetrabutyl ammonium bromide (0.500 g, 1.500 mmol) were 
dissolved in dioxane (1.6 ml) and sealed tightly in a small vial.  The reaction was heated at 130oC for 18 
hours until TLC showed complete conversion.  The solids were filtered and the solvent removed.  The 
resulting residue was purified with silica gel chromatography to give dibromide (0.065 g, 86%). 
 
FT-IR (thin film/NaCl) 3076, 2977, 2936, 1602, 1462, 1321, 1195, 1054, 997, 916 cm-1; 1H NMR (400 
MHz, CDCl3) δ = 7.32 – 7.03 (m, 5H), 6.58 (s, 2H), 5.83 (m, 2H), 5.16 – 5.00 (m, 4H), 3.80 (s, 4H), 
3.76 (s, 3H), 3.34 (d, J=6.5, 4H), 3.27 (s, 2H); 13C NMR (101 MHz, CDCl3) δ = 156.2, 145.1, 136.8, 
135.9, 135.2, 131.1, 128.4, 127.3, 117.1, 113.6, 82.5, 55.6, 41.3, 37.4, 35.6; HRMS (ESI) m/z 515.0209 
[calc’d for C23H26Br2O2 (M+Na) 515.0197]. 
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Starting material (0.025 g, 0.051 mmol) and tris(pentafluorobenzene) borane (0.003 g, 0.005 mmol) 
were mixed at room temperature and 0.5 ml of a 10% solution of triethylsilane (0.09 ml, 0.56 mmol)  in 
dichloromethane (4.9 ml) was added.  The reaction was allowed to stir 36 hours for complete 
consumption of starting material.  The TES group was then removed by addition of DBU (0.01 ml) and 
0.5 ml of acetonitrile and stirring 5 minutes.  The reaction was treated with saturated ammonium 
chloride and extracted with dichloromethane.  The organics were then dried over sodium sulfate, 
concentrated down and purified with silica gel to give free phenol (0.018 g, 75%). 
 
FT-IR (thin film/NaCl) 3061, 2956, 2930, 1600, 1496, 1452, 1184, 996, 703 cm-1; 1H NMR (400 MHz, 
CDCl3) δ = 7.26-7.14 (m, 5H), 6.52 (s, 2H), 5.81 (m, 2H), 5.14-5.05 (m, 4H), 4.56 (bs, 1H), 3.79 (s, 
3H), 3.31 (d, J=6.4, 4H), 3.27 (s, 2H); 13C NMR (101 MHz, CDCl3) δ = 152.2, 145.2, 136.6, 136.3, 
135.2, 131.1, 128.4, 127.4, 117.2, 115.1, 82.6, 41.4, 37.4, 35.4; HRMS (EI) m/z 478.0139 [calc’d for 
C22H24O2Br2 (M+) 478.0143]. 
 
___________________________________________________________________________________ 
 
 
 
 
Starting phenol (0.008 g, 0.016 mmol) and anhydrous methanol (0.2 ml) were mixed at room 
temperature and iodobenzene diacetate (0.005 g, 0.016 mmol) was added.  The reaction was stirred five 
minutes and then the solvent was removed and the residue purified with silica gel chromatography to 
yield pure dearomatized bis-bromide (0006 g, 75%). 
 
FT-IR (thin film/NaCl) 2965, 1657, 1640, 1495, 1426, 1294, 1015, 922, 703 cm-1; 1H NMR (400 MHz, 
CDCl3) δ = 7.38 – 7.14 (m, 5H), 6.22 (s, 2H), 5.69 (m, 2H), 5.25 – 4.99 (m, 4H), 3.54 (q, J=11.4, 4H), 
3.26 – 3.10 (m, 4H), 2.92 (s, 3H), 2.84 (m, 2H); 13C NMR (101 MHz, CDCl3) δ = 184.7, 159.5, 135.2, 
132.8, 131.1, 129.9, 128.8, 127.8, 120.0, 97.6, 81.5, 50.7, 41.8, 37.8, 33.8; HRMS (DART) m/z 
509.03447 [calc’d for C23H27O3Br2 (M+H) 509.03273]. 
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Starting material (0.040 g, 0.078 mmol) was dissolved in dry toluene (1.6 ml) at room temperature and 
tris(trimethylsilyl)silane (0.07 ml, 0.24 mmol) was added followed by triethyl borane (0.07 ml, 0.07 
mmol).  The reaction was purged with air and subsequently stirred for 4 hour.  The reaction was loaded 
directly onto a silica gel column and purified to provide the bicyclic product (0.020 g, 73%). 
 
FT-IR (thin film/NaCl) 2952, 2892, 1672, 1455, 1244, 1083, 914 cm-1; 1H NMR (600 MHz, CDCl3) δ 
= 7.31-7.18 (m, 5H), 5.62 (dd, J=10.0, 16.0, 2H), 5.03 (d, J=10.0, 2H), 4.92 (d, J=16.0, 2H), 3.67 (s, 
3H), 2.96 (s, 2H), 2.40 (d, J=13.3, 1H), 2.33 (dd, J=7.4, 13.7, 1H), 2.26 (d, J=13.3, 1H), 2.15 (dd, 
J=8.5, 13.7, 1H), 1.74 (d, J=11.5, 1H), 1.18 (d, J=11.5, 1H); 13C NMR (HSQC-AD/gHMBC-AD 
Derived 150 MHz, CDCl3) δ = 211.0, 136.9, 133.6, 130.0, 128.2, 126.6, 118.8, 108.1, 79.4, 55.5, 51.1, 
47.4, 44.5, 42.6, 42.3; HRMS (ESI) m/z 375.1935 [calc’d for C23H28O3 (M+Na) 375.1936]. 
___________________________________________________________________________________ 
 
 
Starting material (0.010 g, 0.028 mmol) was dissolved in dry dichloromethane (2.0 ml) and to this was 
added Grubbs second generation catalyst (0.002 g, 0.003 mmol).  Meanwhile, 2-methyl-propene (2.0 
ml) was condensed into a pressure vessel at -78oC and to this was added the starting material/Grubbs 
mixture.  The pressure vessel was sealed and heated at 40oC for 8 hours.  The reaction was then 
removed from the bath and pressure was carefully allowed to escape.  The remaining solution was 
filtered through a plug of silica gel with 30% ethyl acetate 70% hexanes to afford pure prenylated 
product (0.010 g, 87%). 
 
FT-IR (thin film/NaCl) 2957, 2926, 2855, 1715, 1455, 1251, 1066, 841 cm-1; 1H NMR (600 MHz, 
CDCl3) δ = 7.25-7.18 (m, 5H), 4.98 (t, J = 7.6, 2H), 3.69 (s, 3H), 2.94 (s, 2H), 2.37 (d, J = 13.3, 2H), 
2.29 (d, J = 13.3, 2H), 2.27 (dd, J = 7.5, 13.9, 2H), 2.13 (dd, J = 7.6, 13.9, 2H), 1.70-1.66 (m, 8H), 1.49 
(s, 6H), 1.17 (d, J = 11.4, 2H); 13C NMR (HSQC-AD/gHMBC-AD Derived 150 MHz, CDCl3) δ = 
211.7, 136.7, 134.6, 129.9, 128.1, 126.5, 118.9, 108.3, 79.3, 55.2, 52.1, 46.8, 44.5, 42.3, 35.7, 26.0, 
17.8; HRMS (EI) m/z 408.2662 [calc’d for C27H36O3 (M+) 408.2665]. 
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Starting ketone (0.005 g, 0.012 mmol) was dissolved in dry THF (0.25 mL) and cooled to 0oC under 
nitrogen.  A solution of LHMDS (1M, 0.06 mmol, 0.06 mL) was added over the course of 2 minutes.  
The reaction was allowed to stir 10 additional minutes before a 3:1 mixture of TMSCl:Et3N (0.06 
mmol, 0.01 mL) was added and the reaction was allowed to warm to room temperature.  After 30 
minutes, the reaction was diluted with ether and washed with water.  The combined organics were 
concentrated and purified with silica gel chromatography to give the TMS enol ether (0.005 g, 85%) 
 
FT-IR (thin film/NaCl) 2956, 2924, 2853, 1454, 1250, 1164, 1064, 1031, 841 cm-1; 1H NMR (600 
MHz, CDCl3) δ = 7.25-7.16 (m, 5H), 5.15 (t, J = 7.4, 1H), 5.04 (t, J = 7.4, 1H), 4.92 (s, 1H), 3.58 (s, 
3H), 2.95 – 2.92 (m, 2H), 2.31 – 2.02 (m, 6H), 1.78 (dd, J = 12.2, 2.9, 1H) 1.73 – 1.71 (m, 1H), 1.72 (s, 
3H), 1.71 (s, 3H), 1.56 (s, 3H), 1.51 (s, 3H), 1.39 (d, J = 11.1, 1H), 1.32 (d, J = 12.2, 1H), 0.14 (s, 9H); 
13C NMR (HSQC-AD/gHMBC-AD Derived 150 MHz, CDCl3) δ = 146.6, 137.4, 133.9, 133.5, 130.1, 
128.5, 128.1, 126.4, 125.7, 120.6, 119.9, 111.2, 108.6, 78.9, 54.2, 51.8, 47.7, 47.1, 45.1, 42.6, 37.7, 
35.2, 34.6, 26.2, 26.1, 18.1, 18.0, 0.49; HRMS (EI) m/z 480.3050 [calc’d for C30H44O3Si (M+) 
480.3060]. 
___________________________________________________________________________________ 
 
 
 
The TMS enol ether (0.002 g, 0.004 mmol) was dissolved in dry DME (0.1 mL) and cooled to 0oC 
under nitrogen.  To this was added MeLi (0.04 mmol, 0.04 mL) and the reaction was allowed to stir for 
5 minutes.  Methyl iodide (0.04 mmol, 0.01 mL) was then added and the bath was removed.  After 45 
minutes at room temperature, the reaction was diluted with ether and washed with water.  The 
combined organics were dried over sodium sulfate, concentrated and purified with silica gel 
chromatography to give the methylated product (0.003 g, 86%). 
 
 
FT-IR (thin film/NaCl) 2917, 2849, 1735, 1559, 1365, 1275, 1222, 750 cm-1; 1H NMR (600 MHz, 
CDCl3) δ 7.26-7.18 (m, 5H), 5.00 (t, J = 7.3, 1H), 4.89 (t, J = 7.3, 1H), 3.67 (s, 3H), 2.91 (s, 2H), 2.60 
(d, J = 13.7, 1H), 2.47 (dd, J = 7.3, 14.0, 1H), 2.38 (q, J = 7.0, 1H), 2.28 (dd, J = 7.5, 13.7, 1H), 2.16 (d, 
J = 13.7, 1H), 2.16 – 2.04 (m, 2H), 1.73 – 1.63 (m, 2H), 1.68 (s, 3H), 1.67 (s, 3H), 1.50 (s, 3H), 1.48 (s, 
3H), 1.23 – 1.10 (m, 2H), 1.13 (d, J = 7.0, 3H); 13C NMR (HSQC-AD/gHMBC-AD Derived 150 MHz, 
CDCl3) δ = 130.0, 129.9, 128.4, 128.2, 126.5, 119.1, 118.1, 55.4, 50.1, 45.6, 45.1, 42.8, 42.5, 35.8, 
30.7, 26.0, 26.0, 17.9, 17.9, 13.8; HRMS (EI) m/z 422.2832 [calc’d for C28H38O3 (M+) 422.2821]. 
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Bis [(R)-1-phenylethyl]amine (0.03 mmol, 0.01 mL) was added to a reaction vial along with  dry THF 
(0.2 mL).  After cooling to -78oC, nBuLi (0.03 mmol, 0.02 mL) was added and the reaction was allowed 
to stir 15 minutes.  LiCl (0.5 eq, 0.2 mg) was added immediately following the nBuLi.  At which time 
the starting ketone (0.004 g, 0.010 mmol) was added drop-wise and allowed to stir 15 minutes.  To this 
was added (S)-Mosher acid chloride (0.012 mmol, 0.002 mL) and the reaction was maintained at -78oC 
for 30 minutes.  The bath was then removed and at room temperature the reaction was loaded directly 
on a silica gel plug and eluted with 30% ethyl acetate: 70% hexanes to give the respective Mosher ester 
(0.005 g, 83%, 10:1).  The product ratios were simply determined by 19F NMR peak integration.  The 
two respective diastereomers have 19F NMR shifts of -74.942 and -74.970 relative to an internal 
standard of hexafluorobenzene. 
 
1H NMR (400 MHz, CDCl3) δ 7.55-7.00 (m, 10H), 5.49 (s, 1H), 5.15 – 5.06 (m, 1H), 5.03 – 4.94 (m, 
1H), 3.61 (s, 3H), 3.57 (s, 3H), 3.01 – 2.89 (m, 2H), 2.39 – 2.08 (m, 6H), 1.85 – 1.65 (m, 2H), 1.71 (s, 
3H), 1.70 (s, 3H), 1.51 (s, 6H), 1.48 – 1.40 (m, 2H). 
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C 13C ( ppm) HSQC-AD    
1H ( ppm) 
gHMBC-AD                                  
(1H-Correlations) 
1 198.1  --- 2.49, 2.42 
2 159.5  --- 3.05 
3 133.9  5.80 3.05 
4 133.9  5.69 5.06, 2.38, 2.19 
5 127.1  5.85 3.05, 2.42 
6 119.3  5.04, 5.06 2.38, 2.19 
7 118.8  5.12, 5.16 3.05 
8 105.3  --- 5.85, 3.46, 3.05, 2.49, 2.38. 1.75 
9 75.2  4.33 1.87, 1.75, 1.36 
10 52.6  --- 2.49, 2.42, 2.38, 2.19, 1.87, 1.75 
11 52.3  3.46 ---- 
12 44.3  2.49, 2.42 5.85, 2.38, 2.19, 1.87, 1.75 
13 43.2  1.87, 1.75 2.49, 2.42, 2.19, 1.36 
14 39.3  2.38, 2.19 5.69, 5.06, 2.49, 2.42, 1.75 
15  35.3  3.05 5.85, 5.16 
16  21.4  1.36 1.75 
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C 13C (ppm) HSQC-AD        
( ppm)
gHMBC-AD  (1H-Correlations)  
1 211.0 ----- 2.40, 2.26 
2 136.9 ----- 7.28, 2.96 
3 133.6 5.62 2.33, 2.15 
4 130.0 7.21 7.24, 7.21, 2.96 
5 128.2 7.28 7.28, 7.21 
6 126.6 7.24 7.21 
7 118.8 5.03, 4.92 2.33, 2.15 
8 108.1 ----- 3.67, 2.26, 2.15, 1.19 
9 79.4 ----- 2.96, 1.74, 1.19 
10 55.5 3.67 ----- 
11 51.1 ----- 2.40, 2.33, 2.26, 2.15, 1.74, 1.19 
12 47.4 2.40, 2.26 2.33, 2.15, 1.19 
13 44.5 1.74, 1.19 2.96, 2.40, 2.33, 2.26, 2.15, 1.74, 1.19 
14 42.6 2.33, 2.15 5.62, 5.03, 4.92, 2.40, 1.19 
15 42.3 2.96 7.21, 1.74 
 
Table A3.2 2D-NMR Data for 3.73 
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C 13C ( ppm) HSQC-AD    
1H ( ppm) 
gHMBC-AD                           
(1H-Correlations) 
1 211.7 ----- 2.37, 2.29 
2 136.7 ----- 7.22, 2.94 
3 134.6 ----- 2.27, 2.13, 1.67, 1.49  
4 129.9 7.22 2.94 
5 128.1 7.23 7.22 
6 126.5 7.22 7.22 
7 118.9 4.98 2.27, 2.13, 1.67, 1.49 
8 108.3 ----- 2.29, 2.13, 1.67, 1.17 
9 79.3 ----- 2.94, 1.67 
10 55.2 3.69 -----  
11 52.1 ----- 2.37, 2.27, 2.13, 1.67, 1.17 
12 46.8 2.37, 2.29 2.13, 1.17 
13 44.5 1.67, 1.17 2.94, 2.37, 2.27, 1.17 
14 42.3 2.94 1.67 
15 35.7 2.27, 2.13 2.37, 1.67 
16 26.0 1.67 4.98, 1.49 
17 17.8 1.49 4.98, 1.67 
 
Table A3.3 2D-NMR Data for 3.74 
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C 13C ( ppm) HSQC-AD    
1H ( ppm) 
gHMBC-AD                  
(1H-Correlations) 
1 146.6 ----- 4.92, 2.07 
2 137.4 ----- 7.25, 2.94, 2.93 
3 133.9 ----- 2.25, 2.13, 1.71, 1.51 
4 133.5 ----- 2.20, 2.07, 1.72, 1.56 
5 130.1 7.21 7.20, 2.94, 2.93  
6 128.5 7.17 7.25  
7 128.1 7.25 -----  
8 126.4 7.20 7.21  
9 125.7 7.16 -----  
10 120.6 5.15 2.20, 2.07, 1.72, 1.56  
11 119.9 5.04 2.25, 2.13, 1.71, 1.51  
12 111.2 4.92 2.07, 1.39  
13 108.6 ----- 4.92, 3.58, 2.07, 1.39 
14 78.9 ----- 2.94, 2.93 
15 54.2 3.58 -----  
16 51.8 1.71, 1.39 2.20  
17 47.7 ----- 2.25, 2.07 
18 47.1 ----- 2.20, 2.07 
19 45.1 1.78, 1.32 2.94, 2.07  
20 42.6 2.94, 2.93 7.21  
21 37.7 2.07 4.92  
22 35.2 2.20, 2.07 4.92  
23 34.6 2.25, 2.13 2.07, 1.78, 1.32  
24 26.2 1.72 1.56  
25 26.1 1.71 1.51  
26 18.1 1.56 1.72  
27 18.0 1.51 1.71  
28 0.49 0.14 -----  
 
Table A3.4 2D-NMR Data for 3.74 (Enol Ether) 
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C 13C ( ppm) HSQC-AD       
1H ( ppm) 
gHMBC-AD              
(1H-Correlations) 
1 216.2 ----- 2.60, 2.38, 2.16, 1.13 
2 136.9 ----- 7.26, 2.91 
3 134.5 ----- 1.68, 1.67, 1.50, 1.48 
4 134.5 ----- 1.68, 1.67, 1.50, 1.48 
5 130.0 7.25 2.91  
6 129.9 7.20 7.21, 2.91  
7 128.4 7.18 7.25  
8 128.2 7.26 7.25  
9 126.5 7.21 7.20, 7.18  
10 119.1 5.00 2.28, 2.13, 1.68, 1.50  
11 118.1 4.89 2.47, 2.09, 1.67, 1.48  
12 108.9 ----- 3.67, 2.38, 2.16  
13 79.4 ----- 2.91, 1.66  
14 55.4 3.67 -----  
15 53.1 ----- 1.13  
16 51.7 ----- 2.60, 2.28, 2.13  
17 50.1 2.38 1.13, 1.11  
18 45.6 (a)1.69, (b)1.11  2.91  
19 45.1 (a)1.66, (b)1.20  2.91, 2.60, 2.28  
20 42.8 (a)2.60, (b)2.16  2.13, 1.20  
21 42.5 2.91 1.66  
22 35.8 2.28, 2.13 2.60  
23 30.7 2.47, 2.09 1.11  
24 26.0 1.68 1.50, 1.48  
25 26.0 1.67 1.50, 1.48  
26 17.9 1.48 1.68, 1.67  
27 17.9 1.50 1.68, 1.67  
28 13.8 1.13 2.38  
 
Table A3.5 2D-NMR Data for 3.75 
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A3.3 DFT Calculations for Chapter 3 
 
Coordinates and calculated energies 
DFT calculations were performed with the program Gaussian03[1] by using the WebMO interface (WebMO, 
version 9.1.002p; www.webmo.net) for importing and constructing models. Transition states were verified by 
following the reaction coordinate forward and reverse (IRC).  
 
[1] Gaussian 03, Revision E.01,  M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria,  M. A. Robb, J. R. Cheeseman, J. A. 
Montgomery, Jr., T. Vreven,  K. N. Kudin, J. C. Burant, J. M. Millam, S. S. Iyengar, J. Tomasi, V. Barone, B. Mennucci, M. 
Cossi, G. Scalmani, N. Rega, G. A. Petersson, H. Nakatsuji, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, 
T. Nakajima, Y. Honda, O. Kitao, H. Nakai, M. Klene, X. Li, J. E. Knox, H. P. Hratchian, J. B. Cross,  V. Bakken, C. Adamo, J. 
Jaramillo, R. Gomperts, R. E. Stratmann, O. Yazyev, A. J. Austin, R. Cammi, C. Pomelli, J. W. Ochterski, P. Y. Ayala, K. 
Morokuma, G. A. Voth, P. Salvador, J. J. Dannenberg, V. G. Zakrzewski, S. Dapprich, A. D. Daniels, M. C. Strain, O. Farkas, D. 
K. Malick, A. D. Rabuck, K. Raghavachari,  J. B. Foresman, J. V. Ortiz, Q. Cui, A. G. Baboul, S. Clifford, J. Cioslowski, B. B. 
Stefanov, G. Liu, A. Liashenko, P. Piskorz, I. Komaromi, R. L. Martin, D. J. Fox, T. Keith, M. A. Al-Laham, C. Y. Peng, A. 
Nanayakkara, M. Challacombe, P. M. W. Gill, B. Johnson, W. Chen, M. W. Wong, C. Gonzalez, and J. A. Pople, Gaussian, Inc., 
Wallingford CT, 2004. 
Structure Method Basis Set 
Coorected Energy 
(hartree) 
Corrected 
Energy 
(kcal/mol) 
Relative Energy 
(kcal/mol) 
Frequency 
(cm-1) 
3.76 UB3LYP 6-31G(d) -3418.68 -2153769 0  
3.78 UB3LYP 6-31G(d) -3418.67 -2153765 3.6 -376.28 
3.79 UB3LYP 6-31G(d) -3418.72 -2153791 -22.1  
3.78b UB3LYP  6-31G(d) -3418.67 -2153762 6.3 -315.96 
3.79b UB3LYP 6-31G(d) -3418.71 -2153790 -21.6  
3.77 UB3LYP 6-31G(d) -3688.94 -2324032 0  
3.80 UB3LYP 6-31G(d) -3688.94 -2324029 2.7 -267.35 
3.81 UB3LYP 6-31G(d) -3688.98 -2324057 -25.0  
3.80b UB3LYP 6-31G(d) -3688.93 -2324028 4.1 -313.73 
3.81b UB3LYP 6-31G(d) -3688.97 -2324054 -21.7  
 
 
Table A3.6 Calculated Energies For Cyclization 
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3.76 
C    0.00000000  0.00000000  0.00000000 
C   -0.63759200 -1.34408100  0.37255100 
C   -0.79721100 -1.70603500  1.65568700 
C   -0.45514800 -0.81875000  2.78492700 
C    0.05763400  0.52623000  2.44586900 
C    0.25225900  0.93849600  1.18253300 
C    0.73175400  2.34538000  0.88207400 
C   -0.37496900  3.31587700  0.52283300 
C   -0.27863500  4.26258100 -0.41034900 
H   -1.08796000  4.96350200 -0.59503200 
H    0.61437100  4.38028500 -1.02138200 
H   -1.28384400  3.23361700  1.11788300 
H    1.47938000  2.33392600  0.08072000 
H    1.23858300  2.71711300  1.78369000 
H    0.25579300  1.17803700  3.29411800 
O   -0.60596500 -1.16980900  3.95121900 
H   -1.21204600 -2.67271100  1.92643200 
C   -1.04458800 -2.20850900 -0.80288200 
C   -1.80801100 -3.45505300 -0.45055100 
C   -1.40877500 -4.69601900 -0.73030000 
H   -2.01179500 -5.56245600 -0.47285900 
H   -0.46470200 -4.89395600 -1.23439100 
H   -2.76208300 -3.30361000  0.05533200 
H   -1.65650100 -1.57639700 -1.46178300 
H   -0.14752000 -2.46439300 -1.38217200 
O   -0.89248000  0.64131600 -0.89524100 
C   -0.42794300  1.10543300 -2.16326700 
H   -1.30499900  1.56580600 -2.62348200 
H    0.35956100  1.85911700 -2.07145700 
H   -0.07040200  0.28483600 -2.79278500 
O    1.23090800 -0.22898000 -0.70451800 
C    2.32651500 -0.89326200  0.00303700 
C    2.41211900 -2.33318900 -0.36716600 
H    2.85102300 -2.62450900 -1.31654000 
H    1.95964900 -3.09812700  0.25241400 
C    3.55839500 -0.09317600 -0.41686600 
Br   5.17238300 -0.79138200  0.47830500 
H    3.47626400  0.95292900 -0.12705500 
H    3.73945300 -0.17270700 -1.48918100 
H    2.17685300 -0.78050400  1.08072700 
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3.78 
C    0.00000000  0.00000000  0.00000000 
C    0.00000000  0.00000000  1.53295900 
C    1.14454200  0.00000000  2.23498100 
C    2.48043700 -0.05785700  1.60431800 
C    2.52038000 -0.11199000  0.14096300 
C    1.40369600  0.02929100 -0.64267700 
C    1.47904200 -0.31016500 -2.13248300 
C    1.72037600 -1.78107600 -2.38331000 
C    2.73690300 -2.25917100 -3.10135500 
H    2.86984700 -3.32592800 -3.26024500 
H    3.47556400 -1.60497000 -3.56126100 
H    1.00372100 -2.46150700 -1.92908100 
H    0.54920800  0.00748500 -2.61994300 
H    2.29158900  0.26419000 -2.59079200 
H    3.50216200 -0.24376500 -0.30712800 
O    3.50996800 -0.08407300  2.28078400 
H    1.14006200  0.02383400  3.32105400 
C   -1.37680600  0.03355800  2.16712000 
C   -1.40075100 -0.19589100  3.65332600 
C   -1.85718500  0.68197700  4.54690300 
H   -1.87247800  0.45995300  5.61054500 
H   -2.23811800  1.65644000  4.24748200 
H   -1.02520700 -1.16099800  3.99512400 
H   -1.97973700 -0.74096800  1.67098400 
H   -1.86295700  0.98758500  1.92202000 
O   -0.64950200 -1.18968100 -0.42762500 
C   -1.83753800 -1.09722700 -1.21904400 
H   -2.16468800 -2.13196000 -1.34566200 
H   -2.62158800 -0.52121100 -0.71952900 
H   -1.64867000 -0.65595200 -2.20376900 
O   -0.77087400  1.10771600 -0.45891700 
C   -0.10591700  2.35451200 -0.22577400 
C   -1.02681900  3.44661300 -0.75375700 
Br  -2.73507700  3.50042700  0.25257500 
H   -0.58059000  4.43284100 -0.63398800 
H   -1.29694600  3.27143500 -1.79514800 
C    1.21937300  2.34787600 -0.92052600 
H    1.22607200  2.34417400 -2.00699100 
H    2.07681500  2.80266900 -0.43490000 
H    0.03750000  2.50292300  0.85218700 
 
 
 
 
 
 
 
 
 
 
 
O
O
O
Br
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3.79 
C    0.00000000  0.00000000  0.00000000 
C   -0.56674800  1.02344200  0.98864600 
C   -1.24501000  0.61800200  2.07666400 
C   -1.51615900 -0.79690800  2.40271200 
C   -1.16580300 -1.76958600  1.40551600 
C   -0.66731300 -1.42254700  0.03721900 
C   -1.82952200 -1.62361000 -0.99217300 
C   -3.01621500 -0.71644700 -0.81080300 
C   -4.23670600 -1.12644100 -0.46394200 
H   -5.06466800 -0.43078100 -0.35772500 
H   -4.45782800 -2.17485400 -0.27236700 
H   -2.83520900  0.34104800 -0.99527900 
H   -1.40333400 -1.47177700 -1.98964500 
H   -2.15159500 -2.67041000 -0.92318200 
C    0.54941600 -2.30813900 -0.33230900 
C    1.70118000 -1.60489300  0.39040100 
O    1.36545800 -0.20722000  0.34597800 
C    3.05513400 -1.83701700 -0.24953500 
Br   4.51064000 -0.96710800  0.76341700 
H    3.30128600 -2.89943000 -0.26793600 
H    3.10100000 -1.42089600 -1.25580200 
H    1.74300700 -1.91550200  1.44284400 
H    0.70476200 -2.28969100 -1.41790100 
H    0.42741900 -3.34926900 -0.01913500 
H   -1.38324400 -2.81037100  1.63599200 
O   -2.02599100 -1.12970200  3.48740600 
H   -1.61473900  1.33803400  2.80320000 
C   -0.28477700  2.49405800  0.75962200 
C    1.13543900  2.91096000  1.08444500 
C    1.85888200  3.76885500  0.36429600 
H    2.85876500  4.06507900  0.66917200 
H    1.47779000  4.21481500 -0.55265200 
H    1.55348100  2.48776200  1.99691500 
H   -0.96725100  3.06138400  1.40762100 
H   -0.52435600  2.76812700 -0.27381800 
O   -0.13112400  0.49630400 -1.32927500 
C    1.02752000  0.97063400 -2.01241000 
H    0.64452600  1.49548100 -2.89174800 
H    1.62511000  1.65338900 -1.40430400 
H    1.66762800  0.14490600 -2.34974500 
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3.78b 
C    0.00000000  0.00000000  0.00000000 
C    0.00000000  0.00000000  1.54972600 
C    1.18916500  0.00000000  2.22201000 
C    2.49745700  0.11321500  1.56649900 
C    2.51127800  0.04891900  0.09555600 
C    1.39336900 -0.04531300 -0.64009500 
C    1.39314800 -0.11740700 -2.15386100 
C    2.73330200 -0.38904800 -2.77971400 
C    3.34935900  0.42288800 -3.63916100 
H    4.30813400  0.16665000 -4.08177900 
H    2.91464600  1.37479500 -3.93814400 
H    3.20525300 -1.33285200 -2.50444700 
H    0.68773400 -0.90977100 -2.43982200 
H    0.97061100  0.81606400 -2.54790100 
H    3.49134700  0.07890400 -0.37138200 
O    3.53424600  0.21447100  2.22420100 
H    1.22216600 -0.06993100  3.30432300 
C   -1.28133700 -0.49045600  2.22957900 
C   -1.28903400 -0.44684500  3.73371100 
C   -2.15812900  0.25360100  4.46375000 
H   -2.14137100  0.23041600  5.54980900 
H   -2.92998400  0.86899300  4.00458300 
H   -0.54901100 -1.06305600  4.24278700 
H   -1.40641600 -1.53185900  1.89941000 
H   -2.15840700  0.04477600  1.85337400 
O   -0.68583000 -1.17263800 -0.44686900 
C   -2.00626600 -1.04609700 -0.97535800 
H   -2.21193900 -2.00133200 -1.46446700 
H   -2.75445100 -0.89005700 -0.18625800 
H   -2.08205100 -0.23243700 -1.70047100 
O   -0.57799600  1.17442200 -0.56239100 
C   -1.31351000  2.05882800  0.29329000 
C   -1.53418600  3.33141000 -0.51953700 
Br  -2.62479600  2.97769500 -2.13983700 
H   -2.08654800  4.07531800  0.05277000 
H   -0.58952700  3.74070100 -0.87623300 
C   -0.54202300  2.32799200  1.53720000 
H    0.45042000  2.75731300  1.44234600 
H   -1.05066700  2.45235700  2.48700300 
H   -2.29804100  1.63280200  0.52800300 
 
 
 
 
 
 
 
 
 
 
 
 
 
O
O
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3.79b 
C    0.00000000  0.00000000  0.00000000 
C   -0.37037400  0.65414800  1.33499700 
C   -0.68872100 -0.11194000  2.39318900 
C   -0.71995600 -1.58860900  2.36230900 
C   -0.58206200 -2.21296100  1.07515300 
C   -0.53959400 -1.45394500 -0.21320400 
C   -1.94498400 -1.53925500 -0.90065800 
C   -3.07961400 -0.90282800 -0.14544700 
C   -4.10739200 -1.56943500  0.38128500 
H   -4.91107300 -1.06002700  0.90595600 
H   -4.18655800 -2.65255600  0.30872100 
H   -3.03783700  0.18122900 -0.05296900 
H   -1.84642400 -1.05939400 -1.88033200 
H   -2.16419100 -2.60118900 -1.06956500 
C    0.55200300 -2.01960800 -1.15979400 
C    1.84319100 -1.29035300 -0.73533700 
O    1.41261800 -0.12329300 -0.01280100 
C    2.73717900 -2.13781500  0.15704600 
Br   4.37687300 -1.16929700  0.67874100 
H    2.23821500 -2.40694800  1.08837400 
H    3.07650600 -3.03363800 -0.36455700 
H    2.42236900 -0.96105900 -1.60594200 
H    0.30578400 -1.77075700 -2.19674700 
H    0.63659600 -3.10893100 -1.09036300 
H   -0.64120300 -3.29901900  1.04647400 
O   -0.86427000 -2.26001500  3.39982700 
H   -0.91821900  0.33534100  3.35768100 
C   -0.30001400  2.16091400  1.46683800 
C    1.11030400  2.70300900  1.59314800 
C    1.54203200  3.83330000  1.03256600 
H    2.55291700  4.19755500  1.19359700 
H    0.90039600  4.44306600  0.39882300 
H    1.78424200  2.12051200  2.22008200 
H   -0.85636300  2.43509500  2.37397400 
H   -0.80941900  2.64073400  0.62374900 
O   -0.47841100  0.78206400 -1.09126500 
C    0.45249200  1.60118500 -1.79889400 
H   -0.15876700  2.22379100 -2.45754800 
H    1.04467300  2.23500800 -1.13508800 
H    1.13497500  1.00164600 -2.41508800 
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3.77 
C    0.00000000  0.00000000  0.00000000 
C   -0.38694400 -1.37739800  0.54005900 
C   -0.98591800 -1.52280600  1.73316100 
C   -1.24509700 -0.38408400  2.63400600 
C   -0.92138200  0.96294900  2.11951700 
C   -0.39061400  1.17520100  0.90363900 
C   -0.20178000  2.55106300  0.29458600 
C   -0.29140800  3.71150300  1.25009000 
C    0.72112700  4.54252300  1.50438100 
H    0.61460500  5.37917200  2.18982900 
H    1.69219300  4.41514200  1.02959100 
H   -1.25272500  3.87532200  1.73720900 
H    0.75637600  2.58560200 -0.23219800 
H   -0.97289400  2.65288800 -0.48486300 
H   -1.18468100  1.78360600  2.78010100 
O   -1.72622900 -0.54388400  3.75309300 
H   -1.29232500 -2.49975600  2.09962300 
C   -0.14389800 -2.55532200 -0.38871500 
C   -1.41470800 -3.02852000 -1.05596200 
C   -1.89476700 -4.26896700 -0.96874900 
H   -2.81414900 -4.56036600 -1.46936400 
H   -1.38737100 -5.04322300 -0.39616700 
H   -1.94876100 -2.27243900 -1.62827300 
H    0.29442100 -3.38377500  0.18059100 
H    0.58856600 -2.26202800 -1.14961000 
O   -0.73655200  0.14180700 -1.21827700 
C   -0.05367700  0.48040800 -2.42968800 
H   -0.85365700  0.68286200 -3.14635700 
H    0.57980900  1.36480200 -2.32358700 
H    0.56107600 -0.34782900 -2.79815800 
O    1.37750000  0.04667100 -0.36947900 
C    2.50998600 -0.13224500  0.54639600 
C    2.19536500 -0.89894500  1.78824000 
H    1.73163000 -0.41544300  2.63970700 
H    2.48094300 -1.93901100  1.88641100 
C    3.01312500  1.24867500  0.99973400 
Br   3.46122400  2.46325100 -0.50719200 
H    2.26071700  1.77861200  1.58281400 
H    3.93335300  1.15504900  1.57430200 
C    3.53899600 -0.88174100 -0.34735600 
C    4.87928900 -1.19595800  0.28735100 
C    5.12842400 -2.46276300  0.83501600 
C    6.36021200 -2.76893000  1.41502900 
C    7.37250600 -1.80930500  1.45335300 
C    7.14399700 -0.54714900  0.90250400 
C    5.91119600 -0.24447900  0.32313700 
H    5.74730000  0.73835700 -0.11126800 
H    7.92960500  0.20385600  0.91584300 
H    8.33422200 -2.04564600  1.90059000 
H    6.53018500 -3.75907800  1.82968800 
H    4.35371700 -3.22545600  0.79227300 
H    3.67446600 -0.27550800 -1.24795500 
H    3.05320000 -1.81202900 -0.65896900 
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3.80 
C    0.00000000  0.00000000  0.00000000 
C    0.00000000  0.00000000  1.53637600 
C    1.16960300  0.00000000  2.23354300 
C    2.46376300 -0.27444200  1.60025400 
C    2.47082300 -0.40953500  0.12903800 
C    1.37378800 -0.25782400 -0.63260900 
C    1.40134200 -0.26110800 -2.15019200 
C    2.66976000 -0.77537900 -2.77949700 
C    2.74071700 -1.90157900 -3.49109000 
H    3.67287200 -2.23626800 -3.93863000 
H    1.86481600 -2.52774600 -3.64958400 
H    3.56656400 -0.17080700 -2.64314800 
H    0.54684200 -0.83447000 -2.52198900 
H    1.22901400  0.77799700 -2.47229000 
H    3.44535600 -0.60066600 -0.31033700 
O    3.50006100 -0.37001100  2.25860200 
H    1.18169500  0.15371300  3.30958700 
C   -1.30177700  0.42704800  2.20958300 
C   -1.27412800  1.87159900  2.65136100 
C   -1.47991500  2.27784900  3.90432800 
H   -1.45444700  3.33035800  4.17336800 
H   -1.68461700  1.57588700  4.71076100 
H   -1.06363800  2.59538800  1.86687000 
H   -1.48739800 -0.20976200  3.08188900 
H   -2.13200700  0.27128200  1.51110400 
O   -0.40694700  1.32035700 -0.36460800 
C   -1.41641000  1.50015100 -1.36125500 
H   -1.48942300  2.58354900 -1.48483600 
H   -1.14666800  1.04409700 -2.31906800 
H   -2.38456200  1.10286100 -1.04252600 
O   -0.97529700 -0.89406500 -0.52230100 
C   -1.05995700 -2.25146400  0.00278200 
C   -0.40254200 -2.37197500  1.34716600 
H    0.62639700 -2.70898000  1.41048500 
H   -1.01157000 -2.52876300  2.22990200 
C   -0.32084800 -3.20656000 -0.95002000 
Br  -1.00007600 -3.14539200 -2.81357800 
H    0.73665600 -2.95516300 -1.02234700 
H   -0.43911400 -4.24196100 -0.63392000 
C   -2.58911400 -2.52525100  0.06295000 
C   -3.00714900 -3.89326700  0.56497200 
C   -3.38465800 -4.07440500  1.90365700 
C   -3.77505800 -5.32634500  2.38099500 
C   -3.79958500 -6.42526400  1.52151500 
C   -3.43855700 -6.25889000  0.18334000 
C   -3.04916000 -5.00555700 -0.29075000 
H   -2.77999200 -4.88601500 -1.33706000 
H   -3.46642900 -7.10534200 -0.49789200 
H   -4.10607500 -7.40088100  1.88891200 
H   -4.06646300 -5.44013200  3.42184400 
H   -3.39005500 -3.22035600  2.57786700 
H   -2.98070500 -2.34972300 -0.94372400 
H   -3.01643700 -1.75244600  0.70962800 
O
O
O
Br
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3.81 
C    0.00000000  0.00000000  0.00000000 
C   -0.37730300  1.28338700  0.82553000 
C    0.56513800  1.56925400  1.94697200 
C    1.31494500  0.53528700  2.60590400 
C    1.26966400 -0.81680900  2.00529600 
C    0.69887900 -1.09135400  0.81884100 
C    0.73557100 -2.45763800  0.15767000 
C    1.24170700 -3.58708500  1.01470000 
C    0.47137100 -4.58771700  1.44444400 
H    0.86800500 -5.39386600  2.05597900 
H   -0.58833200 -4.63114900  1.19861300 
H    2.29925500 -3.57077200  1.27914600 
H   -0.26994800 -2.69465000 -0.20660800 
H    1.36518500 -2.36590300 -0.74152800 
H    1.77908800 -1.58846000  2.57549600 
O    1.98122500  0.76232200  3.63216500 
H    0.64048500  2.57605700  2.34675300 
C   -0.53462700  2.53253300 -0.09610700 
C    0.74906200  3.24691100 -0.43490400 
C    0.96838800  4.54017600 -0.19142000 
H    1.90422000  5.02126600 -0.46286000 
H    0.22013400  5.17190900  0.28481200 
H    1.51921600  2.64544900 -0.91089700 
H   -1.20599400  3.23987700  0.40725100 
H   -1.04147600  2.22037100 -1.01854700 
O    0.85254900  0.30924500 -1.08891500 
C    0.44799900 -0.03676100 -2.41392500 
H    1.28818000  0.25549000 -3.04834000 
H    0.26665900 -1.11110500 -2.52379400 
H   -0.45033200  0.50473300 -2.72751500 
O   -1.24371000 -0.47656600 -0.50037200 
C   -2.32354300 -0.21636200  0.41391700 
C   -1.77351600  0.85538900  1.39902900 
H   -1.65660700  0.43374100  2.40228200 
H   -2.44881800  1.70884000  1.49214200 
C   -2.64029000 -1.48415100  1.21825700 
Br  -3.14580300 -3.02850900  0.08451400 
H   -1.76953800 -1.82029800  1.77919200 
H   -3.48114900 -1.32298000  1.89251700 
C   -3.50933100  0.26304200 -0.46129800 
C   -4.78131600  0.63214000  0.27631800 
C   -5.06977000  1.97228900  0.57276500 
C   -6.23743400  2.32626200  1.25097600 
C   -7.14412900  1.34078700  1.64262900 
C   -6.87678700  0.00325300  1.34456900 
C   -5.70916500 -0.34712500  0.66593700 
H   -5.51533400 -1.39021900  0.42928600 
H   -7.58226200 -0.77116700  1.63418300 
H   -8.05549400  1.61304200  2.16798400 
H   -6.44065400  3.37206500  1.46592600 
H   -4.37974100  2.75047300  0.25310700 
H   -3.70742500 -0.53474700 -1.18481800 
H   -3.15173500  1.12675800 -1.03110000 
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3.80b 
C    0.00000000  0.00000000  0.00000000 
C    0.00000000  0.00000000  1.52935200 
C    1.13993600  0.00000000  2.23810000 
C    2.47437000  0.02338400  1.60957700 
C    2.51540700  0.07271700  0.14354800 
C    1.40207300 -0.03449200 -0.63913600 
C    1.43738800  0.27506300 -2.13451900 
C    2.74464200  0.02550900 -2.83653000 
C    2.89043600 -0.76673100 -3.89967200 
H    3.85187400 -0.89499500 -4.38910600 
H    2.05106200 -1.30872500 -4.33205500 
H    3.61348400  0.56258600 -2.45828800 
H    0.63687400 -0.26823500 -2.64639000 
H    1.18271800  1.34230200 -2.22473900 
H    3.50841500  0.14989800 -0.28741900 
O    3.50643900  0.02871300  2.28206100 
H    1.12809700  0.01968700  3.32555000 
C   -1.36600700  0.07245400  2.19303400 
C   -1.65851600  1.44879000  2.74394700 
C   -1.96435300  1.70375500  4.01604200 
H   -2.17309900  2.71304000  4.36052700 
H   -2.02294000  0.91390900  4.76260000 
H   -1.60109900  2.26094700  2.02142000 
H   -1.41758700 -0.66083700  3.00687000 
H   -2.13220300 -0.20590300  1.46085700 
O   -0.63419100  1.23160400 -0.34774500 
C   -1.63877200  1.25799300 -1.36823900 
H   -2.06731700  2.26108800 -1.30447700 
H   -1.21699500  1.11591000 -2.36998600 
H   -2.41483700  0.50797300 -1.20358600 
O   -0.82387800 -1.04130200 -0.50147300 
C   -0.30340500 -2.39988100 -0.57333900 
C    1.17930300 -2.40508400 -0.81429900 
H    1.56961500 -2.41384000 -1.82663600 
H    1.83850800 -2.80362300 -0.05224500 
C   -0.98310900 -2.99246500 -1.81389900 
Br  -2.96434700 -2.91014200 -1.73316800 
H   -0.71732400 -2.42566000 -2.70516800 
H   -0.73472900 -4.04434400 -1.94097700 
C   -0.69361200 -3.14165000  0.73775900 
C   -0.32913300 -4.61205100  0.80235800 
C    0.84395800 -5.03023700  1.44738300 
C    1.18546700 -6.38176000  1.51634500 
C    0.35281100 -7.34368100  0.94319000 
C   -0.82452000 -6.94392500  0.30797300 
C   -1.16336000 -5.59203300  0.24064400 
H   -2.08713500 -5.29021700 -0.24715200 
H   -1.48656800 -7.68624200 -0.13032100 
H    0.61425400 -8.39697400  0.99891900 
H    2.09791900 -6.68198400  2.02476600 
H    1.48939200 -4.29096900  1.91690300 
H   -1.77286700 -3.01275300  0.86348800 
H   -0.20474300 -2.61281900  1.56080800 
O
O
O
Br
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3.81b 
C    0.00000000  0.00000000  0.00000000 
C    0.49696500  0.22310600 -1.42787800 
C    0.72716200  1.44353100 -1.93852500 
C    0.50808400  2.69464300 -1.19137300 
C   -0.01377900  2.57797500  0.14122600 
C   -0.43149100  1.30194000  0.80016400 
C    0.13775000  1.24835700  2.26061700 
C   -0.26227300  2.39918600  3.14296800 
C   -1.02799900  2.28759800  4.23069100 
H   -1.27203700  3.14646600  4.84997500 
H   -1.42747500  1.32804300  4.55461000 
H    0.12911200  3.38159700  2.88013200 
H   -0.20034900  0.31671800  2.72609500 
H    1.22938500  1.19122600  2.19059400 
H   -0.17353700  3.51308500  0.67005500 
O    0.75674700  3.80765200 -1.69176400 
H    1.11292300  1.55996500 -2.94894800 
C    0.78170800 -1.03794700 -2.23103600 
C    2.26054600 -1.32472500 -2.34610300 
C    2.91763800 -1.45401800 -3.49873900 
H    3.98344400 -1.66423600 -3.52697900 
H    2.41565100 -1.35902400 -4.45981800 
H    2.79251200 -1.41702300 -1.40074200 
H    0.35576900 -0.92924800 -3.23573700 
H    0.26911000 -1.88412400 -1.76006300 
O    1.06753800 -0.70193900  0.62524700 
C    0.78761600 -1.89903100  1.35276800 
H    1.76583100 -2.26409300  1.67427300 
H    0.16655000 -1.71938900  2.23853300 
H    0.29596400 -2.65238000  0.73178200 
O   -1.14539900 -0.83746500 -0.02343800 
C   -2.37553800 -0.10491100  0.10504700 
C   -1.99826900  1.21199800  0.83012300 
H   -2.34237400  1.21350100  1.86934300 
H   -2.47365700  2.06859200  0.34783400 
C   -3.28617500 -0.92924000  1.01275900 
Br  -3.69581900 -2.72776700  0.29150300 
H   -2.80522800 -1.11435700  1.97236300 
H   -4.24875600 -0.44028900  1.15760200 
C   -2.96009400  0.11884000 -1.31776900 
C   -4.26694100  0.88310000 -1.39183700 
C   -4.27585700  2.25575300 -1.68097200 
C   -5.47343900  2.96990600 -1.75015600 
C   -6.68890300  2.31918000 -1.53606900 
C   -6.69701000  0.95047300 -1.25955100 
C   -5.49871000  0.23922100 -1.19030800 
H   -5.51526900 -0.82830600 -0.98461400 
H   -7.63935700  0.43150200 -1.10423100 
H   -7.62299800  2.87150000 -1.59335600 
H   -5.45497000  4.03200400 -1.97984200 
H   -3.33526300  2.76844200 -1.87133800 
H   -3.07246900 -0.87134300 -1.77085500 
H   -2.19492100  0.64820700 -1.89453300 
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APPENDIX 4 
 
A4.1 A Graphical Journey of Organic Architectures That Have Improved Our Lives 
 
Just like there is a great need for advancing the frontiers of the field of chemistry, 
chemists are often faced with the equally important task of finding new and more 
effective ways to both communicate the results of their research activities and justify 
why investing in chemistry is important for society.  Although classically inspired by 
the architectures of natural products in many of our chemical development endeavors 
we have become equally inspired and intrigued by the diverse pharmaceutical 
structural space.1  We decided to graphically capture this wealth of information on 
single page (posters),2 which in turn would allow anyone to easily visually mine it for 
a wealth of interesting information, statistics, structural patterns, etc.  The fruits of our 
labor can now be found at the following web address, where high resolution PDF files 
of each of the posters can now be downloaded and printed in any size: 
http://www.chem.cornell.edu/jn96/outreach.html.  In addition to the electronic form, a 
graphical representation of one of the drug posters can be found in A4.2. 
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Figure A4.1. Graphical Representation of the 2008 Top Selling Drugs 
 
 
We and others (in academia and industry) have learned over the last few years that 
hanging large printed versions of the posters in public spaces results in a magnetic 
effect, wherein people tend to be attracted by the visual language of organic 
chemistry.3 The posters can also serve as useful tools for educating the public, teaching 
both undergraduate and graduate students, and serving as a spring board of ideas for 
researchers interested in the development of new synthetic methods and strategies.  
The following questions are examples of the wealth of information that can be 
gathered about the organic architectures used for pharmaceuticals simply by looking at 
the structures shown on these posters, and without reading a book!4  
 
Sample Questions: 
 
1.  How many of the top 20 brand name drugs contain: 
      a) an aromatic ring?   b) a heterocycle? c) a fused ring system?    
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2.  Which of the top 20 brand name drugs: 
a) promote cardiovascular health? b) affect neurotransmitters?                                    
c) suppress immune system activity? d) decrease stomach acid production? 
 
3.  In addition to carbon, hydrogen, oxygen, and nitrogen what are the three most 
commonly used elements found in brand name drugs? 
 
4.  Identify at least one brand name drug that contains: 
      a) an adamantane   b) an alkyne   c) an azide 
      d) a nitrile    e) a cyclopropane  f) no rings 
 
5.  Locate a brand name drug that is clearly derived from: 
a) a steroid  b) an alkaloid   c) a nucleoside 
 
6.  Randomly choose 3 generic drugs and assign the hybridization of each carbon 
atom.  Is there a trend in the relative number of sp, sp2, and sp3 hybridized carbons 
found in generic drugs? 
 
7.  Five and six membered rings are most frequently used for pharmaceutical 
structures.  In general, are small rings (3-4) or large rings (7+) more common in 
the generic drugs?  
 
8.  Randomly choose 3 generic drugs and identify all the asymmetric carbon atoms. 
 
9.  Are there more macromolecules (biologics or polymers) present in the brand name 
or generic drug poster? 
 
10.  Comparing the brand name and generic drug posters, which has a greater number 
of drugs with more than one active ingredient (combination therapies)?  
 
Visually exploring the drug posters either on your own or by answering the above 
questions leads to a greater understanding of the organic architectures that affect our 
everyday life.  Displaying this information in the form of an interactive website that 
enables simple mining of the data would serve as a nice supplement to this manuscript 
and will be explored in the future. 
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A4.2 Top Selling Brand Name Drugs in 2008 
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